[
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0003000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            227,
            126
          ],
          [
            1059,
            128
          ],
          [
            1059,
            169
          ],
          [
            227,
            167
          ]
        ],
        "transcription": "NIH Wednesday Afternoon Lecture"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            313,
            241
          ],
          [
            961,
            242
          ],
          [
            961,
            274
          ],
          [
            313,
            273
          ]
        ],
        "transcription": "\"Genetics and immunology of alopecia areata\""
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            520,
            364
          ],
          [
            765,
            364
          ],
          [
            765,
            390
          ],
          [
            520,
            390
          ]
        ],
        "transcription": "Masur Auditorium"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            185,
            455
          ],
          [
            1100,
            455
          ],
          [
            1100,
            482
          ],
          [
            185,
            482
          ]
        ],
        "transcription": "Angela M. Christiano, Ph.D., Columbia University Medical Center"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            541,
            544
          ],
          [
            743,
            544
          ],
          [
            743,
            570
          ],
          [
            541,
            570
          ]
        ],
        "transcription": "March 1,2017"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0007000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            277,
            60
          ],
          [
            1037,
            61
          ],
          [
            1037,
            97
          ],
          [
            277,
            95
          ]
        ],
        "transcription": "Wednesday Afternoon Lecture Series"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            257,
            193
          ],
          [
            1057,
            195
          ],
          [
            1057,
            221
          ],
          [
            257,
            220
          ]
        ],
        "transcription": "The Planning Committee members of this activity have reported no"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            264,
            228
          ],
          [
            761,
            228
          ],
          [
            761,
            250
          ],
          [
            264,
            250
          ]
        ],
        "transcription": "relevant financial relationships to disclose"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            247,
            294
          ],
          [
            1071,
            295
          ],
          [
            1071,
            322
          ],
          [
            247,
            320
          ]
        ],
        "transcription": "The Speaker for this activity has reported reported relevant financial"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            260,
            326
          ],
          [
            1000,
            327
          ],
          [
            1000,
            353
          ],
          [
            260,
            352
          ]
        ],
        "transcription": "relationships to disclose with: Pfizer and Aclaris Therapeutics"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            257,
            396
          ],
          [
            940,
            397
          ],
          [
            940,
            421
          ],
          [
            257,
            420
          ]
        ],
        "transcription": "The Speaker for this activity will be discussing unlabeled,"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            263,
            427
          ],
          [
            949,
            430
          ],
          [
            949,
            453
          ],
          [
            263,
            450
          ]
        ],
        "transcription": "investigational, or alternative uses of a product, device, or"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            261,
            459
          ],
          [
            400,
            459
          ],
          [
            400,
            486
          ],
          [
            261,
            486
          ]
        ],
        "transcription": "techniques."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            517,
            651
          ],
          [
            613,
            651
          ],
          [
            613,
            664
          ],
          [
            517,
            664
          ]
        ],
        "transcription": "one program"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            517,
            667
          ],
          [
            616,
            667
          ],
          [
            616,
            682
          ],
          [
            517,
            682
          ]
        ],
        "transcription": "many people"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            516,
            679
          ],
          [
            665,
            679
          ],
          [
            665,
            698
          ],
          [
            516,
            698
          ]
        ],
        "transcription": "infinite possibilities"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            259,
            659
          ],
          [
            482,
            660
          ],
          [
            482,
            679
          ],
          [
            259,
            677
          ]
        ],
        "transcription": "Intramural Research Program"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            258,
            680
          ],
          [
            400,
            680
          ],
          [
            400,
            692
          ],
          [
            258,
            692
          ]
        ],
        "transcription": "Our Research Changes Lives"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0180450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            252,
            124
          ],
          [
            1016,
            127
          ],
          [
            1016,
            176
          ],
          [
            252,
            173
          ]
        ],
        "transcription": "Genetics, Immunology and Targeted"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            324,
            190
          ],
          [
            945,
            195
          ],
          [
            945,
            240
          ],
          [
            324,
            235
          ]
        ],
        "transcription": "Therapies for Alopecia Areata"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            317,
            246
          ],
          [
            947,
            248
          ],
          [
            947,
            271
          ],
          [
            317,
            270
          ]
        ],
        "transcription": "NIH Director's Wednesday Afternoon Lecture Series (WALS)"
      },
      {
        "index_in_para": 3,
        "index_para": 0,
        "points": [
          [
            560,
            281
          ],
          [
            704,
            281
          ],
          [
            704,
            303
          ],
          [
            560,
            303
          ]
        ],
        "transcription": "March 1,2017"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            432,
            348
          ],
          [
            831,
            348
          ],
          [
            831,
            380
          ],
          [
            432,
            380
          ]
        ],
        "transcription": "Angela M.Christiano, Ph.D"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            437,
            434
          ],
          [
            835,
            434
          ],
          [
            835,
            457
          ],
          [
            437,
            457
          ]
        ],
        "transcription": "Julian Mackay-Wiggan & Raphael Clynes"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            546,
            460
          ],
          [
            723,
            463
          ],
          [
            722,
            486
          ],
          [
            545,
            483
          ]
        ],
        "transcription": "Columbia University"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            484,
            488
          ],
          [
            787,
            490
          ],
          [
            787,
            516
          ],
          [
            484,
            515
          ]
        ],
        "transcription": "College of Physicians & Surgeons"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            492,
            577
          ],
          [
            775,
            577
          ],
          [
            775,
            600
          ],
          [
            492,
            600
          ]
        ],
        "transcription": "Madeleine Duvic, MD Anderson"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            479,
            606
          ],
          [
            793,
            606
          ],
          [
            793,
            629
          ],
          [
            479,
            629
          ]
        ],
        "transcription": "Maria Hordinsky, Univ of Minnesota"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            557,
            634
          ],
          [
            713,
            634
          ],
          [
            713,
            656
          ],
          [
            557,
            656
          ]
        ],
        "transcription": "Vera Price, UCSF"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            475,
            662
          ],
          [
            793,
            663
          ],
          [
            793,
            687
          ],
          [
            475,
            686
          ]
        ],
        "transcription": "David Norris, University of Colorado"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0455000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            317,
            46
          ],
          [
            871,
            49
          ],
          [
            871,
            79
          ],
          [
            317,
            77
          ]
        ],
        "transcription": "Challenge of Alopecia Areata Pathogenesis:"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            316,
            85
          ],
          [
            925,
            86
          ],
          [
            925,
            116
          ],
          [
            316,
            115
          ]
        ],
        "transcription": "Collapse of Immune privilege of the Hair Follicle"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            535,
            165
          ],
          [
            667,
            165
          ],
          [
            667,
            183
          ],
          [
            535,
            183
          ]
        ],
        "transcription": "Loss of immune privilege"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            569,
            179
          ],
          [
            640,
            179
          ],
          [
            640,
            197
          ],
          [
            569,
            197
          ]
        ],
        "transcription": "medated by:"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            585,
            199
          ],
          [
            614,
            199
          ],
          [
            614,
            214
          ],
          [
            585,
            214
          ]
        ],
        "transcription": "IFN-Y"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            529,
            207
          ],
          [
            667,
            207
          ],
          [
            667,
            224
          ],
          [
            529,
            224
          ]
        ],
        "transcription": "Neuropeptides (substance P)"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            563,
            224
          ],
          [
            643,
            224
          ],
          [
            643,
            237
          ],
          [
            563,
            237
          ]
        ],
        "transcription": "Immunogenetics"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            544,
            234
          ],
          [
            660,
            236
          ],
          [
            660,
            250
          ],
          [
            544,
            249
          ]
        ],
        "transcription": "Insufficient Treg activities"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            323,
            274
          ],
          [
            408,
            275
          ],
          [
            408,
            290
          ],
          [
            323,
            288
          ]
        ],
        "transcription": "Unknown anagen-"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            313,
            290
          ],
          [
            413,
            290
          ],
          [
            413,
            303
          ],
          [
            313,
            303
          ]
        ],
        "transcription": "associated autoantige"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            795,
            274
          ],
          [
            919,
            275
          ],
          [
            919,
            290
          ],
          [
            795,
            288
          ]
        ],
        "transcription": "Presentation of antigen by"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            784,
            287
          ],
          [
            931,
            287
          ],
          [
            931,
            304
          ],
          [
            784,
            304
          ]
        ],
        "transcription": "ectopic MHC class I expression"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            577,
            303
          ],
          [
            626,
            306
          ],
          [
            625,
            321
          ],
          [
            576,
            317
          ]
        ],
        "transcription": "Increased"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            573,
            318
          ],
          [
            629,
            318
          ],
          [
            629,
            331
          ],
          [
            573,
            331
          ]
        ],
        "transcription": "MHC classI"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            909,
            319
          ],
          [
            931,
            319
          ],
          [
            931,
            336
          ],
          [
            909,
            336
          ]
        ],
        "transcription": "AA"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            860,
            336
          ],
          [
            980,
            336
          ],
          [
            980,
            353
          ],
          [
            860,
            353
          ]
        ],
        "transcription": "Secondary autoimmune"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            900,
            352
          ],
          [
            939,
            352
          ],
          [
            939,
            365
          ],
          [
            900,
            365
          ]
        ],
        "transcription": "events"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            867,
            364
          ],
          [
            972,
            364
          ],
          [
            972,
            381
          ],
          [
            867,
            381
          ]
        ],
        "transcription": "Activatod CD4T colls"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            885,
            382
          ],
          [
            957,
            382
          ],
          [
            957,
            397
          ],
          [
            885,
            397
          ]
        ],
        "transcription": "Autoantbocies"
      },
      {
        "index_in_para": 5,
        "index_para": 5,
        "points": [
          [
            871,
            397
          ],
          [
            968,
            400
          ],
          [
            968,
            413
          ],
          [
            871,
            410
          ]
        ],
        "transcription": "Proinfiammatory and"
      },
      {
        "index_in_para": 6,
        "index_para": 5,
        "points": [
          [
            875,
            410
          ],
          [
            964,
            412
          ],
          [
            964,
            426
          ],
          [
            875,
            425
          ]
        ],
        "transcription": "catagen-promoting"
      },
      {
        "index_in_para": 7,
        "index_para": 5,
        "points": [
          [
            886,
            422
          ],
          [
            955,
            424
          ],
          [
            954,
            438
          ],
          [
            885,
            437
          ]
        ],
        "transcription": "Thi cytckines"
      },
      {
        "index_in_para": 8,
        "index_para": 5,
        "points": [
          [
            899,
            439
          ],
          [
            941,
            439
          ],
          [
            941,
            454
          ],
          [
            899,
            454
          ]
        ],
        "transcription": "HLA-DR"
      },
      {
        "index_in_para": 9,
        "index_para": 5,
        "points": [
          [
            875,
            452
          ],
          [
            966,
            457
          ],
          [
            965,
            471
          ],
          [
            874,
            467
          ]
        ],
        "transcription": "ICA-1exprecsicn"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            299,
            343
          ],
          [
            393,
            344
          ],
          [
            393,
            359
          ],
          [
            299,
            357
          ]
        ],
        "transcription": "Immune privelege"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            319,
            357
          ],
          [
            376,
            357
          ],
          [
            376,
            371
          ],
          [
            319,
            371
          ]
        ],
        "transcription": "guardians"
      },
      {
        "index_in_para": 2,
        "index_para": 6,
        "points": [
          [
            328,
            372
          ],
          [
            365,
            372
          ],
          [
            365,
            386
          ],
          [
            328,
            386
          ]
        ],
        "transcription": "a-MSH"
      },
      {
        "index_in_para": 3,
        "index_para": 6,
        "points": [
          [
            327,
            385
          ],
          [
            365,
            385
          ],
          [
            365,
            400
          ],
          [
            327,
            400
          ]
        ],
        "transcription": "TGF-1"
      },
      {
        "index_in_para": 4,
        "index_para": 6,
        "points": [
          [
            331,
            397
          ],
          [
            361,
            397
          ],
          [
            361,
            412
          ],
          [
            331,
            412
          ]
        ],
        "transcription": "IGF-1"
      },
      {
        "index_in_para": 5,
        "index_para": 6,
        "points": [
          [
            298,
            407
          ],
          [
            394,
            410
          ],
          [
            393,
            429
          ],
          [
            297,
            426
          ]
        ],
        "transcription": "NK cell suppression"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            538,
            386
          ],
          [
            596,
            389
          ],
          [
            595,
            404
          ],
          [
            537,
            401
          ]
        ],
        "transcription": "Autoreactive"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            541,
            401
          ],
          [
            595,
            398
          ],
          [
            596,
            413
          ],
          [
            542,
            416
          ]
        ],
        "transcription": "CD8Tcel"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            793,
            431
          ],
          [
            820,
            431
          ],
          [
            820,
            447
          ],
          [
            793,
            447
          ]
        ],
        "transcription": "MHC"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            789,
            446
          ],
          [
            821,
            446
          ],
          [
            821,
            461
          ],
          [
            789,
            461
          ]
        ],
        "transcription": "classI"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            579,
            461
          ],
          [
            677,
            462
          ],
          [
            677,
            477
          ],
          [
            579,
            475
          ]
        ],
        "transcription": "Costimulatory\"signals"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            580,
            474
          ],
          [
            676,
            475
          ],
          [
            676,
            490
          ],
          [
            580,
            488
          ]
        ],
        "transcription": "and CD4T coll heip"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            571,
            506
          ],
          [
            595,
            506
          ],
          [
            595,
            521
          ],
          [
            571,
            521
          ]
        ],
        "transcription": "CD4"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            572,
            519
          ],
          [
            592,
            519
          ],
          [
            592,
            529
          ],
          [
            572,
            529
          ]
        ],
        "transcription": "Tce"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            274,
            574
          ],
          [
            328,
            577
          ],
          [
            327,
            596
          ],
          [
            273,
            593
          ]
        ],
        "transcription": "Figure 3"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            273,
            594
          ],
          [
            996,
            594
          ],
          [
            996,
            611
          ],
          [
            273,
            611
          ]
        ],
        "transcription": "Proposed pathogenesis of AA. Cytokines and cellular factors responsible for maintaining immune privilege are listed in the left box. Those fac-"
      },
      {
        "index_in_para": 2,
        "index_para": 11,
        "points": [
          [
            273,
            610
          ],
          [
            999,
            610
          ],
          [
            999,
            627
          ],
          [
            273,
            627
          ]
        ],
        "transcription": "tors believed to mediate loss of immune privilege and initiation of disease are listed in the middle box. Loss of immune privilege is associated"
      },
      {
        "index_in_para": 3,
        "index_para": 11,
        "points": [
          [
            272,
            626
          ],
          [
            999,
            627
          ],
          [
            999,
            646
          ],
          [
            272,
            645
          ]
        ],
        "transcription": "with expression of MHC class I molecules, which are capable of presenting hair follicle autoantigens to T lymphocytes.Secondary autoimmune"
      },
      {
        "index_in_para": 4,
        "index_para": 11,
        "points": [
          [
            272,
            643
          ],
          [
            756,
            643
          ],
          [
            756,
            662
          ],
          [
            272,
            662
          ]
        ],
        "transcription": "amplification circuits that may help establish or amplify the pathology are listed in the right box"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            293,
            686
          ],
          [
            556,
            686
          ],
          [
            556,
            704
          ],
          [
            293,
            704
          ]
        ],
        "transcription": "From Gilhar, Paus &KalishJCI,2007"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0511450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            271,
            33
          ],
          [
            612,
            33
          ],
          [
            612,
            74
          ],
          [
            271,
            74
          ]
        ],
        "transcription": "Functional Genomics"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            351,
            94
          ],
          [
            424,
            97
          ],
          [
            423,
            115
          ],
          [
            350,
            112
          ]
        ],
        "transcription": "Genomics"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            647,
            139
          ],
          [
            716,
            142
          ],
          [
            715,
            162
          ],
          [
            646,
            159
          ]
        ],
        "transcription": "Cancer"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            859,
            163
          ],
          [
            1001,
            164
          ],
          [
            1001,
            187
          ],
          [
            859,
            185
          ]
        ],
        "transcription": "Drugs & Biomarkers"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            645,
            210
          ],
          [
            716,
            213
          ],
          [
            715,
            232
          ],
          [
            644,
            229
          ]
        ],
        "transcription": "Prevention"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            648,
            230
          ],
          [
            715,
            230
          ],
          [
            715,
            249
          ],
          [
            648,
            249
          ]
        ],
        "transcription": "Diagnosis"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            649,
            253
          ],
          [
            715,
            253
          ],
          [
            715,
            267
          ],
          [
            649,
            267
          ]
        ],
        "transcription": "Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            342,
            267
          ],
          [
            435,
            272
          ],
          [
            434,
            294
          ],
          [
            341,
            289
          ]
        ],
        "transcription": "Epigenomics"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            617,
            371
          ],
          [
            744,
            371
          ],
          [
            744,
            388
          ],
          [
            617,
            388
          ]
        ],
        "transcription": "Cell Regulatory Logic"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            335,
            463
          ],
          [
            444,
            463
          ],
          [
            444,
            480
          ],
          [
            335,
            480
          ]
        ],
        "transcription": "Transcripiomics"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            418,
            601
          ],
          [
            500,
            605
          ],
          [
            499,
            624
          ],
          [
            417,
            619
          ]
        ],
        "transcription": "Other Omics:"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            428,
            619
          ],
          [
            511,
            622
          ],
          [
            510,
            641
          ],
          [
            428,
            638
          ]
        ],
        "transcription": "Metabolomics"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            429,
            638
          ],
          [
            495,
            641
          ],
          [
            494,
            659
          ],
          [
            428,
            656
          ]
        ],
        "transcription": "Proteomics"
      },
      {
        "index_in_para": 3,
        "index_para": 8,
        "points": [
          [
            431,
            658
          ],
          [
            491,
            658
          ],
          [
            491,
            676
          ],
          [
            431,
            676
          ]
        ],
        "transcription": "Glycomics"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            885,
            654
          ],
          [
            980,
            654
          ],
          [
            980,
            672
          ],
          [
            885,
            672
          ]
        ],
        "transcription": "Clinical Trials"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0533450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            557,
            58
          ],
          [
            711,
            61
          ],
          [
            710,
            114
          ],
          [
            556,
            111
          ]
        ],
        "transcription": "Outline"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            284,
            183
          ],
          [
            707,
            183
          ],
          [
            707,
            213
          ],
          [
            284,
            213
          ]
        ],
        "transcription": "Genetics of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            285,
            306
          ],
          [
            763,
            306
          ],
          [
            763,
            338
          ],
          [
            285,
            338
          ]
        ],
        "transcription": "Immunology of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            287,
            428
          ],
          [
            844,
            428
          ],
          [
            844,
            458
          ],
          [
            287,
            458
          ]
        ],
        "transcription": "Translational and Biomarker Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            283,
            547
          ],
          [
            685,
            548
          ],
          [
            685,
            584
          ],
          [
            283,
            582
          ]
        ],
        "transcription": "Clinical Development Plan"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0669000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            241,
            46
          ],
          [
            988,
            46
          ],
          [
            988,
            73
          ],
          [
            241,
            73
          ]
        ],
        "transcription": "Genomewide Association Study (GWAS) in Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            404,
            197
          ],
          [
            823,
            197
          ],
          [
            823,
            216
          ],
          [
            404,
            216
          ]
        ],
        "transcription": "Joint analysis of ~1000 cases vs ~3000 controls"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            695,
            241
          ],
          [
            708,
            241
          ],
          [
            708,
            255
          ],
          [
            695,
            255
          ]
        ],
        "transcription": "A"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            521,
            265
          ],
          [
            568,
            265
          ],
          [
            568,
            291
          ],
          [
            521,
            291
          ]
        ],
        "transcription": "HLA"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            559,
            339
          ],
          [
            698,
            342
          ],
          [
            697,
            365
          ],
          [
            558,
            363
          ]
        ],
        "transcription": "ULBP3/ULBP6"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            315,
            381
          ],
          [
            432,
            381
          ],
          [
            432,
            404
          ],
          [
            315,
            404
          ]
        ],
        "transcription": "CTLA4/ICOS"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            779,
            405
          ],
          [
            877,
            405
          ],
          [
            877,
            428
          ],
          [
            779,
            428
          ]
        ],
        "transcription": "Eos/ErbB3"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            687,
            406
          ],
          [
            747,
            406
          ],
          [
            747,
            426
          ],
          [
            687,
            426
          ]
        ],
        "transcription": "IL2RA"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            730,
            427
          ],
          [
            802,
            427
          ],
          [
            802,
            450
          ],
          [
            730,
            450
          ]
        ],
        "transcription": "PRDX5"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            640,
            429
          ],
          [
            708,
            428
          ],
          [
            708,
            454
          ],
          [
            640,
            453
          ]
        ],
        "transcription": "STX17"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            369,
            614
          ],
          [
            861,
            614
          ],
          [
            861,
            637
          ],
          [
            369,
            637
          ]
        ],
        "transcription": "Is NKG2D Ligand expression an End-Organ Precipitant"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            447,
            645
          ],
          [
            781,
            645
          ],
          [
            781,
            667
          ],
          [
            447,
            667
          ]
        ],
        "transcription": "of Autoimmunity and Alopecia Areata?"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            807,
            687
          ],
          [
            1025,
            687
          ],
          [
            1025,
            709
          ],
          [
            807,
            709
          ]
        ],
        "transcription": "Pethukova, Nature 2010"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0721450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            249,
            11
          ],
          [
            663,
            11
          ],
          [
            663,
            33
          ],
          [
            249,
            33
          ]
        ],
        "transcription": "Genome-wide Association Study in AA"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            956,
            50
          ],
          [
            1007,
            50
          ],
          [
            1007,
            69
          ],
          [
            956,
            69
          ]
        ],
        "transcription": "nature"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            699,
            78
          ],
          [
            765,
            78
          ],
          [
            765,
            96
          ],
          [
            699,
            96
          ]
        ],
        "transcription": "Maximum"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            695,
            89
          ],
          [
            761,
            89
          ],
          [
            761,
            112
          ],
          [
            695,
            112
          ]
        ],
        "transcription": "odds ratio"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            578,
            80
          ],
          [
            697,
            80
          ],
          [
            697,
            97
          ],
          [
            578,
            97
          ]
        ],
        "transcription": "Strongest association"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            612,
            95
          ],
          [
            667,
            95
          ],
          [
            667,
            115
          ],
          [
            612,
            115
          ]
        ],
        "transcription": "(P value)"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            260,
            82
          ],
          [
            303,
            85
          ],
          [
            301,
            106
          ],
          [
            258,
            103
          ]
        ],
        "transcription": "Region"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            316,
            85
          ],
          [
            351,
            85
          ],
          [
            351,
            106
          ],
          [
            316,
            106
          ]
        ],
        "transcription": "Gene"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            315,
            114
          ],
          [
            363,
            114
          ],
          [
            363,
            134
          ],
          [
            315,
            134
          ]
        ],
        "transcription": "CTLA4"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            317,
            134
          ],
          [
            352,
            134
          ],
          [
            352,
            154
          ],
          [
            317,
            154
          ]
        ],
        "transcription": "ICOS"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            317,
            155
          ],
          [
            399,
            155
          ],
          [
            399,
            173
          ],
          [
            317,
            173
          ]
        ],
        "transcription": "L-21/I-2"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            316,
            175
          ],
          [
            361,
            175
          ],
          [
            361,
            195
          ],
          [
            316,
            195
          ]
        ],
        "transcription": "ULBP6"
      },
      {
        "index_in_para": 5,
        "index_para": 5,
        "points": [
          [
            317,
            193
          ],
          [
            360,
            193
          ],
          [
            360,
            213
          ],
          [
            317,
            213
          ]
        ],
        "transcription": "ULBP3"
      },
      {
        "index_in_para": 6,
        "index_para": 5,
        "points": [
          [
            317,
            216
          ],
          [
            360,
            216
          ],
          [
            360,
            230
          ],
          [
            317,
            230
          ]
        ],
        "transcription": "STX17"
      },
      {
        "index_in_para": 7,
        "index_para": 5,
        "points": [
          [
            318,
            232
          ],
          [
            371,
            232
          ],
          [
            371,
            250
          ],
          [
            318,
            250
          ]
        ],
        "transcription": "IL-2RA"
      },
      {
        "index_in_para": 8,
        "index_para": 5,
        "points": [
          [
            316,
            252
          ],
          [
            363,
            252
          ],
          [
            363,
            270
          ],
          [
            316,
            270
          ]
        ],
        "transcription": "PRDX5"
      },
      {
        "index_in_para": 9,
        "index_para": 5,
        "points": [
          [
            317,
            275
          ],
          [
            394,
            275
          ],
          [
            394,
            292
          ],
          [
            317,
            292
          ]
        ],
        "transcription": "Eos(IKZF4)"
      },
      {
        "index_in_para": 10,
        "index_para": 5,
        "points": [
          [
            317,
            291
          ],
          [
            364,
            291
          ],
          [
            364,
            311
          ],
          [
            317,
            311
          ]
        ],
        "transcription": "ERBB3"
      },
      {
        "index_in_para": 11,
        "index_para": 5,
        "points": [
          [
            321,
            311
          ],
          [
            358,
            311
          ],
          [
            358,
            327
          ],
          [
            321,
            327
          ]
        ],
        "transcription": "MICA"
      },
      {
        "index_in_para": 12,
        "index_para": 5,
        "points": [
          [
            317,
            334
          ],
          [
            375,
            334
          ],
          [
            375,
            348
          ],
          [
            317,
            348
          ]
        ],
        "transcription": "NOTCH4"
      },
      {
        "index_in_para": 13,
        "index_para": 5,
        "points": [
          [
            317,
            352
          ],
          [
            371,
            352
          ],
          [
            371,
            371
          ],
          [
            317,
            371
          ]
        ],
        "transcription": "C6orf10"
      },
      {
        "index_in_para": 14,
        "index_para": 5,
        "points": [
          [
            317,
            371
          ],
          [
            363,
            371
          ],
          [
            363,
            390
          ],
          [
            317,
            390
          ]
        ],
        "transcription": "BTNL2"
      },
      {
        "index_in_para": 15,
        "index_para": 5,
        "points": [
          [
            317,
            389
          ],
          [
            381,
            389
          ],
          [
            381,
            414
          ],
          [
            317,
            414
          ]
        ],
        "transcription": "HLA-DRA"
      },
      {
        "index_in_para": 16,
        "index_para": 5,
        "points": [
          [
            318,
            410
          ],
          [
            389,
            410
          ],
          [
            389,
            427
          ],
          [
            318,
            427
          ]
        ],
        "transcription": "HLA-DOA1"
      },
      {
        "index_in_para": 17,
        "index_para": 5,
        "points": [
          [
            318,
            428
          ],
          [
            393,
            428
          ],
          [
            393,
            446
          ],
          [
            318,
            446
          ]
        ],
        "transcription": "HLA-DOA2"
      },
      {
        "index_in_para": 18,
        "index_para": 5,
        "points": [
          [
            319,
            452
          ],
          [
            389,
            452
          ],
          [
            389,
            470
          ],
          [
            319,
            470
          ]
        ],
        "transcription": "HLA-DQB2"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            392,
            86
          ],
          [
            444,
            86
          ],
          [
            444,
            106
          ],
          [
            392,
            106
          ]
        ],
        "transcription": "Function"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            393,
            115
          ],
          [
            527,
            115
          ],
          [
            527,
            134
          ],
          [
            393,
            134
          ]
        ],
        "transcription": "Co-stimulatory family"
      },
      {
        "index_in_para": 2,
        "index_para": 6,
        "points": [
          [
            393,
            134
          ],
          [
            527,
            135
          ],
          [
            527,
            154
          ],
          [
            393,
            152
          ]
        ],
        "transcription": "Co-stimulatory family"
      },
      {
        "index_in_para": 3,
        "index_para": 6,
        "points": [
          [
            391,
            156
          ],
          [
            584,
            156
          ],
          [
            584,
            173
          ],
          [
            391,
            173
          ]
        ],
        "transcription": "T-B-and NK-cell proliferation"
      },
      {
        "index_in_para": 4,
        "index_para": 6,
        "points": [
          [
            393,
            176
          ],
          [
            545,
            176
          ],
          [
            545,
            195
          ],
          [
            393,
            195
          ]
        ],
        "transcription": "NKG2D activating ligand"
      },
      {
        "index_in_para": 5,
        "index_para": 6,
        "points": [
          [
            392,
            192
          ],
          [
            547,
            193
          ],
          [
            547,
            216
          ],
          [
            392,
            214
          ]
        ],
        "transcription": "NKG2D activating ligand"
      },
      {
        "index_in_para": 6,
        "index_para": 6,
        "points": [
          [
            392,
            213
          ],
          [
            535,
            216
          ],
          [
            534,
            234
          ],
          [
            392,
            232
          ]
        ],
        "transcription": "Premature hair greying"
      },
      {
        "index_in_para": 7,
        "index_para": 6,
        "points": [
          [
            393,
            233
          ],
          [
            508,
            234
          ],
          [
            508,
            253
          ],
          [
            393,
            251
          ]
        ],
        "transcription": "T-cell proliferation"
      },
      {
        "index_in_para": 8,
        "index_para": 6,
        "points": [
          [
            393,
            253
          ],
          [
            519,
            254
          ],
          [
            519,
            273
          ],
          [
            393,
            271
          ]
        ],
        "transcription": "Antioxidant enzyme"
      },
      {
        "index_in_para": 9,
        "index_para": 6,
        "points": [
          [
            393,
            270
          ],
          [
            551,
            270
          ],
          [
            551,
            294
          ],
          [
            393,
            294
          ]
        ],
        "transcription": "Treg transcription factor"
      },
      {
        "index_in_para": 10,
        "index_para": 6,
        "points": [
          [
            392,
            291
          ],
          [
            597,
            293
          ],
          [
            602,
            310
          ],
          [
            392,
            314
          ]
        ],
        "transcription": "Epidermal growth factor receptor"
      },
      {
        "index_in_para": 11,
        "index_para": 6,
        "points": [
          [
            395,
            314
          ],
          [
            545,
            314
          ],
          [
            545,
            332
          ],
          [
            395,
            332
          ]
        ],
        "transcription": "NKG2D activating ligand"
      },
      {
        "index_in_para": 12,
        "index_para": 6,
        "points": [
          [
            393,
            334
          ],
          [
            583,
            334
          ],
          [
            583,
            351
          ],
          [
            393,
            351
          ]
        ],
        "transcription": "Haematopoietic differentiation"
      },
      {
        "index_in_para": 13,
        "index_para": 6,
        "points": [
          [
            393,
            352
          ],
          [
            455,
            352
          ],
          [
            455,
            371
          ],
          [
            393,
            371
          ]
        ],
        "transcription": "Unknown"
      },
      {
        "index_in_para": 14,
        "index_para": 6,
        "points": [
          [
            392,
            371
          ],
          [
            525,
            372
          ],
          [
            525,
            391
          ],
          [
            392,
            389
          ]
        ],
        "transcription": "Co-stimulatory family"
      },
      {
        "index_in_para": 15,
        "index_para": 6,
        "points": [
          [
            397,
            389
          ],
          [
            527,
            389
          ],
          [
            527,
            410
          ],
          [
            397,
            410
          ]
        ],
        "transcription": "Antigen presentation"
      },
      {
        "index_in_para": 16,
        "index_para": 6,
        "points": [
          [
            394,
            410
          ],
          [
            536,
            410
          ],
          [
            536,
            432
          ],
          [
            394,
            432
          ]
        ],
        "transcription": "Antigen presentation"
      },
      {
        "index_in_para": 17,
        "index_para": 6,
        "points": [
          [
            397,
            431
          ],
          [
            535,
            431
          ],
          [
            535,
            454
          ],
          [
            397,
            454
          ]
        ],
        "transcription": "Antigen presentation"
      },
      {
        "index_in_para": 18,
        "index_para": 6,
        "points": [
          [
            394,
            454
          ],
          [
            540,
            454
          ],
          [
            540,
            473
          ],
          [
            394,
            473
          ]
        ],
        "transcription": "Antigen presentation"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            765,
            115
          ],
          [
            935,
            115
          ],
          [
            935,
            132
          ],
          [
            765,
            132
          ]
        ],
        "transcription": "T1D.RACeD.MS, SLE, GD"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            765,
            155
          ],
          [
            873,
            155
          ],
          [
            873,
            173
          ],
          [
            765,
            173
          ]
        ],
        "transcription": "T1D, RA, CeD, PS"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            763,
            175
          ],
          [
            804,
            175
          ],
          [
            804,
            195
          ],
          [
            763,
            195
          ]
        ],
        "transcription": "None"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            763,
            195
          ],
          [
            801,
            195
          ],
          [
            801,
            214
          ],
          [
            763,
            214
          ]
        ],
        "transcription": "None"
      },
      {
        "index_in_para": 3,
        "index_para": 8,
        "points": [
          [
            764,
            216
          ],
          [
            801,
            216
          ],
          [
            801,
            233
          ],
          [
            764,
            233
          ]
        ],
        "transcription": "None"
      },
      {
        "index_in_para": 4,
        "index_para": 8,
        "points": [
          [
            764,
            234
          ],
          [
            875,
            234
          ],
          [
            875,
            251
          ],
          [
            764,
            251
          ]
        ],
        "transcription": "T1D, MS.GD.GV"
      },
      {
        "index_in_para": 5,
        "index_para": 8,
        "points": [
          [
            764,
            254
          ],
          [
            789,
            254
          ],
          [
            789,
            271
          ],
          [
            764,
            271
          ]
        ],
        "transcription": "MS"
      },
      {
        "index_in_para": 6,
        "index_para": 8,
        "points": [
          [
            764,
            273
          ],
          [
            823,
            273
          ],
          [
            823,
            291
          ],
          [
            764,
            291
          ]
        ],
        "transcription": "T1D, SLE"
      },
      {
        "index_in_para": 7,
        "index_para": 8,
        "points": [
          [
            764,
            292
          ],
          [
            824,
            292
          ],
          [
            824,
            311
          ],
          [
            764,
            311
          ]
        ],
        "transcription": "T1D, SLE"
      },
      {
        "index_in_para": 8,
        "index_para": 8,
        "points": [
          [
            765,
            312
          ],
          [
            929,
            312
          ],
          [
            929,
            331
          ],
          [
            765,
            331
          ]
        ],
        "transcription": "T1D, RA, CeD, UC, PS, SLE"
      },
      {
        "index_in_para": 9,
        "index_para": 8,
        "points": [
          [
            765,
            332
          ],
          [
            847,
            332
          ],
          [
            847,
            351
          ],
          [
            765,
            351
          ]
        ],
        "transcription": "T1D, RA, MS"
      },
      {
        "index_in_para": 10,
        "index_para": 8,
        "points": [
          [
            767,
            353
          ],
          [
            867,
            353
          ],
          [
            867,
            368
          ],
          [
            767,
            368
          ]
        ],
        "transcription": "T1D, RA, PS.GV"
      },
      {
        "index_in_para": 11,
        "index_para": 8,
        "points": [
          [
            765,
            372
          ],
          [
            953,
            372
          ],
          [
            953,
            390
          ],
          [
            765,
            390
          ]
        ],
        "transcription": "T1D, RA, UC, CD, SLE, MS, GV"
      },
      {
        "index_in_para": 12,
        "index_para": 8,
        "points": [
          [
            765,
            392
          ],
          [
            907,
            392
          ],
          [
            907,
            409
          ],
          [
            765,
            409
          ]
        ],
        "transcription": "T1D, RA, CeD, MS, GV"
      },
      {
        "index_in_para": 13,
        "index_para": 8,
        "points": [
          [
            765,
            412
          ],
          [
            1008,
            412
          ],
          [
            1008,
            430
          ],
          [
            765,
            430
          ]
        ],
        "transcription": "T1D, RA, CeD, MS, SLE, PS, CD, UC, GD"
      },
      {
        "index_in_para": 14,
        "index_para": 8,
        "points": [
          [
            764,
            431
          ],
          [
            820,
            431
          ],
          [
            820,
            450
          ],
          [
            764,
            450
          ]
        ],
        "transcription": "T1D, RA"
      },
      {
        "index_in_para": 15,
        "index_para": 8,
        "points": [
          [
            761,
            450
          ],
          [
            791,
            450
          ],
          [
            791,
            471
          ],
          [
            761,
            471
          ]
        ],
        "transcription": "RA"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            244,
            502
          ],
          [
            373,
            502
          ],
          [
            373,
            529
          ],
          [
            244,
            529
          ]
        ],
        "transcription": "Surprises"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            716,
            538
          ],
          [
            960,
            543
          ],
          [
            960,
            579
          ],
          [
            716,
            574
          ]
        ],
        "transcription": "Aligned Diseases"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            393,
            540
          ],
          [
            534,
            546
          ],
          [
            532,
            579
          ],
          [
            392,
            573
          ]
        ],
        "transcription": "Pathways"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            391,
            588
          ],
          [
            648,
            590
          ],
          [
            648,
            617
          ],
          [
            391,
            614
          ]
        ],
        "transcription": "Costimulatory Pathway"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            713,
            591
          ],
          [
            884,
            586
          ],
          [
            884,
            614
          ],
          [
            714,
            618
          ]
        ],
        "transcription": "Type 1 diabetes"
      },
      {
        "index_in_para": 1,
        "index_para": 12,
        "points": [
          [
            715,
            627
          ],
          [
            940,
            627
          ],
          [
            940,
            654
          ],
          [
            715,
            654
          ]
        ],
        "transcription": "Rheumatoid arthritis"
      },
      {
        "index_in_para": 2,
        "index_para": 12,
        "points": [
          [
            715,
            666
          ],
          [
            868,
            666
          ],
          [
            868,
            692
          ],
          [
            715,
            692
          ]
        ],
        "transcription": "Celiac disease"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            392,
            629
          ],
          [
            521,
            629
          ],
          [
            521,
            652
          ],
          [
            392,
            652
          ]
        ],
        "transcription": "NKG2D axis"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            393,
            667
          ],
          [
            591,
            667
          ],
          [
            591,
            695
          ],
          [
            393,
            695
          ]
        ],
        "transcription": "Cytokine signaling"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0748000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            245,
            16
          ],
          [
            936,
            16
          ],
          [
            936,
            46
          ],
          [
            245,
            46
          ]
        ],
        "transcription": "Meta Analysis Study Design with European Cohort"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            707,
            125
          ],
          [
            787,
            129
          ],
          [
            786,
            147
          ],
          [
            706,
            144
          ]
        ],
        "transcription": "Genotyping"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            706,
            145
          ],
          [
            767,
            150
          ],
          [
            766,
            169
          ],
          [
            705,
            164
          ]
        ],
        "transcription": "Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            429,
            126
          ],
          [
            639,
            128
          ],
          [
            639,
            146
          ],
          [
            429,
            143
          ]
        ],
        "transcription": "Cohort(Ascertainment Source)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            259,
            127
          ],
          [
            319,
            127
          ],
          [
            319,
            146
          ],
          [
            259,
            146
          ]
        ],
        "transcription": "Analysis"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            952,
            127
          ],
          [
            1007,
            127
          ],
          [
            1007,
            146
          ],
          [
            952,
            146
          ]
        ],
        "transcription": "Sample"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            952,
            148
          ],
          [
            996,
            148
          ],
          [
            996,
            167
          ],
          [
            952,
            167
          ]
        ],
        "transcription": "Count"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            369,
            128
          ],
          [
            435,
            128
          ],
          [
            435,
            143
          ],
          [
            369,
            143
          ]
        ],
        "transcription": "Disease"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            368,
            147
          ],
          [
            414,
            150
          ],
          [
            412,
            168
          ],
          [
            366,
            165
          ]
        ],
        "transcription": "Status"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            813,
            128
          ],
          [
            887,
            128
          ],
          [
            887,
            143
          ],
          [
            813,
            143
          ]
        ],
        "transcription": "Publication"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            812,
            192
          ],
          [
            928,
            192
          ],
          [
            928,
            209
          ],
          [
            812,
            209
          ]
        ],
        "transcription": "PMID20596022"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            812,
            213
          ],
          [
            929,
            213
          ],
          [
            929,
            232
          ],
          [
            812,
            232
          ]
        ],
        "transcription": "PMID20596022"
      },
      {
        "index_in_para": 2,
        "index_para": 7,
        "points": [
          [
            809,
            237
          ],
          [
            939,
            237
          ],
          [
            939,
            254
          ],
          [
            809,
            254
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 3,
        "index_para": 7,
        "points": [
          [
            805,
            262
          ],
          [
            940,
            262
          ],
          [
            940,
            279
          ],
          [
            805,
            279
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            259,
            193
          ],
          [
            359,
            193
          ],
          [
            359,
            208
          ],
          [
            259,
            208
          ]
        ],
        "transcription": "meta analysis"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            257,
            212
          ],
          [
            289,
            212
          ],
          [
            289,
            232
          ],
          [
            257,
            232
          ]
        ],
        "transcription": "and"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            257,
            232
          ],
          [
            293,
            232
          ],
          [
            293,
            253
          ],
          [
            257,
            253
          ]
        ],
        "transcription": "HLA"
      },
      {
        "index_in_para": 3,
        "index_para": 8,
        "points": [
          [
            259,
            255
          ],
          [
            333,
            255
          ],
          [
            333,
            274
          ],
          [
            259,
            274
          ]
        ],
        "transcription": "imputation"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            361,
            193
          ],
          [
            403,
            193
          ],
          [
            403,
            208
          ],
          [
            361,
            208
          ]
        ],
        "transcription": "case"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            431,
            193
          ],
          [
            517,
            193
          ],
          [
            517,
            208
          ],
          [
            431,
            208
          ]
        ],
        "transcription": "US1(NAAR"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            428,
            212
          ],
          [
            519,
            215
          ],
          [
            518,
            234
          ],
          [
            428,
            231
          ]
        ],
        "transcription": "US2(NAAR)"
      },
      {
        "index_in_para": 2,
        "index_para": 10,
        "points": [
          [
            431,
            237
          ],
          [
            543,
            237
          ],
          [
            543,
            255
          ],
          [
            431,
            255
          ]
        ],
        "transcription": "Central Europe1"
      },
      {
        "index_in_para": 3,
        "index_para": 10,
        "points": [
          [
            431,
            261
          ],
          [
            548,
            261
          ],
          [
            548,
            279
          ],
          [
            431,
            279
          ]
        ],
        "transcription": "Central Europe 2"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            708,
            193
          ],
          [
            791,
            193
          ],
          [
            791,
            208
          ],
          [
            708,
            208
          ]
        ],
        "transcription": "Illumina 610"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            708,
            216
          ],
          [
            791,
            216
          ],
          [
            791,
            230
          ],
          [
            708,
            230
          ]
        ],
        "transcription": "lllumina 610"
      },
      {
        "index_in_para": 2,
        "index_para": 11,
        "points": [
          [
            707,
            237
          ],
          [
            792,
            237
          ],
          [
            792,
            255
          ],
          [
            707,
            255
          ]
        ],
        "transcription": "Illumina 660"
      },
      {
        "index_in_para": 3,
        "index_para": 11,
        "points": [
          [
            707,
            261
          ],
          [
            809,
            261
          ],
          [
            809,
            279
          ],
          [
            707,
            279
          ]
        ],
        "transcription": "Illumina Omni"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            367,
            310
          ],
          [
            519,
            310
          ],
          [
            519,
            328
          ],
          [
            367,
            328
          ]
        ],
        "transcription": "controlUS1(NYCP)"
      },
      {
        "index_in_para": 1,
        "index_para": 12,
        "points": [
          [
            428,
            332
          ],
          [
            529,
            332
          ],
          [
            529,
            351
          ],
          [
            428,
            351
          ]
        ],
        "transcription": "US2(CGEMS"
      },
      {
        "index_in_para": 2,
        "index_para": 12,
        "points": [
          [
            423,
            351
          ],
          [
            707,
            351
          ],
          [
            707,
            375
          ],
          [
            423,
            375
          ]
        ],
        "transcription": "Central Europe1 (PopGen, KORA, HNR)"
      },
      {
        "index_in_para": 3,
        "index_para": 12,
        "points": [
          [
            431,
            379
          ],
          [
            707,
            379
          ],
          [
            707,
            395
          ],
          [
            431,
            395
          ]
        ],
        "transcription": "Central Europe2 (PopGen, KORA, HNR)"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            707,
            310
          ],
          [
            791,
            310
          ],
          [
            791,
            328
          ],
          [
            707,
            328
          ]
        ],
        "transcription": "Illumina 550"
      },
      {
        "index_in_para": 1,
        "index_para": 13,
        "points": [
          [
            707,
            332
          ],
          [
            792,
            332
          ],
          [
            792,
            351
          ],
          [
            707,
            351
          ]
        ],
        "transcription": "Illumina 550"
      },
      {
        "index_in_para": 2,
        "index_para": 13,
        "points": [
          [
            704,
            350
          ],
          [
            805,
            350
          ],
          [
            805,
            375
          ],
          [
            704,
            375
          ]
        ],
        "transcription": "Illumina Omni"
      },
      {
        "index_in_para": 3,
        "index_para": 13,
        "points": [
          [
            707,
            374
          ],
          [
            793,
            374
          ],
          [
            793,
            398
          ],
          [
            707,
            398
          ]
        ],
        "transcription": "llumina 550"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            812,
            310
          ],
          [
            929,
            310
          ],
          [
            929,
            327
          ],
          [
            812,
            327
          ]
        ],
        "transcription": "PMID20596022"
      },
      {
        "index_in_para": 1,
        "index_para": 14,
        "points": [
          [
            812,
            332
          ],
          [
            929,
            332
          ],
          [
            929,
            349
          ],
          [
            812,
            349
          ]
        ],
        "transcription": "PMID20596022"
      },
      {
        "index_in_para": 2,
        "index_para": 14,
        "points": [
          [
            808,
            355
          ],
          [
            939,
            355
          ],
          [
            939,
            373
          ],
          [
            808,
            373
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 3,
        "index_para": 14,
        "points": [
          [
            812,
            380
          ],
          [
            941,
            380
          ],
          [
            941,
            397
          ],
          [
            812,
            397
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            431,
            425
          ],
          [
            519,
            425
          ],
          [
            519,
            443
          ],
          [
            431,
            443
          ]
        ],
        "transcription": "US3 (NAAR)"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            707,
            425
          ],
          [
            784,
            425
          ],
          [
            784,
            443
          ],
          [
            707,
            443
          ]
        ],
        "transcription": "Sequenom"
      },
      {
        "index_in_para": 1,
        "index_para": 16,
        "points": [
          [
            707,
            446
          ],
          [
            792,
            446
          ],
          [
            792,
            465
          ],
          [
            707,
            465
          ]
        ],
        "transcription": "Immunochip"
      },
      {
        "index_in_para": 2,
        "index_para": 16,
        "points": [
          [
            707,
            467
          ],
          [
            784,
            467
          ],
          [
            784,
            486
          ],
          [
            707,
            486
          ]
        ],
        "transcription": "Sequenom"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            368,
            426
          ],
          [
            403,
            426
          ],
          [
            403,
            442
          ],
          [
            368,
            442
          ]
        ],
        "transcription": "case"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            812,
            426
          ],
          [
            940,
            426
          ],
          [
            940,
            443
          ],
          [
            812,
            443
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            260,
            427
          ],
          [
            331,
            427
          ],
          [
            331,
            442
          ],
          [
            260,
            442
          ]
        ],
        "transcription": "replication"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            365,
            467
          ],
          [
            404,
            467
          ],
          [
            404,
            487
          ],
          [
            365,
            487
          ]
        ],
        "transcription": "case"
      },
      {
        "index_in_para": 0,
        "index_para": 21,
        "points": [
          [
            432,
            469
          ],
          [
            548,
            469
          ],
          [
            548,
            486
          ],
          [
            432,
            486
          ]
        ],
        "transcription": "Central Europe 3"
      },
      {
        "index_in_para": 0,
        "index_para": 22,
        "points": [
          [
            812,
            469
          ],
          [
            939,
            469
          ],
          [
            939,
            486
          ],
          [
            812,
            486
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 0,
        "index_para": 23,
        "points": [
          [
            367,
            514
          ],
          [
            416,
            514
          ],
          [
            416,
            532
          ],
          [
            367,
            532
          ]
        ],
        "transcription": "control"
      },
      {
        "index_in_para": 1,
        "index_para": 23,
        "points": [
          [
            367,
            537
          ],
          [
            417,
            537
          ],
          [
            417,
            556
          ],
          [
            367,
            556
          ]
        ],
        "transcription": "control"
      },
      {
        "index_in_para": 2,
        "index_para": 23,
        "points": [
          [
            367,
            560
          ],
          [
            419,
            560
          ],
          [
            419,
            578
          ],
          [
            367,
            578
          ]
        ],
        "transcription": "control"
      },
      {
        "index_in_para": 0,
        "index_para": 24,
        "points": [
          [
            431,
            514
          ],
          [
            528,
            514
          ],
          [
            528,
            532
          ],
          [
            431,
            532
          ]
        ],
        "transcription": "US3a(NAAR)"
      },
      {
        "index_in_para": 1,
        "index_para": 24,
        "points": [
          [
            431,
            536
          ],
          [
            583,
            536
          ],
          [
            583,
            555
          ],
          [
            431,
            555
          ]
        ],
        "transcription": "US3b(NIDDK IBDGC)"
      },
      {
        "index_in_para": 2,
        "index_para": 24,
        "points": [
          [
            431,
            560
          ],
          [
            549,
            560
          ],
          [
            549,
            577
          ],
          [
            431,
            577
          ]
        ],
        "transcription": "Central Europe 3"
      },
      {
        "index_in_para": 0,
        "index_para": 25,
        "points": [
          [
            707,
            514
          ],
          [
            784,
            514
          ],
          [
            784,
            532
          ],
          [
            707,
            532
          ]
        ],
        "transcription": "Sequenom"
      },
      {
        "index_in_para": 1,
        "index_para": 25,
        "points": [
          [
            708,
            539
          ],
          [
            791,
            539
          ],
          [
            791,
            553
          ],
          [
            708,
            553
          ]
        ],
        "transcription": "Immunochip"
      },
      {
        "index_in_para": 2,
        "index_para": 25,
        "points": [
          [
            707,
            560
          ],
          [
            784,
            560
          ],
          [
            784,
            578
          ],
          [
            707,
            578
          ]
        ],
        "transcription": "Sequenom"
      },
      {
        "index_in_para": 0,
        "index_para": 26,
        "points": [
          [
            811,
            515
          ],
          [
            940,
            515
          ],
          [
            940,
            532
          ],
          [
            811,
            532
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 1,
        "index_para": 26,
        "points": [
          [
            812,
            537
          ],
          [
            940,
            537
          ],
          [
            940,
            555
          ],
          [
            812,
            555
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 2,
        "index_para": 26,
        "points": [
          [
            809,
            560
          ],
          [
            941,
            558
          ],
          [
            941,
            577
          ],
          [
            809,
            578
          ]
        ],
        "transcription": "current publication"
      },
      {
        "index_in_para": 0,
        "index_para": 27,
        "points": [
          [
            273,
            621
          ],
          [
            697,
            623
          ],
          [
            697,
            646
          ],
          [
            273,
            643
          ]
        ],
        "transcription": "Collaboration with Regina Betz, Markus Nothen"
      },
      {
        "index_in_para": 1,
        "index_para": 27,
        "points": [
          [
            272,
            648
          ],
          [
            406,
            651
          ],
          [
            405,
            674
          ],
          [
            272,
            671
          ]
        ],
        "transcription": "Paul deBakker"
      },
      {
        "index_in_para": 0,
        "index_para": 28,
        "points": [
          [
            821,
            630
          ],
          [
            1000,
            630
          ],
          [
            1000,
            647
          ],
          [
            821,
            647
          ]
        ],
        "transcription": "Total Case Count3,096"
      },
      {
        "index_in_para": 1,
        "index_para": 28,
        "points": [
          [
            805,
            654
          ],
          [
            1001,
            654
          ],
          [
            1001,
            672
          ],
          [
            805,
            672
          ]
        ],
        "transcription": "Total Control Count7,439"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0764000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            243,
            36
          ],
          [
            693,
            38
          ],
          [
            693,
            66
          ],
          [
            243,
            63
          ]
        ],
        "transcription": "Manhattan Plot of Meta-analysis"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            239,
            75
          ],
          [
            648,
            78
          ],
          [
            648,
            102
          ],
          [
            239,
            99
          ]
        ],
        "transcription": "Collaboration with Regina Betz, Bonn Germany"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            252,
            330
          ],
          [
            272,
            330
          ],
          [
            272,
            435
          ],
          [
            252,
            435
          ]
        ],
        "transcription": "-log10(p)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            581,
            381
          ],
          [
            663,
            381
          ],
          [
            663,
            404
          ],
          [
            581,
            404
          ]
        ],
        "transcription": "ULBP3/6"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            607,
            656
          ],
          [
            687,
            659
          ],
          [
            686,
            678
          ],
          [
            606,
            675
          ]
        ],
        "transcription": "Chromosome"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            263,
            688
          ],
          [
            564,
            688
          ],
          [
            564,
            707
          ],
          [
            263,
            707
          ]
        ],
        "transcription": "Betz/Petukhova Nat.Comm.2015"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0820000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            256,
            15
          ],
          [
            816,
            16
          ],
          [
            816,
            48
          ],
          [
            256,
            46
          ]
        ],
        "transcription": "Resolving GWAS signals in the HLA locus"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            305,
            91
          ],
          [
            964,
            91
          ],
          [
            964,
            110
          ],
          [
            305,
            110
          ]
        ],
        "transcription": "Four independent effects account for entire HLA association"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            719,
            134
          ],
          [
            992,
            134
          ],
          [
            992,
            160
          ],
          [
            719,
            160
          ]
        ],
        "transcription": "How does this compare?"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            673,
            181
          ],
          [
            774,
            180
          ],
          [
            775,
            204
          ],
          [
            674,
            205
          ]
        ],
        "transcription": "AA has 4"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            676,
            213
          ],
          [
            885,
            213
          ],
          [
            885,
            232
          ],
          [
            676,
            232
          ]
        ],
        "transcription": "HLA-DRB1aa13.37"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            673,
            240
          ],
          [
            845,
            240
          ],
          [
            845,
            262
          ],
          [
            673,
            262
          ]
        ],
        "transcription": "HLA-DRB1-0401"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            672,
            267
          ],
          [
            821,
            267
          ],
          [
            821,
            294
          ],
          [
            672,
            294
          ]
        ],
        "transcription": "HLA-A eQTL"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            679,
            324
          ],
          [
            777,
            324
          ],
          [
            777,
            348
          ],
          [
            679,
            348
          ]
        ],
        "transcription": "RA has 6"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            679,
            353
          ],
          [
            925,
            353
          ],
          [
            925,
            376
          ],
          [
            679,
            376
          ]
        ],
        "transcription": "HLA-DRB1 aa 11,71,74"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            679,
            382
          ],
          [
            815,
            382
          ],
          [
            815,
            405
          ],
          [
            679,
            405
          ]
        ],
        "transcription": "HLA-A aa 77"
      },
      {
        "index_in_para": 3,
        "index_para": 4,
        "points": [
          [
            679,
            412
          ],
          [
            803,
            412
          ],
          [
            803,
            434
          ],
          [
            679,
            434
          ]
        ],
        "transcription": "HLA-B aa 9"
      },
      {
        "index_in_para": 4,
        "index_para": 4,
        "points": [
          [
            679,
            441
          ],
          [
            845,
            441
          ],
          [
            845,
            463
          ],
          [
            679,
            463
          ]
        ],
        "transcription": "HLA-DPB1 aa 9"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            455,
            345
          ],
          [
            617,
            345
          ],
          [
            617,
            363
          ],
          [
            455,
            363
          ]
        ],
        "transcription": "residues 70-74 (shared epitope"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            463,
            363
          ],
          [
            571,
            363
          ],
          [
            571,
            380
          ],
          [
            463,
            380
          ]
        ],
        "transcription": "of HLA-DR1*0401)"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            253,
            391
          ],
          [
            293,
            391
          ],
          [
            293,
            409
          ],
          [
            253,
            409
          ]
        ],
        "transcription": "Tyr37"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            544,
            430
          ],
          [
            585,
            430
          ],
          [
            585,
            449
          ],
          [
            544,
            449
          ]
        ],
        "transcription": "His13"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            681,
            522
          ],
          [
            848,
            520
          ],
          [
            848,
            544
          ],
          [
            681,
            545
          ]
        ],
        "transcription": "psoriasis has 6"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            684,
            549
          ],
          [
            916,
            549
          ],
          [
            916,
            572
          ],
          [
            684,
            572
          ]
        ],
        "transcription": "HLA-C-0602 and 1203"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            683,
            578
          ],
          [
            819,
            578
          ],
          [
            819,
            601
          ],
          [
            683,
            601
          ]
        ],
        "transcription": "HLA-A aa 95"
      },
      {
        "index_in_para": 3,
        "index_para": 8,
        "points": [
          [
            683,
            608
          ],
          [
            845,
            608
          ],
          [
            845,
            630
          ],
          [
            683,
            630
          ]
        ],
        "transcription": "HLA-B aa 9,67"
      },
      {
        "index_in_para": 4,
        "index_para": 8,
        "points": [
          [
            683,
            637
          ],
          [
            863,
            637
          ],
          [
            863,
            659
          ],
          [
            683,
            659
          ]
        ],
        "transcription": "HLA-DQB1 aa 53"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            680,
            686
          ],
          [
            976,
            687
          ],
          [
            976,
            709
          ],
          [
            680,
            708
          ]
        ],
        "transcription": "Collaboration with Paul deBakker"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0853450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            359,
            91
          ],
          [
            892,
            91
          ],
          [
            892,
            131
          ],
          [
            359,
            131
          ]
        ],
        "transcription": "Genome-wide meta-analysis in"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            372,
            146
          ],
          [
            879,
            144
          ],
          [
            879,
            181
          ],
          [
            372,
            183
          ]
        ],
        "transcription": "alopecia areata resolves HLA"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            332,
            201
          ],
          [
            919,
            201
          ],
          [
            919,
            233
          ],
          [
            332,
            233
          ]
        ],
        "transcription": "associations and reveals two new"
      },
      {
        "index_in_para": 3,
        "index_para": 0,
        "points": [
          [
            469,
            251
          ],
          [
            783,
            251
          ],
          [
            783,
            292
          ],
          [
            469,
            292
          ]
        ],
        "transcription": "susceptibility loci"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            283,
            323
          ],
          [
            965,
            323
          ],
          [
            965,
            341
          ],
          [
            283,
            341
          ]
        ],
        "transcription": "Regina C.Betz*,Lynn Petukhova*, Stephan Ripke*,Hailiang Huang,Androniki Menelaou, Silke Redler"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            288,
            343
          ],
          [
            961,
            343
          ],
          [
            961,
            360
          ],
          [
            288,
            360
          ]
        ],
        "transcription": "Tim Becker, Stefanie Heilmann, Tarek Yamany, Madeliene Duvic, Maria Hordinsky, David Norris, Vera"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            291,
            361
          ],
          [
            957,
            361
          ],
          [
            957,
            379
          ],
          [
            291,
            379
          ]
        ],
        "transcription": "H.Price, Julian Mackay-Wiggan, Annemieke de Jong, Gina M.DeStefano, Susanne Moebus, Markus"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            295,
            381
          ],
          [
            955,
            381
          ],
          [
            955,
            400
          ],
          [
            295,
            400
          ]
        ],
        "transcription": "Bohm, Ulrike Blume-Peytavi, Hans Wolff, Gerhard Lutz, Roland Kruse, Li Bian, Christopher I. Amos"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            292,
            401
          ],
          [
            957,
            401
          ],
          [
            957,
            418
          ],
          [
            292,
            418
          ]
        ],
        "transcription": "Annette Lee, Peter K.Gregersen, Bettina Blaumeiser, David Altshuler, Raphael Clynes, Paul I.W.de"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            413,
            418
          ],
          [
            835,
            420
          ],
          [
            835,
            438
          ],
          [
            413,
            437
          ]
        ],
        "transcription": "Bakker, Markus M.Nothen, Mark J.Daly, Angela M.Christiano"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            482,
            455
          ],
          [
            797,
            455
          ],
          [
            797,
            479
          ],
          [
            482,
            479
          ]
        ],
        "transcription": "Nature Communications(2015,6:5966)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            258,
            509
          ],
          [
            419,
            512
          ],
          [
            418,
            540
          ],
          [
            257,
            537
          ]
        ],
        "transcription": "What's next..."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            259,
            574
          ],
          [
            997,
            574
          ],
          [
            997,
            597
          ],
          [
            259,
            597
          ]
        ],
        "transcription": "ONGOING: Whole exome plus custom capture sequencing to identify variants"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            257,
            602
          ],
          [
            695,
            605
          ],
          [
            695,
            627
          ],
          [
            257,
            625
          ]
        ],
        "transcription": "And determine their functional consequences"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            257,
            659
          ],
          [
            1027,
            660
          ],
          [
            1027,
            683
          ],
          [
            257,
            682
          ]
        ],
        "transcription": "PLANNED: Additional GWAS and family based studies -10,000 individuals is our"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0899000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            244,
            16
          ],
          [
            713,
            16
          ],
          [
            713,
            46
          ],
          [
            244,
            46
          ]
        ],
        "transcription": "Rationale for Meta-analysis GWAS"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            306,
            202
          ],
          [
            329,
            201
          ],
          [
            338,
            428
          ],
          [
            315,
            429
          ]
        ],
        "transcription": "Countof GWAS risk loci"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            309,
            513
          ],
          [
            669,
            562
          ],
          [
            666,
            585
          ],
          [
            306,
            535
          ]
        ],
        "transcription": "OR distribution in www.genome.gov/gwastudies"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            296,
            601
          ],
          [
            851,
            601
          ],
          [
            851,
            619
          ],
          [
            296,
            619
          ]
        ],
        "transcription": "Empirical distribution of effect sizes(OR) for autoimmune diseases in"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            292,
            629
          ],
          [
            1012,
            626
          ],
          [
            1012,
            649
          ],
          [
            292,
            651
          ]
        ],
        "transcription": "genome.gov/gwastudies(data download on 6/13).AA, with the smallest case count has"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            295,
            658
          ],
          [
            959,
            658
          ],
          [
            959,
            676
          ],
          [
            295,
            676
          ]
        ],
        "transcription": "not identified any risk allele with OR<1.3, while nearly 80% of risk alleles for other"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            293,
            684
          ],
          [
            780,
            684
          ],
          [
            780,
            707
          ],
          [
            293,
            707
          ]
        ],
        "transcription": "autoimmune diseases reside within this range(1.0<OR<1.3)"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0918000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            284,
            151
          ],
          [
            917,
            151
          ],
          [
            917,
            191
          ],
          [
            284,
            191
          ]
        ],
        "transcription": "How have genetic studies advanced"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            312,
            205
          ],
          [
            805,
            205
          ],
          [
            805,
            241
          ],
          [
            312,
            241
          ]
        ],
        "transcription": "our understanding of disease"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            309,
            256
          ],
          [
            558,
            251
          ],
          [
            559,
            292
          ],
          [
            310,
            297
          ]
        ],
        "transcription": "pathogenesis?"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            305,
            439
          ],
          [
            848,
            439
          ],
          [
            848,
            476
          ],
          [
            305,
            476
          ]
        ],
        "transcription": "How have genetic studies led to"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            312,
            492
          ],
          [
            960,
            491
          ],
          [
            960,
            523
          ],
          [
            312,
            524
          ]
        ],
        "transcription": "translational research and new clinical"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            308,
            544
          ],
          [
            528,
            537
          ],
          [
            530,
            578
          ],
          [
            309,
            585
          ]
        ],
        "transcription": "approaches?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0947000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            255,
            37
          ],
          [
            1003,
            37
          ],
          [
            1003,
            82
          ],
          [
            255,
            82
          ]
        ],
        "transcription": "Autoimmunity has a \"Common Cause"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            446,
            124
          ],
          [
            608,
            127
          ],
          [
            608,
            150
          ],
          [
            445,
            147
          ]
        ],
        "transcription": "Autoimmune Disease"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            685,
            124
          ],
          [
            758,
            127
          ],
          [
            757,
            151
          ],
          [
            684,
            148
          ]
        ],
        "transcription": "Rate per"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            687,
            152
          ],
          [
            747,
            152
          ],
          [
            747,
            172
          ],
          [
            687,
            172
          ]
        ],
        "transcription": "100,000"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            688,
            177
          ],
          [
            724,
            177
          ],
          [
            724,
            197
          ],
          [
            688,
            197
          ]
        ],
        "transcription": "1700"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            687,
            201
          ],
          [
            755,
            201
          ],
          [
            755,
            222
          ],
          [
            687,
            222
          ]
        ],
        "transcription": "696-1527"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            687,
            226
          ],
          [
            747,
            226
          ],
          [
            747,
            245
          ],
          [
            687,
            245
          ]
        ],
        "transcription": "310-800"
      },
      {
        "index_in_para": 5,
        "index_para": 2,
        "points": [
          [
            687,
            250
          ],
          [
            747,
            250
          ],
          [
            747,
            270
          ],
          [
            687,
            270
          ]
        ],
        "transcription": "227-355"
      },
      {
        "index_in_para": 6,
        "index_para": 2,
        "points": [
          [
            688,
            275
          ],
          [
            747,
            275
          ],
          [
            747,
            294
          ],
          [
            688,
            294
          ]
        ],
        "transcription": "177-358"
      },
      {
        "index_in_para": 7,
        "index_para": 2,
        "points": [
          [
            687,
            299
          ],
          [
            737,
            299
          ],
          [
            737,
            319
          ],
          [
            687,
            319
          ]
        ],
        "transcription": "34-150"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            448,
            179
          ],
          [
            557,
            179
          ],
          [
            557,
            197
          ],
          [
            448,
            197
          ]
        ],
        "transcription": "Alopecia Areata"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            445,
            201
          ],
          [
            513,
            201
          ],
          [
            513,
            220
          ],
          [
            445,
            220
          ]
        ],
        "transcription": "Psoriasis"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            447,
            225
          ],
          [
            588,
            226
          ],
          [
            588,
            246
          ],
          [
            447,
            245
          ]
        ],
        "transcription": "Rheumatoid arthritis"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            448,
            251
          ],
          [
            559,
            251
          ],
          [
            559,
            270
          ],
          [
            448,
            270
          ]
        ],
        "transcription": "Type 1 diabetes"
      },
      {
        "index_in_para": 4,
        "index_para": 3,
        "points": [
          [
            448,
            275
          ],
          [
            567,
            275
          ],
          [
            567,
            294
          ],
          [
            448,
            294
          ]
        ],
        "transcription": "Multiple sclerosis"
      },
      {
        "index_in_para": 5,
        "index_para": 3,
        "points": [
          [
            447,
            299
          ],
          [
            664,
            300
          ],
          [
            664,
            319
          ],
          [
            447,
            318
          ]
        ],
        "transcription": "Systemic lupus erythematosus"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            335,
            343
          ],
          [
            1016,
            343
          ],
          [
            1016,
            369
          ],
          [
            335,
            369
          ]
        ],
        "transcription": "Are AA, Type I Diabetes, Rheumatoid Arthritis, Celiac Disease"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            253,
            366
          ],
          [
            948,
            366
          ],
          [
            948,
            392
          ],
          [
            253,
            392
          ]
        ],
        "transcription": "unrelated diseases? or are there common pathways involved?"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            255,
            433
          ],
          [
            601,
            433
          ],
          [
            601,
            459
          ],
          [
            255,
            459
          ]
        ],
        "transcription": "Support for Common pathways"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            257,
            465
          ],
          [
            977,
            465
          ],
          [
            977,
            487
          ],
          [
            257,
            487
          ]
        ],
        "transcription": "Autoimmunity is Clustered: e.g., AA, Celiac Disease, Tvpe I diabetes"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            968,
            513
          ],
          [
            249,
            513
          ],
          [
            249,
            489
          ],
          [
            968,
            489
          ]
        ],
        "transcription": "occurs together in families and sometimes in the same individual."
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            253,
            517
          ],
          [
            955,
            519
          ],
          [
            955,
            545
          ],
          [
            253,
            544
          ]
        ],
        "transcription": "Genetic evidence: same genes predispose to many autoimmune"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            254,
            541
          ],
          [
            370,
            544
          ],
          [
            369,
            567
          ],
          [
            253,
            564
          ]
        ],
        "transcription": "conditions"
      },
      {
        "index_in_para": 5,
        "index_para": 5,
        "points": [
          [
            255,
            572
          ],
          [
            1031,
            572
          ],
          [
            1031,
            598
          ],
          [
            255,
            598
          ]
        ],
        "transcription": "Pathology is the same: common mediators of tissue injury CD8+NKG2D+"
      },
      {
        "index_in_para": 6,
        "index_para": 5,
        "points": [
          [
            256,
            598
          ],
          [
            589,
            598
          ],
          [
            589,
            621
          ],
          [
            256,
            621
          ]
        ],
        "transcription": "TCells in diabetesCeD and AA"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            261,
            655
          ],
          [
            639,
            655
          ],
          [
            639,
            682
          ],
          [
            261,
            682
          ]
        ],
        "transcription": "Implications: SHARED TREATMENT"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-0998000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            1003,
            75
          ],
          [
            312,
            75
          ],
          [
            312,
            36
          ],
          [
            1003,
            36
          ]
        ],
        "transcription": "Common pathways with other Autoimmune diseases."
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            482,
            79
          ],
          [
            873,
            83
          ],
          [
            873,
            111
          ],
          [
            481,
            107
          ]
        ],
        "transcription": "NK ligands in the target organs"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            280,
            177
          ],
          [
            964,
            179
          ],
          [
            964,
            205
          ],
          [
            280,
            204
          ]
        ],
        "transcription": "In RA, synoviocytes aberrantly express MIC ligands, leading to"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            283,
            214
          ],
          [
            600,
            214
          ],
          [
            600,
            233
          ],
          [
            283,
            233
          ]
        ],
        "transcription": "autoreactive T cell stimulation"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            280,
            275
          ],
          [
            920,
            277
          ],
          [
            920,
            300
          ],
          [
            280,
            299
          ]
        ],
        "transcription": "In Celiac disease, Mic ligands are overexpressed in the gut"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            278,
            310
          ],
          [
            634,
            309
          ],
          [
            634,
            334
          ],
          [
            279,
            332
          ]
        ],
        "transcription": "epithelium during active disease."
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            279,
            371
          ],
          [
            950,
            371
          ],
          [
            950,
            398
          ],
          [
            279,
            398
          ]
        ],
        "transcription": "In Type 1diabetes, Islet cells in prediabetic NOD mice express"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            280,
            402
          ],
          [
            421,
            402
          ],
          [
            421,
            429
          ],
          [
            280,
            429
          ]
        ],
        "transcription": "RAE-1 ligand"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            281,
            516
          ],
          [
            987,
            513
          ],
          [
            987,
            540
          ],
          [
            281,
            543
          ]
        ],
        "transcription": "Hypothesis: In AA, do we find overexpression of ULBP3"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            283,
            555
          ],
          [
            512,
            555
          ],
          [
            512,
            577
          ],
          [
            283,
            577
          ]
        ],
        "transcription": "in the hair follicle?"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            280,
            625
          ],
          [
            941,
            627
          ],
          [
            941,
            654
          ],
          [
            280,
            651
          ]
        ],
        "transcription": "The aberrant expression of NK activating ligands in genetically"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            284,
            663
          ],
          [
            913,
            663
          ],
          [
            913,
            684
          ],
          [
            284,
            684
          ]
        ],
        "transcription": "predisposed individuals may induce or exacerbate disease"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1038000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            268,
            34
          ],
          [
            1013,
            33
          ],
          [
            1013,
            65
          ],
          [
            268,
            66
          ]
        ],
        "transcription": "Danger Signals: ULBP3 Expression in the Hair Follicle"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            428,
            199
          ],
          [
            572,
            199
          ],
          [
            572,
            217
          ],
          [
            428,
            217
          ]
        ],
        "transcription": "control individuals"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            428,
            523
          ],
          [
            524,
            523
          ],
          [
            524,
            547
          ],
          [
            428,
            547
          ]
        ],
        "transcription": "AA patients"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1085000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            472,
            14
          ],
          [
            815,
            17
          ],
          [
            814,
            54
          ],
          [
            472,
            52
          ]
        ],
        "transcription": "Human Buzzing Bees"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            397,
            75
          ],
          [
            887,
            75
          ],
          [
            887,
            107
          ],
          [
            397,
            107
          ]
        ],
        "transcription": "AA is caused by swarm of bees"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            339,
            128
          ],
          [
            947,
            130
          ],
          [
            947,
            167
          ],
          [
            339,
            165
          ]
        ],
        "transcription": "Killer CD8 T cells attracted by NKG2DL"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            689,
            202
          ],
          [
            724,
            202
          ],
          [
            724,
            230
          ],
          [
            689,
            230
          ]
        ],
        "transcription": "AA"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            592,
            232
          ],
          [
            833,
            232
          ],
          [
            833,
            258
          ],
          [
            592,
            258
          ]
        ],
        "transcription": "\"2010\": Bees are identified"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            336,
            291
          ],
          [
            372,
            291
          ],
          [
            372,
            318
          ],
          [
            336,
            318
          ]
        ],
        "transcription": "AA"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            304,
            320
          ],
          [
            409,
            320
          ],
          [
            409,
            344
          ],
          [
            304,
            344
          ]
        ],
        "transcription": "\"Pre-2010\""
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            289,
            352
          ],
          [
            424,
            352
          ],
          [
            424,
            375
          ],
          [
            289,
            375
          ]
        ],
        "transcription": "Swarm of Bees"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            299,
            606
          ],
          [
            457,
            606
          ],
          [
            457,
            629
          ],
          [
            299,
            629
          ]
        ],
        "transcription": "Collaboration with"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            297,
            634
          ],
          [
            443,
            634
          ],
          [
            443,
            660
          ],
          [
            297,
            660
          ]
        ],
        "transcription": "Raphael Clynes"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1087000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            557,
            58
          ],
          [
            711,
            61
          ],
          [
            710,
            114
          ],
          [
            556,
            111
          ]
        ],
        "transcription": "Outline"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            284,
            181
          ],
          [
            707,
            181
          ],
          [
            707,
            213
          ],
          [
            284,
            213
          ]
        ],
        "transcription": "Genetics of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            287,
            306
          ],
          [
            763,
            306
          ],
          [
            763,
            338
          ],
          [
            287,
            338
          ]
        ],
        "transcription": "Immunology of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            288,
            428
          ],
          [
            844,
            428
          ],
          [
            844,
            458
          ],
          [
            288,
            458
          ]
        ],
        "transcription": "Translational and Biomarker Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            283,
            547
          ],
          [
            685,
            548
          ],
          [
            685,
            584
          ],
          [
            283,
            582
          ]
        ],
        "transcription": "Clinical Development Plan"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1172000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            297,
            95
          ],
          [
            968,
            98
          ],
          [
            968,
            126
          ],
          [
            297,
            123
          ]
        ],
        "transcription": "Pre-clinical C3H-HeJ mouse model of alopecia areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            275,
            156
          ],
          [
            920,
            158
          ],
          [
            920,
            180
          ],
          [
            275,
            179
          ]
        ],
        "transcription": "C3H/HeJ Spontaneous alopecia areata -> 15% incidence in 6-12 months"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            391,
            213
          ],
          [
            936,
            213
          ],
          [
            936,
            236
          ],
          [
            391,
            236
          ]
        ],
        "transcription": "C3H/HeJ Skin Graft Model -> 100%incidence in 6-12weeks"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            472,
            244
          ],
          [
            653,
            242
          ],
          [
            653,
            266
          ],
          [
            472,
            267
          ]
        ],
        "transcription": "McEIwee, JID1998"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            287,
            283
          ],
          [
            749,
            287
          ],
          [
            749,
            314
          ],
          [
            287,
            310
          ]
        ],
        "transcription": "Prevention Model->Give drug at the time of grafting"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            289,
            345
          ],
          [
            911,
            345
          ],
          [
            911,
            368
          ],
          [
            289,
            368
          ]
        ],
        "transcription": "Treatment Molel->Give drug after onset of disease6 weeks or later)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            239,
            419
          ],
          [
            367,
            422
          ],
          [
            366,
            446
          ],
          [
            238,
            443
          ]
        ],
        "transcription": "AA skin donor"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            473,
            421
          ],
          [
            639,
            421
          ],
          [
            639,
            447
          ],
          [
            473,
            447
          ]
        ],
        "transcription": "AA graft recipients"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            403,
            609
          ],
          [
            445,
            609
          ],
          [
            445,
            629
          ],
          [
            403,
            629
          ]
        ],
        "transcription": "1cm2"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            381,
            631
          ],
          [
            467,
            634
          ],
          [
            466,
            658
          ],
          [
            380,
            655
          ]
        ],
        "transcription": "skin grafts"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            703,
            624
          ],
          [
            784,
            628
          ],
          [
            783,
            656
          ],
          [
            702,
            652
          ]
        ],
        "transcription": "6 weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            886,
            624
          ],
          [
            974,
            628
          ],
          [
            973,
            655
          ],
          [
            885,
            652
          ]
        ],
        "transcription": "16 weeks"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1199000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            352,
            4
          ],
          [
            941,
            4
          ],
          [
            941,
            30
          ],
          [
            352,
            30
          ]
        ],
        "transcription": "Shared Pathogenesis in Human and Mouse"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            445,
            56
          ],
          [
            844,
            56
          ],
          [
            844,
            78
          ],
          [
            445,
            78
          ]
        ],
        "transcription": "Comparative Transcriptomics Reveals"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            480,
            89
          ],
          [
            816,
            89
          ],
          [
            816,
            111
          ],
          [
            480,
            111
          ]
        ],
        "transcription": "Shared IFN Response Signature"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            311,
            138
          ],
          [
            519,
            138
          ],
          [
            519,
            160
          ],
          [
            311,
            160
          ]
        ],
        "transcription": "Human Alopecia Areata"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            332,
            167
          ],
          [
            495,
            167
          ],
          [
            495,
            189
          ],
          [
            332,
            189
          ]
        ],
        "transcription": "And Normal Scalp"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            571,
            160
          ],
          [
            945,
            160
          ],
          [
            945,
            179
          ],
          [
            571,
            179
          ]
        ],
        "transcription": "Gene Expression in Human and Mouse AA"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            596,
            210
          ],
          [
            661,
            210
          ],
          [
            661,
            234
          ],
          [
            596,
            234
          ]
        ],
        "transcription": "Human"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            836,
            213
          ],
          [
            897,
            213
          ],
          [
            897,
            233
          ],
          [
            836,
            233
          ]
        ],
        "transcription": "Mouse"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            693,
            271
          ],
          [
            732,
            271
          ],
          [
            732,
            292
          ],
          [
            693,
            292
          ]
        ],
        "transcription": "Fold"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            627,
            300
          ],
          [
            731,
            300
          ],
          [
            731,
            323
          ],
          [
            627,
            323
          ]
        ],
        "transcription": "Upregulated"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            935,
            271
          ],
          [
            972,
            271
          ],
          [
            972,
            292
          ],
          [
            935,
            292
          ]
        ],
        "transcription": "Fold"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            871,
            300
          ],
          [
            972,
            300
          ],
          [
            972,
            323
          ],
          [
            871,
            323
          ]
        ],
        "transcription": "Upregulated"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            791,
            299
          ],
          [
            839,
            299
          ],
          [
            839,
            323
          ],
          [
            791,
            323
          ]
        ],
        "transcription": "Gene"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            555,
            302
          ],
          [
            601,
            302
          ],
          [
            601,
            322
          ],
          [
            555,
            322
          ]
        ],
        "transcription": "Gene"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            547,
            336
          ],
          [
            608,
            336
          ],
          [
            608,
            356
          ],
          [
            547,
            356
          ]
        ],
        "transcription": "CXCL10"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            551,
            368
          ],
          [
            605,
            368
          ],
          [
            605,
            392
          ],
          [
            551,
            392
          ]
        ],
        "transcription": "CXCL9"
      },
      {
        "index_in_para": 2,
        "index_para": 10,
        "points": [
          [
            553,
            402
          ],
          [
            601,
            402
          ],
          [
            601,
            426
          ],
          [
            553,
            426
          ]
        ],
        "transcription": "CD8A"
      },
      {
        "index_in_para": 3,
        "index_para": 10,
        "points": [
          [
            551,
            437
          ],
          [
            603,
            437
          ],
          [
            603,
            461
          ],
          [
            551,
            461
          ]
        ],
        "transcription": "STAT1"
      },
      {
        "index_in_para": 4,
        "index_para": 10,
        "points": [
          [
            556,
            471
          ],
          [
            599,
            471
          ],
          [
            599,
            491
          ],
          [
            556,
            491
          ]
        ],
        "transcription": "IFI44"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            788,
            336
          ],
          [
            841,
            336
          ],
          [
            841,
            356
          ],
          [
            788,
            356
          ]
        ],
        "transcription": "Cxcl10"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            791,
            368
          ],
          [
            849,
            368
          ],
          [
            849,
            392
          ],
          [
            791,
            392
          ]
        ],
        "transcription": "Cxc19"
      },
      {
        "index_in_para": 2,
        "index_para": 11,
        "points": [
          [
            791,
            402
          ],
          [
            837,
            402
          ],
          [
            837,
            426
          ],
          [
            791,
            426
          ]
        ],
        "transcription": "Cd8a"
      },
      {
        "index_in_para": 3,
        "index_para": 11,
        "points": [
          [
            791,
            437
          ],
          [
            837,
            437
          ],
          [
            837,
            461
          ],
          [
            791,
            461
          ]
        ],
        "transcription": "Stat1"
      },
      {
        "index_in_para": 4,
        "index_para": 11,
        "points": [
          [
            793,
            469
          ],
          [
            835,
            469
          ],
          [
            835,
            494
          ],
          [
            793,
            494
          ]
        ],
        "transcription": "Ifi44"
      },
      {
        "index_in_para": 5,
        "index_para": 11,
        "points": [
          [
            795,
            504
          ],
          [
            833,
            504
          ],
          [
            833,
            525
          ],
          [
            795,
            525
          ]
        ],
        "transcription": "Ccl2"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            555,
            506
          ],
          [
            600,
            506
          ],
          [
            600,
            525
          ],
          [
            555,
            525
          ]
        ],
        "transcription": "CCL2"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            789,
            539
          ],
          [
            840,
            539
          ],
          [
            840,
            562
          ],
          [
            789,
            562
          ]
        ],
        "transcription": "Gzma"
      },
      {
        "index_in_para": 1,
        "index_para": 13,
        "points": [
          [
            788,
            572
          ],
          [
            841,
            572
          ],
          [
            841,
            596
          ],
          [
            788,
            596
          ]
        ],
        "transcription": "Rsad2"
      },
      {
        "index_in_para": 2,
        "index_para": 13,
        "points": [
          [
            791,
            606
          ],
          [
            840,
            606
          ],
          [
            840,
            630
          ],
          [
            791,
            630
          ]
        ],
        "transcription": "Ptprc"
      },
      {
        "index_in_para": 3,
        "index_para": 13,
        "points": [
          [
            796,
            639
          ],
          [
            832,
            639
          ],
          [
            832,
            660
          ],
          [
            796,
            660
          ]
        ],
        "transcription": "TIr3"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            552,
            540
          ],
          [
            604,
            540
          ],
          [
            604,
            560
          ],
          [
            552,
            560
          ]
        ],
        "transcription": "GZMA"
      },
      {
        "index_in_para": 1,
        "index_para": 14,
        "points": [
          [
            548,
            572
          ],
          [
            607,
            572
          ],
          [
            607,
            596
          ],
          [
            548,
            596
          ]
        ],
        "transcription": "RSAD2"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            549,
            608
          ],
          [
            605,
            608
          ],
          [
            605,
            627
          ],
          [
            549,
            627
          ]
        ],
        "transcription": "PTPRC"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            556,
            639
          ],
          [
            597,
            639
          ],
          [
            597,
            660
          ],
          [
            556,
            660
          ]
        ],
        "transcription": "TLR3"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            549,
            674
          ],
          [
            605,
            674
          ],
          [
            605,
            698
          ],
          [
            549,
            698
          ]
        ],
        "transcription": "CD274"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            787,
            674
          ],
          [
            843,
            674
          ],
          [
            843,
            698
          ],
          [
            787,
            698
          ]
        ],
        "transcription": "Cd274"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            381,
            694
          ],
          [
            416,
            694
          ],
          [
            416,
            715
          ],
          [
            381,
            715
          ]
        ],
        "transcription": "AA"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            436,
            695
          ],
          [
            501,
            695
          ],
          [
            501,
            715
          ],
          [
            436,
            715
          ]
        ],
        "transcription": "Normal"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1225000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            305,
            37
          ],
          [
            963,
            37
          ],
          [
            963,
            68
          ],
          [
            305,
            68
          ]
        ],
        "transcription": "Shared Pathogenesis in Human and Mouse"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            457,
            132
          ],
          [
            808,
            132
          ],
          [
            808,
            164
          ],
          [
            457,
            164
          ]
        ],
        "transcription": "NKG2D\"Stress\"Ligands"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            392,
            176
          ],
          [
            873,
            175
          ],
          [
            873,
            210
          ],
          [
            392,
            212
          ]
        ],
        "transcription": "are Upregulated in the Hair Follicle"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            765,
            292
          ],
          [
            919,
            292
          ],
          [
            919,
            319
          ],
          [
            765,
            319
          ]
        ],
        "transcription": "Mouse Alopecia"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            361,
            294
          ],
          [
            519,
            294
          ],
          [
            519,
            320
          ],
          [
            361,
            320
          ]
        ],
        "transcription": "Human Alopecia"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            807,
            341
          ],
          [
            868,
            341
          ],
          [
            868,
            361
          ],
          [
            807,
            361
          ]
        ],
        "transcription": "C3H/HeJ"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            800,
            364
          ],
          [
            880,
            364
          ],
          [
            880,
            379
          ],
          [
            800,
            379
          ]
        ],
        "transcription": "non-lesional"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            590,
            358
          ],
          [
            493,
            358
          ],
          [
            493,
            342
          ],
          [
            590,
            342
          ]
        ],
        "transcription": "control individual"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            312,
            343
          ],
          [
            393,
            343
          ],
          [
            393,
            356
          ],
          [
            312,
            356
          ]
        ],
        "transcription": "HF of an AA patie"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            932,
            345
          ],
          [
            991,
            345
          ],
          [
            991,
            365
          ],
          [
            932,
            365
          ]
        ],
        "transcription": "C3H/HeJ"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            935,
            367
          ],
          [
            991,
            367
          ],
          [
            991,
            385
          ],
          [
            935,
            385
          ]
        ],
        "transcription": "lesional"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            700,
            353
          ],
          [
            752,
            353
          ],
          [
            752,
            373
          ],
          [
            700,
            373
          ]
        ],
        "transcription": "C57/BI6"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            308,
            606
          ],
          [
            525,
            606
          ],
          [
            525,
            629
          ],
          [
            308,
            629
          ]
        ],
        "transcription": "Pethukova, Nature 2010"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1261000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            325,
            58
          ],
          [
            945,
            60
          ],
          [
            945,
            86
          ],
          [
            325,
            85
          ]
        ],
        "transcription": "CD8NKG2D Cytotoxic T Cells infiltrate the AA Hair follicle"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            405,
            135
          ],
          [
            563,
            135
          ],
          [
            563,
            158
          ],
          [
            405,
            158
          ]
        ],
        "transcription": "Human Alopecia"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            852,
            341
          ],
          [
            893,
            341
          ],
          [
            893,
            367
          ],
          [
            852,
            367
          ]
        ],
        "transcription": "Skin"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            656,
            367
          ],
          [
            611,
            367
          ],
          [
            611,
            346
          ],
          [
            656,
            346
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            613,
            368
          ],
          [
            655,
            368
          ],
          [
            655,
            382
          ],
          [
            613,
            382
          ]
        ],
        "transcription": "NKG2D"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            375,
            367
          ],
          [
            403,
            367
          ],
          [
            403,
            382
          ],
          [
            375,
            382
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            492,
            368
          ],
          [
            531,
            368
          ],
          [
            531,
            382
          ],
          [
            492,
            382
          ]
        ],
        "transcription": "NKG20"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            767,
            394
          ],
          [
            789,
            394
          ],
          [
            789,
            475
          ],
          [
            767,
            475
          ]
        ],
        "transcription": "C3HAA"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            369,
            404
          ],
          [
            587,
            404
          ],
          [
            587,
            426
          ],
          [
            369,
            426
          ]
        ],
        "transcription": "Pethukova, Nature 2010"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            423,
            495
          ],
          [
            559,
            495
          ],
          [
            559,
            518
          ],
          [
            423,
            518
          ]
        ],
        "transcription": "Mouse Alopecia"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            455,
            519
          ],
          [
            513,
            519
          ],
          [
            513,
            539
          ],
          [
            455,
            539
          ]
        ],
        "transcription": "NKG2D"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            320,
            518
          ],
          [
            356,
            518
          ],
          [
            356,
            539
          ],
          [
            320,
            539
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            568,
            518
          ],
          [
            669,
            518
          ],
          [
            669,
            540
          ],
          [
            568,
            540
          ]
        ],
        "transcription": "CD8/NKG2D"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            772,
            552
          ],
          [
            787,
            552
          ],
          [
            787,
            596
          ],
          [
            772,
            596
          ]
        ],
        "transcription": "HED"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            792,
            585
          ],
          [
            811,
            585
          ],
          [
            811,
            682
          ],
          [
            792,
            682
          ]
        ],
        "transcription": "NKG2D"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            280,
            688
          ],
          [
            341,
            688
          ],
          [
            341,
            708
          ],
          [
            280,
            708
          ]
        ],
        "transcription": "C3HAA"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            419,
            688
          ],
          [
            477,
            688
          ],
          [
            477,
            707
          ],
          [
            419,
            707
          ]
        ],
        "transcription": "C3HAA"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            560,
            688
          ],
          [
            619,
            688
          ],
          [
            619,
            707
          ],
          [
            560,
            707
          ]
        ],
        "transcription": "C3H AA"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            825,
            692
          ],
          [
            869,
            692
          ],
          [
            869,
            715
          ],
          [
            825,
            715
          ]
        ],
        "transcription": "CD8"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1302450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            356,
            16
          ],
          [
            905,
            16
          ],
          [
            905,
            42
          ],
          [
            356,
            42
          ]
        ],
        "transcription": "NKG2D+CD8+T cells are Necessary and Sufficient"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            497,
            53
          ],
          [
            759,
            53
          ],
          [
            759,
            79
          ],
          [
            497,
            79
          ]
        ],
        "transcription": "for T Cell Transfer of AA"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            503,
            251
          ],
          [
            592,
            251
          ],
          [
            592,
            266
          ],
          [
            503,
            266
          ]
        ],
        "transcription": "Total Cutaneous"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            493,
            269
          ],
          [
            600,
            269
          ],
          [
            600,
            286
          ],
          [
            493,
            286
          ]
        ],
        "transcription": "Lymph node T cells"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            561,
            291
          ],
          [
            600,
            291
          ],
          [
            600,
            304
          ],
          [
            561,
            304
          ]
        ],
        "transcription": "NKG2D'"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            389,
            417
          ],
          [
            483,
            417
          ],
          [
            483,
            435
          ],
          [
            389,
            435
          ]
        ],
        "transcription": "Alopecic C3H"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            411,
            443
          ],
          [
            461,
            443
          ],
          [
            461,
            458
          ],
          [
            411,
            458
          ]
        ],
        "transcription": "mouse"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            493,
            455
          ],
          [
            587,
            455
          ],
          [
            587,
            470
          ],
          [
            493,
            470
          ]
        ],
        "transcription": "NKG2D depleted"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            487,
            474
          ],
          [
            595,
            474
          ],
          [
            595,
            491
          ],
          [
            487,
            491
          ]
        ],
        "transcription": "Lymph node T cells"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            515,
            559
          ],
          [
            572,
            559
          ],
          [
            572,
            578
          ],
          [
            515,
            578
          ]
        ],
        "transcription": "NKG2DT"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            500,
            582
          ],
          [
            589,
            582
          ],
          [
            589,
            597
          ],
          [
            500,
            597
          ]
        ],
        "transcription": "LN cells alone"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            649,
            561
          ],
          [
            733,
            561
          ],
          [
            733,
            580
          ],
          [
            649,
            580
          ]
        ],
        "transcription": "Normal C3H"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            667,
            588
          ],
          [
            717,
            588
          ],
          [
            717,
            602
          ],
          [
            667,
            602
          ]
        ],
        "transcription": "mouse"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            268,
            675
          ],
          [
            559,
            675
          ],
          [
            559,
            698
          ],
          [
            268,
            698
          ]
        ],
        "transcription": "Xing et al, Nature Medicine 2014"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1353000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            459,
            22
          ],
          [
            847,
            25
          ],
          [
            847,
            53
          ],
          [
            459,
            50
          ]
        ],
        "transcription": "Shared Autoimmune Pathways"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            401,
            64
          ],
          [
            905,
            64
          ],
          [
            905,
            90
          ],
          [
            401,
            90
          ]
        ],
        "transcription": "in Human AA and the C3H Mouse Model"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            283,
            139
          ],
          [
            1025,
            139
          ],
          [
            1025,
            169
          ],
          [
            283,
            169
          ]
        ],
        "transcription": "Three lines of evidence support the relevance of the model"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            568,
            178
          ],
          [
            736,
            175
          ],
          [
            736,
            206
          ],
          [
            568,
            209
          ]
        ],
        "transcription": "to human AA"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            346,
            237
          ],
          [
            993,
            239
          ],
          [
            993,
            265
          ],
          [
            345,
            265
          ]
        ],
        "transcription": "1. End-organ drivers -> NKG2DLULBP3, MICA, and IL-15 in HF"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            346,
            271
          ],
          [
            797,
            271
          ],
          [
            797,
            293
          ],
          [
            346,
            293
          ]
        ],
        "transcription": "2.Immune effectors -> CD8 T cell effectors"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            345,
            298
          ],
          [
            878,
            303
          ],
          [
            876,
            324
          ],
          [
            344,
            321
          ]
        ],
        "transcription": "3.Biomarkers -> IFN-transcriptional signature"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            241,
            379
          ],
          [
            996,
            379
          ],
          [
            996,
            405
          ],
          [
            241,
            405
          ]
        ],
        "transcription": "Argues for the translational relevance of mechanistic studies"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            240,
            416
          ],
          [
            481,
            414
          ],
          [
            481,
            442
          ],
          [
            240,
            443
          ]
        ],
        "transcription": "in the mouse model."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            243,
            490
          ],
          [
            972,
            490
          ],
          [
            972,
            520
          ],
          [
            243,
            520
          ]
        ],
        "transcription": "Using the mouse model: can we identify targetable cytokine"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            240,
            531
          ],
          [
            977,
            529
          ],
          [
            977,
            561
          ],
          [
            240,
            563
          ]
        ],
        "transcription": "pathways in AA (as for IL-6/TNF in RA and IL-17 in psoriasis)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            241,
            606
          ],
          [
            769,
            608
          ],
          [
            769,
            635
          ],
          [
            241,
            634
          ]
        ],
        "transcription": "Such as: IFNgamma, IL15, IL2, IL7, others.."
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            300,
            682
          ],
          [
            905,
            682
          ],
          [
            905,
            712
          ],
          [
            300,
            712
          ]
        ],
        "transcription": "Hypothesis: How do we target our CD8+ killers?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1428000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            240,
            79
          ],
          [
            987,
            79
          ],
          [
            987,
            110
          ],
          [
            240,
            110
          ]
        ],
        "transcription": "IL-15: Required for maintaining killer CD8 T cells.."
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            485,
            124
          ],
          [
            736,
            124
          ],
          [
            736,
            152
          ],
          [
            485,
            152
          ]
        ],
        "transcription": "an Achilles heel?"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            423,
            230
          ],
          [
            696,
            230
          ],
          [
            696,
            248
          ],
          [
            423,
            248
          ]
        ],
        "transcription": "Antigen-presenting cell/Epithelial CellO"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            392,
            349
          ],
          [
            479,
            349
          ],
          [
            479,
            373
          ],
          [
            392,
            373
          ]
        ],
        "transcription": "Potential"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            363,
            379
          ],
          [
            476,
            379
          ],
          [
            476,
            401
          ],
          [
            363,
            401
          ]
        ],
        "transcription": "Therapeutic"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            372,
            408
          ],
          [
            478,
            405
          ],
          [
            479,
            433
          ],
          [
            373,
            436
          ]
        ],
        "transcription": "Targets for"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            393,
            437
          ],
          [
            477,
            437
          ],
          [
            477,
            461
          ],
          [
            393,
            461
          ]
        ],
        "transcription": "Alopecia"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            413,
            467
          ],
          [
            477,
            467
          ],
          [
            477,
            487
          ],
          [
            413,
            487
          ]
        ],
        "transcription": "Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            523,
            646
          ],
          [
            643,
            646
          ],
          [
            643,
            670
          ],
          [
            523,
            670
          ]
        ],
        "transcription": "CD8+Tcell"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1464000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            389,
            25
          ],
          [
            892,
            26
          ],
          [
            892,
            57
          ],
          [
            389,
            56
          ]
        ],
        "transcription": "IL-15 and IFNy are Critical Cytokines for"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            471,
            66
          ],
          [
            812,
            66
          ],
          [
            812,
            97
          ],
          [
            471,
            97
          ]
        ],
        "transcription": "Alopecic CD8 Killer T Cells"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            368,
            143
          ],
          [
            915,
            141
          ],
          [
            915,
            167
          ],
          [
            368,
            170
          ]
        ],
        "transcription": "Hypothesis: Target their Effector JAK Kinases?"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            725,
            191
          ],
          [
            951,
            192
          ],
          [
            951,
            218
          ],
          [
            725,
            217
          ]
        ],
        "transcription": "Produced by killer T cells"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            253,
            213
          ],
          [
            513,
            213
          ],
          [
            513,
            236
          ],
          [
            253,
            236
          ]
        ],
        "transcription": "Highly expressed in diseased"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            251,
            242
          ],
          [
            483,
            241
          ],
          [
            483,
            263
          ],
          [
            251,
            265
          ]
        ],
        "transcription": "human and murine AA HF"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            728,
            251
          ],
          [
            996,
            251
          ],
          [
            996,
            274
          ],
          [
            728,
            274
          ]
        ],
        "transcription": "Dominates human and murine"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            726,
            276
          ],
          [
            935,
            281
          ],
          [
            934,
            307
          ],
          [
            725,
            303
          ]
        ],
        "transcription": "AA \"signature\", driving"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            726,
            307
          ],
          [
            847,
            310
          ],
          [
            846,
            334
          ],
          [
            725,
            331
          ]
        ],
        "transcription": "inflammation."
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            581,
            280
          ],
          [
            662,
            283
          ],
          [
            661,
            307
          ],
          [
            580,
            303
          ]
        ],
        "transcription": "CD8 Killer"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            595,
            310
          ],
          [
            653,
            310
          ],
          [
            653,
            334
          ],
          [
            595,
            334
          ]
        ],
        "transcription": "Tcells"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            253,
            299
          ],
          [
            492,
            299
          ],
          [
            492,
            322
          ],
          [
            253,
            322
          ]
        ],
        "transcription": "Drives CD8 killer activation"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            253,
            357
          ],
          [
            520,
            357
          ],
          [
            520,
            380
          ],
          [
            253,
            380
          ]
        ],
        "transcription": "Ab blockade prevents disease"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            729,
            367
          ],
          [
            996,
            367
          ],
          [
            996,
            389
          ],
          [
            729,
            389
          ]
        ],
        "transcription": "Ab blockade prevents disease"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            637,
            435
          ],
          [
            694,
            439
          ],
          [
            692,
            464
          ],
          [
            636,
            460
          ]
        ],
        "transcription": "IFN-Y"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            549,
            437
          ],
          [
            603,
            437
          ],
          [
            603,
            461
          ],
          [
            549,
            461
          ]
        ],
        "transcription": "IL-15"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            841,
            453
          ],
          [
            898,
            457
          ],
          [
            896,
            486
          ],
          [
            839,
            483
          ]
        ],
        "transcription": "IFN-Y"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            360,
            459
          ],
          [
            413,
            459
          ],
          [
            413,
            483
          ],
          [
            360,
            483
          ]
        ],
        "transcription": "IL-15"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1508000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            239,
            16
          ],
          [
            511,
            16
          ],
          [
            511,
            38
          ],
          [
            239,
            38
          ]
        ],
        "transcription": "Positive feedback loop in AA"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            943,
            20
          ],
          [
            1015,
            23
          ],
          [
            1014,
            47
          ],
          [
            942,
            43
          ]
        ],
        "transcription": "Follicular"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            916,
            49
          ],
          [
            1013,
            49
          ],
          [
            1013,
            68
          ],
          [
            916,
            68
          ]
        ],
        "transcription": "epithelial cell"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            731,
            21
          ],
          [
            797,
            26
          ],
          [
            795,
            49
          ],
          [
            729,
            44
          ]
        ],
        "transcription": "Nucleus"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            609,
            93
          ],
          [
            699,
            93
          ],
          [
            699,
            122
          ],
          [
            609,
            122
          ]
        ],
        "transcription": "-STAT1"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            291,
            101
          ],
          [
            408,
            101
          ],
          [
            408,
            119
          ],
          [
            291,
            119
          ]
        ],
        "transcription": "Hair follicle bulb"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            292,
            124
          ],
          [
            407,
            124
          ],
          [
            407,
            143
          ],
          [
            292,
            143
          ]
        ],
        "transcription": "(anagen phase)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            560,
            128
          ],
          [
            637,
            128
          ],
          [
            637,
            151
          ],
          [
            560,
            151
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            505,
            159
          ],
          [
            579,
            162
          ],
          [
            578,
            182
          ],
          [
            504,
            178
          ]
        ],
        "transcription": "Tofacitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            751,
            164
          ],
          [
            841,
            164
          ],
          [
            841,
            183
          ],
          [
            751,
            183
          ]
        ],
        "transcription": "MHC classI"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            759,
            187
          ],
          [
            829,
            187
          ],
          [
            829,
            205
          ],
          [
            759,
            205
          ]
        ],
        "transcription": "+peptide"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            617,
            197
          ],
          [
            649,
            197
          ],
          [
            649,
            217
          ],
          [
            617,
            217
          ]
        ],
        "transcription": "JAK2"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            672,
            212
          ],
          [
            740,
            212
          ],
          [
            740,
            233
          ],
          [
            672,
            233
          ]
        ],
        "transcription": "NKG2DL"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            1018,
            280
          ],
          [
            950,
            280
          ],
          [
            950,
            253
          ],
          [
            1018,
            253
          ]
        ],
        "transcription": "IL-15Ra"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            521,
            255
          ],
          [
            592,
            258
          ],
          [
            591,
            281
          ],
          [
            520,
            278
          ]
        ],
        "transcription": "IFN-yR1-"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            865,
            265
          ],
          [
            908,
            264
          ],
          [
            907,
            291
          ],
          [
            863,
            293
          ]
        ],
        "transcription": "IL-15"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            616,
            288
          ],
          [
            680,
            292
          ],
          [
            679,
            315
          ],
          [
            614,
            312
          ]
        ],
        "transcription": "IFN-yR2"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            816,
            323
          ],
          [
            853,
            323
          ],
          [
            853,
            343
          ],
          [
            816,
            343
          ]
        ],
        "transcription": "TCR"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            519,
            338
          ],
          [
            599,
            338
          ],
          [
            599,
            367
          ],
          [
            519,
            367
          ]
        ],
        "transcription": "IFN-Y"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            873,
            351
          ],
          [
            928,
            351
          ],
          [
            928,
            375
          ],
          [
            873,
            375
          ]
        ],
        "transcription": "IL-2R"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            677,
            382
          ],
          [
            736,
            385
          ],
          [
            735,
            405
          ],
          [
            676,
            402
          ]
        ],
        "transcription": "NKG2D"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            748,
            396
          ],
          [
            784,
            396
          ],
          [
            784,
            416
          ],
          [
            748,
            416
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            892,
            404
          ],
          [
            916,
            404
          ],
          [
            916,
            420
          ],
          [
            892,
            420
          ]
        ],
        "transcription": "AK3"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            919,
            420
          ],
          [
            944,
            420
          ],
          [
            944,
            437
          ],
          [
            919,
            437
          ]
        ],
        "transcription": "JAK1"
      },
      {
        "index_in_para": 0,
        "index_para": 21,
        "points": [
          [
            789,
            422
          ],
          [
            865,
            422
          ],
          [
            865,
            441
          ],
          [
            789,
            441
          ]
        ],
        "transcription": "Tofacitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 22,
        "points": [
          [
            237,
            429
          ],
          [
            276,
            429
          ],
          [
            276,
            450
          ],
          [
            237,
            450
          ]
        ],
        "transcription": "CD8*"
      },
      {
        "index_in_para": 1,
        "index_para": 22,
        "points": [
          [
            236,
            453
          ],
          [
            299,
            453
          ],
          [
            299,
            472
          ],
          [
            236,
            472
          ]
        ],
        "transcription": "NKG2D"
      },
      {
        "index_in_para": 2,
        "index_para": 22,
        "points": [
          [
            234,
            473
          ],
          [
            288,
            477
          ],
          [
            287,
            497
          ],
          [
            233,
            493
          ]
        ],
        "transcription": "T cells"
      },
      {
        "index_in_para": 0,
        "index_para": 23,
        "points": [
          [
            820,
            467
          ],
          [
            872,
            467
          ],
          [
            872,
            492
          ],
          [
            820,
            492
          ]
        ],
        "transcription": "STATS"
      },
      {
        "index_in_para": 0,
        "index_para": 24,
        "points": [
          [
            903,
            488
          ],
          [
            979,
            488
          ],
          [
            979,
            507
          ],
          [
            903,
            507
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 25,
        "points": [
          [
            359,
            510
          ],
          [
            403,
            514
          ],
          [
            401,
            535
          ],
          [
            357,
            532
          ]
        ],
        "transcription": "Tcell"
      },
      {
        "index_in_para": 1,
        "index_para": 25,
        "points": [
          [
            336,
            537
          ],
          [
            425,
            537
          ],
          [
            425,
            556
          ],
          [
            336,
            556
          ]
        ],
        "transcription": "proliferation"
      },
      {
        "index_in_para": 0,
        "index_para": 26,
        "points": [
          [
            525,
            523
          ],
          [
            625,
            523
          ],
          [
            625,
            541
          ],
          [
            525,
            541
          ]
        ],
        "transcription": "CD8-NKG2D"
      },
      {
        "index_in_para": 1,
        "index_para": 26,
        "points": [
          [
            523,
            543
          ],
          [
            569,
            543
          ],
          [
            569,
            566
          ],
          [
            523,
            566
          ]
        ],
        "transcription": "Tcell"
      },
      {
        "index_in_para": 0,
        "index_para": 27,
        "points": [
          [
            731,
            540
          ],
          [
            795,
            540
          ],
          [
            795,
            559
          ],
          [
            731,
            559
          ]
        ],
        "transcription": "Nucleus"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1550000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            417,
            169
          ],
          [
            853,
            169
          ],
          [
            853,
            192
          ],
          [
            417,
            192
          ]
        ],
        "transcription": "JAK 1 and JAK 3 Inhibitors in Clinical Development"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            914,
            182
          ],
          [
            972,
            189
          ],
          [
            968,
            221
          ],
          [
            910,
            213
          ]
        ],
        "transcription": "IFN-Y"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            296,
            193
          ],
          [
            351,
            193
          ],
          [
            351,
            222
          ],
          [
            296,
            222
          ]
        ],
        "transcription": "IL-15"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            689,
            245
          ],
          [
            752,
            245
          ],
          [
            752,
            269
          ],
          [
            689,
            269
          ]
        ],
        "transcription": "STATUS"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            691,
            270
          ],
          [
            816,
            270
          ],
          [
            816,
            292
          ],
          [
            691,
            292
          ]
        ],
        "transcription": "FDAapproved RA"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            691,
            295
          ],
          [
            820,
            295
          ],
          [
            820,
            318
          ],
          [
            691,
            318
          ]
        ],
        "transcription": "Psoriasis Phase ll"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            692,
            320
          ],
          [
            719,
            320
          ],
          [
            719,
            343
          ],
          [
            692,
            343
          ]
        ],
        "transcription": "IBD"
      },
      {
        "index_in_para": 4,
        "index_para": 3,
        "points": [
          [
            761,
            322
          ],
          [
            821,
            322
          ],
          [
            821,
            341
          ],
          [
            761,
            341
          ]
        ],
        "transcription": "Phase II"
      },
      {
        "index_in_para": 5,
        "index_para": 3,
        "points": [
          [
            690,
            343
          ],
          [
            719,
            348
          ],
          [
            715,
            370
          ],
          [
            687,
            366
          ]
        ],
        "transcription": "RA"
      },
      {
        "index_in_para": 6,
        "index_para": 3,
        "points": [
          [
            760,
            344
          ],
          [
            823,
            344
          ],
          [
            823,
            368
          ],
          [
            760,
            368
          ]
        ],
        "transcription": "PhaseII"
      },
      {
        "index_in_para": 7,
        "index_para": 3,
        "points": [
          [
            689,
            371
          ],
          [
            716,
            371
          ],
          [
            716,
            394
          ],
          [
            689,
            394
          ]
        ],
        "transcription": "RA"
      },
      {
        "index_in_para": 8,
        "index_para": 3,
        "points": [
          [
            760,
            371
          ],
          [
            819,
            371
          ],
          [
            819,
            394
          ],
          [
            760,
            394
          ]
        ],
        "transcription": "Phasel"
      },
      {
        "index_in_para": 9,
        "index_para": 3,
        "points": [
          [
            690,
            392
          ],
          [
            847,
            395
          ],
          [
            846,
            421
          ],
          [
            689,
            418
          ]
        ],
        "transcription": "FDA approved MF, PV"
      },
      {
        "index_in_para": 10,
        "index_para": 3,
        "points": [
          [
            689,
            421
          ],
          [
            820,
            421
          ],
          [
            820,
            443
          ],
          [
            689,
            443
          ]
        ],
        "transcription": "Psoriasis Phase Il"
      },
      {
        "index_in_para": 11,
        "index_para": 3,
        "points": [
          [
            689,
            445
          ],
          [
            717,
            445
          ],
          [
            717,
            469
          ],
          [
            689,
            469
          ]
        ],
        "transcription": "RA"
      },
      {
        "index_in_para": 12,
        "index_para": 3,
        "points": [
          [
            761,
            447
          ],
          [
            821,
            447
          ],
          [
            821,
            467
          ],
          [
            761,
            467
          ]
        ],
        "transcription": "Phase II"
      },
      {
        "index_in_para": 13,
        "index_para": 3,
        "points": [
          [
            689,
            471
          ],
          [
            717,
            471
          ],
          [
            717,
            494
          ],
          [
            689,
            494
          ]
        ],
        "transcription": "RA"
      },
      {
        "index_in_para": 14,
        "index_para": 3,
        "points": [
          [
            760,
            471
          ],
          [
            823,
            471
          ],
          [
            823,
            495
          ],
          [
            760,
            495
          ]
        ],
        "transcription": "PhaseII"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            421,
            248
          ],
          [
            469,
            248
          ],
          [
            469,
            267
          ],
          [
            421,
            267
          ]
        ],
        "transcription": "DRUG"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            423,
            271
          ],
          [
            491,
            271
          ],
          [
            491,
            292
          ],
          [
            423,
            292
          ]
        ],
        "transcription": "Tofacitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            537,
            248
          ],
          [
            603,
            248
          ],
          [
            603,
            267
          ],
          [
            537,
            267
          ]
        ],
        "transcription": "TARGET"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            536,
            270
          ],
          [
            607,
            270
          ],
          [
            607,
            292
          ],
          [
            536,
            292
          ]
        ],
        "transcription": "JAK1,2,3"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            617,
            248
          ],
          [
            664,
            248
          ],
          [
            664,
            267
          ],
          [
            617,
            267
          ]
        ],
        "transcription": "Route"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            620,
            270
          ],
          [
            652,
            270
          ],
          [
            652,
            292
          ],
          [
            620,
            292
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 2,
        "index_para": 6,
        "points": [
          [
            620,
            295
          ],
          [
            671,
            295
          ],
          [
            671,
            319
          ],
          [
            620,
            319
          ]
        ],
        "transcription": "topical"
      },
      {
        "index_in_para": 3,
        "index_para": 6,
        "points": [
          [
            621,
            322
          ],
          [
            652,
            322
          ],
          [
            652,
            343
          ],
          [
            621,
            343
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 4,
        "index_para": 6,
        "points": [
          [
            621,
            348
          ],
          [
            652,
            348
          ],
          [
            652,
            368
          ],
          [
            621,
            368
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 5,
        "index_para": 6,
        "points": [
          [
            621,
            372
          ],
          [
            651,
            372
          ],
          [
            651,
            394
          ],
          [
            621,
            394
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 6,
        "index_para": 6,
        "points": [
          [
            621,
            397
          ],
          [
            651,
            397
          ],
          [
            651,
            418
          ],
          [
            621,
            418
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 7,
        "index_para": 6,
        "points": [
          [
            620,
            421
          ],
          [
            671,
            421
          ],
          [
            671,
            445
          ],
          [
            620,
            445
          ]
        ],
        "transcription": "topical"
      },
      {
        "index_in_para": 8,
        "index_para": 6,
        "points": [
          [
            621,
            447
          ],
          [
            652,
            447
          ],
          [
            652,
            469
          ],
          [
            621,
            469
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 9,
        "index_para": 6,
        "points": [
          [
            621,
            472
          ],
          [
            652,
            472
          ],
          [
            652,
            494
          ],
          [
            621,
            494
          ]
        ],
        "transcription": "oral"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            419,
            345
          ],
          [
            476,
            345
          ],
          [
            476,
            369
          ],
          [
            419,
            369
          ]
        ],
        "transcription": "VX-509"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            420,
            373
          ],
          [
            461,
            373
          ],
          [
            461,
            393
          ],
          [
            420,
            393
          ]
        ],
        "transcription": "R348"
      },
      {
        "index_in_para": 2,
        "index_para": 7,
        "points": [
          [
            417,
            394
          ],
          [
            492,
            394
          ],
          [
            492,
            417
          ],
          [
            417,
            417
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            536,
            347
          ],
          [
            576,
            347
          ],
          [
            576,
            368
          ],
          [
            536,
            368
          ]
        ],
        "transcription": "JAK3"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            536,
            372
          ],
          [
            577,
            372
          ],
          [
            577,
            393
          ],
          [
            536,
            393
          ]
        ],
        "transcription": "JAK3"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            536,
            394
          ],
          [
            591,
            394
          ],
          [
            591,
            418
          ],
          [
            536,
            418
          ]
        ],
        "transcription": "JAK1,2"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            536,
            443
          ],
          [
            591,
            446
          ],
          [
            590,
            472
          ],
          [
            534,
            468
          ]
        ],
        "transcription": "JAK1,2"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            535,
            470
          ],
          [
            577,
            470
          ],
          [
            577,
            495
          ],
          [
            535,
            495
          ]
        ],
        "transcription": "JAK1"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            421,
            447
          ],
          [
            489,
            447
          ],
          [
            489,
            469
          ],
          [
            421,
            469
          ]
        ],
        "transcription": "Baricitinib"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            420,
            471
          ],
          [
            501,
            471
          ],
          [
            501,
            494
          ],
          [
            420,
            494
          ]
        ],
        "transcription": "GLPG0634"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            353,
            469
          ],
          [
            379,
            469
          ],
          [
            379,
            486
          ],
          [
            353,
            486
          ]
        ],
        "transcription": "Jak3"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            909,
            469
          ],
          [
            936,
            469
          ],
          [
            936,
            484
          ],
          [
            909,
            484
          ]
        ],
        "transcription": "Jak1"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            287,
            470
          ],
          [
            319,
            463
          ],
          [
            323,
            483
          ],
          [
            290,
            489
          ]
        ],
        "transcription": "Jak1"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            975,
            470
          ],
          [
            999,
            476
          ],
          [
            995,
            493
          ],
          [
            970,
            487
          ]
        ],
        "transcription": "Jak2"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            813,
            684
          ],
          [
            1029,
            686
          ],
          [
            1029,
            709
          ],
          [
            813,
            708
          ]
        ],
        "transcription": "O'Shea, Immunity 2012"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1561000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            297,
            95
          ],
          [
            968,
            98
          ],
          [
            968,
            126
          ],
          [
            297,
            123
          ]
        ],
        "transcription": "Pre-clinical C3H-HeJ mouse model of alopecia areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            275,
            156
          ],
          [
            920,
            158
          ],
          [
            920,
            180
          ],
          [
            275,
            179
          ]
        ],
        "transcription": "C3H/HeJ Spontaneous alopecia areata ->15% incidence in 6-12 months"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            391,
            213
          ],
          [
            936,
            213
          ],
          [
            936,
            236
          ],
          [
            391,
            236
          ]
        ],
        "transcription": "C3H/HeJ Skin Graft Model->100%incidence in 6-12weeks"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            472,
            244
          ],
          [
            653,
            242
          ],
          [
            653,
            266
          ],
          [
            472,
            267
          ]
        ],
        "transcription": "McEIwee, JID 1998"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            287,
            283
          ],
          [
            749,
            287
          ],
          [
            749,
            314
          ],
          [
            287,
            310
          ]
        ],
        "transcription": "Prevention Model->Give drug at the time of grafting"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            289,
            345
          ],
          [
            911,
            345
          ],
          [
            911,
            368
          ],
          [
            289,
            368
          ]
        ],
        "transcription": "Treatment Model-> Give drug after onset of disease6weeks or later)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            239,
            419
          ],
          [
            367,
            422
          ],
          [
            366,
            446
          ],
          [
            238,
            443
          ]
        ],
        "transcription": "AA skin donor"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            473,
            421
          ],
          [
            639,
            421
          ],
          [
            639,
            447
          ],
          [
            473,
            447
          ]
        ],
        "transcription": "AA graft recipients"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            403,
            609
          ],
          [
            445,
            609
          ],
          [
            445,
            629
          ],
          [
            403,
            629
          ]
        ],
        "transcription": "1cm2"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            381,
            631
          ],
          [
            467,
            634
          ],
          [
            466,
            658
          ],
          [
            380,
            655
          ]
        ],
        "transcription": "skin grafts"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            703,
            624
          ],
          [
            784,
            628
          ],
          [
            783,
            656
          ],
          [
            702,
            652
          ]
        ],
        "transcription": "6weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            886,
            624
          ],
          [
            975,
            628
          ],
          [
            974,
            655
          ],
          [
            885,
            652
          ]
        ],
        "transcription": "16 weeks"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1568000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            371,
            278
          ],
          [
            939,
            281
          ],
          [
            939,
            311
          ],
          [
            371,
            308
          ]
        ],
        "transcription": "Pre-clinical studies with systemic delivery of"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            447,
            318
          ],
          [
            857,
            319
          ],
          [
            857,
            347
          ],
          [
            447,
            345
          ]
        ],
        "transcription": "JAK1/2 Inhibitor (ruxolitinib) and"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            487,
            355
          ],
          [
            819,
            357
          ],
          [
            818,
            388
          ],
          [
            487,
            385
          ]
        ],
        "transcription": "JAK3 inhibitor (tofacitinib)"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1620000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            239,
            28
          ],
          [
            1028,
            30
          ],
          [
            1028,
            62
          ],
          [
            239,
            60
          ]
        ],
        "transcription": "JAK 1/2 Inhibitor (Ruxolitinib) Prevents Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            660,
            177
          ],
          [
            783,
            177
          ],
          [
            783,
            196
          ],
          [
            660,
            196
          ]
        ],
        "transcription": "JAK1/2Inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            236,
            212
          ],
          [
            259,
            212
          ],
          [
            259,
            428
          ],
          [
            236,
            428
          ]
        ],
        "transcription": "Mice without hair loss"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            481,
            226
          ],
          [
            609,
            226
          ],
          [
            609,
            249
          ],
          [
            481,
            249
          ]
        ],
        "transcription": "JAK1/2inhibitor"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            521,
            254
          ],
          [
            569,
            254
          ],
          [
            569,
            278
          ],
          [
            521,
            278
          ]
        ],
        "transcription": "(N=7)"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            479,
            295
          ],
          [
            561,
            295
          ],
          [
            561,
            318
          ],
          [
            479,
            318
          ]
        ],
        "transcription": "PBS (N=9)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            707,
            405
          ],
          [
            740,
            405
          ],
          [
            740,
            426
          ],
          [
            707,
            426
          ]
        ],
        "transcription": "PBS"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            496,
            549
          ],
          [
            605,
            549
          ],
          [
            605,
            566
          ],
          [
            496,
            566
          ]
        ],
        "transcription": "JAK1/2Inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            519,
            587
          ],
          [
            551,
            591
          ],
          [
            549,
            611
          ],
          [
            516,
            606
          ]
        ],
        "transcription": "PBS"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            240,
            680
          ],
          [
            533,
            680
          ],
          [
            533,
            703
          ],
          [
            240,
            703
          ]
        ],
        "transcription": "Xing et al, Nature Medicine 2014"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1681000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            391,
            37
          ],
          [
            867,
            38
          ],
          [
            867,
            61
          ],
          [
            391,
            60
          ]
        ],
        "transcription": "Normalization of inflammatory infiltrates following"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            343,
            66
          ],
          [
            911,
            63
          ],
          [
            911,
            87
          ],
          [
            343,
            90
          ]
        ],
        "transcription": "systemic delivery of anti-IL15RB, Tofacitinib and Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            264,
            222
          ],
          [
            291,
            222
          ],
          [
            291,
            237
          ],
          [
            264,
            237
          ]
        ],
        "transcription": "PBS"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            776,
            228
          ],
          [
            923,
            228
          ],
          [
            923,
            245
          ],
          [
            776,
            245
          ]
        ],
        "transcription": "SKIFLOWCYTOMETRY"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            774,
            245
          ],
          [
            836,
            248
          ],
          [
            835,
            266
          ],
          [
            773,
            263
          ]
        ],
        "transcription": "Untreated"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            876,
            249
          ],
          [
            920,
            249
          ],
          [
            920,
            262
          ],
          [
            876,
            262
          ]
        ],
        "transcription": "Treated"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            252,
            275
          ],
          [
            301,
            275
          ],
          [
            301,
            289
          ],
          [
            252,
            289
          ]
        ],
        "transcription": "aJL-15Rb"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            941,
            303
          ],
          [
            1029,
            303
          ],
          [
            1029,
            322
          ],
          [
            941,
            322
          ]
        ],
        "transcription": "Anti-IL-15RmAb"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            257,
            369
          ],
          [
            284,
            369
          ],
          [
            284,
            385
          ],
          [
            257,
            385
          ]
        ],
        "transcription": "PBS"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            948,
            424
          ],
          [
            1021,
            424
          ],
          [
            1021,
            438
          ],
          [
            948,
            438
          ]
        ],
        "transcription": "JAK3 Inhibitor"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            948,
            442
          ],
          [
            1004,
            442
          ],
          [
            1004,
            455
          ],
          [
            948,
            455
          ]
        ],
        "transcription": "Tofacitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            237,
            428
          ],
          [
            305,
            428
          ],
          [
            305,
            442
          ],
          [
            237,
            442
          ]
        ],
        "transcription": "JAK3inhibitor"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            243,
            447
          ],
          [
            296,
            447
          ],
          [
            296,
            462
          ],
          [
            243,
            462
          ]
        ],
        "transcription": "Tofacitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            260,
            539
          ],
          [
            285,
            539
          ],
          [
            285,
            555
          ],
          [
            260,
            555
          ]
        ],
        "transcription": "PBS"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            945,
            544
          ],
          [
            1028,
            544
          ],
          [
            1028,
            559
          ],
          [
            945,
            559
          ]
        ],
        "transcription": "JAK1/2Inhibitor"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            947,
            561
          ],
          [
            1003,
            561
          ],
          [
            1003,
            576
          ],
          [
            947,
            576
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            236,
            597
          ],
          [
            307,
            597
          ],
          [
            307,
            611
          ],
          [
            236,
            611
          ]
        ],
        "transcription": "IAK1/2inhibito"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            244,
            617
          ],
          [
            301,
            617
          ],
          [
            301,
            631
          ],
          [
            244,
            631
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            840,
            623
          ],
          [
            868,
            623
          ],
          [
            868,
            638
          ],
          [
            840,
            638
          ]
        ],
        "transcription": "CD&"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            337,
            654
          ],
          [
            360,
            654
          ],
          [
            360,
            668
          ],
          [
            337,
            668
          ]
        ],
        "transcription": "CD4"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            399,
            654
          ],
          [
            423,
            654
          ],
          [
            423,
            670
          ],
          [
            399,
            670
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            473,
            654
          ],
          [
            507,
            654
          ],
          [
            507,
            668
          ],
          [
            473,
            668
          ]
        ],
        "transcription": "MHC-I"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            540,
            654
          ],
          [
            575,
            654
          ],
          [
            575,
            668
          ],
          [
            540,
            668
          ]
        ],
        "transcription": "MHC-II"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            676,
            654
          ],
          [
            707,
            654
          ],
          [
            707,
            668
          ],
          [
            676,
            668
          ]
        ],
        "transcription": "RAE-1"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            612,
            655
          ],
          [
            632,
            655
          ],
          [
            632,
            668
          ],
          [
            612,
            668
          ]
        ],
        "transcription": "H60"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            240,
            688
          ],
          [
            533,
            688
          ],
          [
            533,
            711
          ],
          [
            240,
            711
          ]
        ],
        "transcription": "Xing et al, Nature Medicine 2014"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1689000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            387,
            277
          ],
          [
            919,
            279
          ],
          [
            919,
            311
          ],
          [
            387,
            308
          ]
        ],
        "transcription": "Pre-clinical studies with TOPICAL delivery"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            460,
            319
          ],
          [
            844,
            319
          ],
          [
            844,
            349
          ],
          [
            460,
            349
          ]
        ],
        "transcription": "of JAK1/2 Inhibitor (ruxolitinib)"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            459,
            356
          ],
          [
            843,
            356
          ],
          [
            843,
            386
          ],
          [
            459,
            386
          ]
        ],
        "transcription": "and JAK3 inhibitor (tofacitinib)"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1752000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            303,
            4
          ],
          [
            981,
            4
          ],
          [
            981,
            22
          ],
          [
            303,
            22
          ]
        ],
        "transcription": "opicaltreatmentusing either JAK1/2 orJAK3inhibitor results in"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            372,
            33
          ],
          [
            907,
            33
          ],
          [
            907,
            56
          ],
          [
            372,
            56
          ]
        ],
        "transcription": "reversal of long-standing AA (2-3 months duration)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            300,
            102
          ],
          [
            411,
            102
          ],
          [
            411,
            124
          ],
          [
            300,
            124
          ]
        ],
        "transcription": "Control Mice"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            527,
            102
          ],
          [
            717,
            102
          ],
          [
            717,
            124
          ],
          [
            527,
            124
          ]
        ],
        "transcription": "JAK3 inhibitor Treated"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            793,
            103
          ],
          [
            996,
            103
          ],
          [
            996,
            122
          ],
          [
            793,
            122
          ]
        ],
        "transcription": "JAK1/2Inhibitor Treated"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            785,
            143
          ],
          [
            841,
            143
          ],
          [
            841,
            161
          ],
          [
            785,
            161
          ]
        ],
        "transcription": "Before"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            784,
            167
          ],
          [
            867,
            167
          ],
          [
            867,
            185
          ],
          [
            784,
            185
          ]
        ],
        "transcription": "Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            513,
            150
          ],
          [
            568,
            150
          ],
          [
            568,
            169
          ],
          [
            513,
            169
          ]
        ],
        "transcription": "Before"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            512,
            175
          ],
          [
            666,
            166
          ],
          [
            667,
            189
          ],
          [
            513,
            198
          ]
        ],
        "transcription": "Treatment 4 weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            247,
            151
          ],
          [
            303,
            151
          ],
          [
            303,
            169
          ],
          [
            247,
            169
          ]
        ],
        "transcription": "Before"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            877,
            154
          ],
          [
            944,
            154
          ],
          [
            944,
            172
          ],
          [
            877,
            172
          ]
        ],
        "transcription": "4weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            956,
            156
          ],
          [
            1019,
            156
          ],
          [
            1019,
            171
          ],
          [
            956,
            171
          ]
        ],
        "transcription": "7weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            332,
            167
          ],
          [
            400,
            167
          ],
          [
            400,
            185
          ],
          [
            332,
            185
          ]
        ],
        "transcription": "4weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            412,
            169
          ],
          [
            477,
            169
          ],
          [
            477,
            188
          ],
          [
            412,
            188
          ]
        ],
        "transcription": "7weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            679,
            169
          ],
          [
            743,
            169
          ],
          [
            743,
            188
          ],
          [
            679,
            188
          ]
        ],
        "transcription": "7weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            248,
            179
          ],
          [
            328,
            179
          ],
          [
            328,
            193
          ],
          [
            248,
            193
          ]
        ],
        "transcription": "Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            1021,
            467
          ],
          [
            937,
            467
          ],
          [
            937,
            443
          ],
          [
            1021,
            443
          ]
        ],
        "transcription": "8 Weeks"
      },
      {
        "index_in_para": 1,
        "index_para": 14,
        "points": [
          [
            940,
            470
          ],
          [
            1023,
            470
          ],
          [
            1023,
            484
          ],
          [
            940,
            484
          ]
        ],
        "transcription": "withdrawal"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            936,
            474
          ],
          [
            857,
            474
          ],
          [
            857,
            451
          ],
          [
            936,
            451
          ]
        ],
        "transcription": "12 weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            656,
            468
          ],
          [
            791,
            470
          ],
          [
            791,
            490
          ],
          [
            656,
            488
          ]
        ],
        "transcription": "Skin Flow Cytometry"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            325,
            506
          ],
          [
            357,
            506
          ],
          [
            357,
            525
          ],
          [
            325,
            525
          ]
        ],
        "transcription": "CD4"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            399,
            506
          ],
          [
            431,
            506
          ],
          [
            431,
            525
          ],
          [
            399,
            525
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            472,
            507
          ],
          [
            516,
            507
          ],
          [
            516,
            525
          ],
          [
            472,
            525
          ]
        ],
        "transcription": "MHC-I"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            553,
            508
          ],
          [
            597,
            508
          ],
          [
            597,
            523
          ],
          [
            553,
            523
          ]
        ],
        "transcription": "MHC-II"
      },
      {
        "index_in_para": 0,
        "index_para": 21,
        "points": [
          [
            740,
            511
          ],
          [
            752,
            511
          ],
          [
            752,
            519
          ],
          [
            740,
            519
          ]
        ],
        "transcription": "17"
      },
      {
        "index_in_para": 0,
        "index_para": 22,
        "points": [
          [
            783,
            531
          ],
          [
            835,
            531
          ],
          [
            835,
            549
          ],
          [
            783,
            549
          ]
        ],
        "transcription": "Control"
      },
      {
        "index_in_para": 0,
        "index_para": 23,
        "points": [
          [
            248,
            551
          ],
          [
            296,
            551
          ],
          [
            296,
            565
          ],
          [
            248,
            565
          ]
        ],
        "transcription": "Control"
      },
      {
        "index_in_para": 0,
        "index_para": 24,
        "points": [
          [
            245,
            611
          ],
          [
            276,
            611
          ],
          [
            276,
            631
          ],
          [
            245,
            631
          ]
        ],
        "transcription": "JAK"
      },
      {
        "index_in_para": 1,
        "index_para": 24,
        "points": [
          [
            237,
            634
          ],
          [
            292,
            634
          ],
          [
            292,
            649
          ],
          [
            237,
            649
          ]
        ],
        "transcription": "inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 25,
        "points": [
          [
            785,
            625
          ],
          [
            817,
            625
          ],
          [
            817,
            645
          ],
          [
            785,
            645
          ]
        ],
        "transcription": "JAK"
      },
      {
        "index_in_para": 1,
        "index_para": 25,
        "points": [
          [
            775,
            646
          ],
          [
            833,
            646
          ],
          [
            833,
            664
          ],
          [
            775,
            664
          ]
        ],
        "transcription": "inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 26,
        "points": [
          [
            365,
            678
          ],
          [
            544,
            679
          ],
          [
            544,
            698
          ],
          [
            365,
            696
          ]
        ],
        "transcription": "Skin Immunohistochemistry"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1777000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            557,
            58
          ],
          [
            711,
            61
          ],
          [
            710,
            114
          ],
          [
            556,
            111
          ]
        ],
        "transcription": "Outline"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            284,
            181
          ],
          [
            707,
            181
          ],
          [
            707,
            213
          ],
          [
            284,
            213
          ]
        ],
        "transcription": "Genetics of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            285,
            306
          ],
          [
            763,
            306
          ],
          [
            763,
            338
          ],
          [
            285,
            338
          ]
        ],
        "transcription": "Immunology of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            285,
            428
          ],
          [
            844,
            428
          ],
          [
            844,
            458
          ],
          [
            285,
            458
          ]
        ],
        "transcription": "Translational and Biomarker Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            283,
            547
          ],
          [
            685,
            548
          ],
          [
            685,
            584
          ],
          [
            283,
            582
          ]
        ],
        "transcription": "Clinical Development Plan"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1800000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            439,
            11
          ],
          [
            828,
            9
          ],
          [
            828,
            33
          ],
          [
            439,
            34
          ]
        ],
        "transcription": "Increasing Efficiency of Clinical Trials"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            347,
            109
          ],
          [
            915,
            109
          ],
          [
            915,
            139
          ],
          [
            347,
            139
          ]
        ],
        "transcription": "Alopecia Areata Translational Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            317,
            182
          ],
          [
            384,
            186
          ],
          [
            383,
            204
          ],
          [
            316,
            201
          ]
        ],
        "transcription": "Genome"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            704,
            183
          ],
          [
            743,
            183
          ],
          [
            743,
            204
          ],
          [
            704,
            204
          ]
        ],
        "transcription": "Skin"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            513,
            184
          ],
          [
            564,
            184
          ],
          [
            564,
            202
          ],
          [
            513,
            202
          ]
        ],
        "transcription": "Blood"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            863,
            187
          ],
          [
            959,
            187
          ],
          [
            959,
            201
          ],
          [
            863,
            201
          ]
        ],
        "transcription": "Environment"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            263,
            358
          ],
          [
            364,
            363
          ],
          [
            363,
            387
          ],
          [
            262,
            382
          ]
        ],
        "transcription": "Genotyping"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            451,
            361
          ],
          [
            603,
            361
          ],
          [
            603,
            384
          ],
          [
            451,
            384
          ]
        ],
        "transcription": "Circulating PBMCs"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            490,
            388
          ],
          [
            622,
            391
          ],
          [
            621,
            414
          ],
          [
            489,
            411
          ]
        ],
        "transcription": "Flow Cytometry"
      },
      {
        "index_in_para": 2,
        "index_para": 7,
        "points": [
          [
            495,
            422
          ],
          [
            597,
            422
          ],
          [
            597,
            441
          ],
          [
            495,
            441
          ]
        ],
        "transcription": "(CD8+NKG2D+)"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            639,
            361
          ],
          [
            759,
            361
          ],
          [
            759,
            384
          ],
          [
            639,
            384
          ]
        ],
        "transcription": "Skin Crawl-out"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            824,
            361
          ],
          [
            911,
            361
          ],
          [
            911,
            385
          ],
          [
            824,
            385
          ]
        ],
        "transcription": "Ecological"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            822,
            389
          ],
          [
            923,
            392
          ],
          [
            922,
            414
          ],
          [
            821,
            411
          ]
        ],
        "transcription": "momentary"
      },
      {
        "index_in_para": 2,
        "index_para": 9,
        "points": [
          [
            824,
            422
          ],
          [
            929,
            422
          ],
          [
            929,
            441
          ],
          [
            824,
            441
          ]
        ],
        "transcription": "assessments"
      },
      {
        "index_in_para": 3,
        "index_para": 9,
        "points": [
          [
            823,
            452
          ],
          [
            988,
            457
          ],
          [
            988,
            481
          ],
          [
            822,
            476
          ]
        ],
        "transcription": "Remote Monitoring"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            674,
            388
          ],
          [
            807,
            391
          ],
          [
            806,
            414
          ],
          [
            673,
            411
          ]
        ],
        "transcription": "Flow Cytometry"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            675,
            421
          ],
          [
            779,
            421
          ],
          [
            779,
            443
          ],
          [
            675,
            443
          ]
        ],
        "transcription": "(CD8+NKG2D+)"
      },
      {
        "index_in_para": 2,
        "index_para": 10,
        "points": [
          [
            640,
            450
          ],
          [
            772,
            450
          ],
          [
            772,
            469
          ],
          [
            640,
            469
          ]
        ],
        "transcription": "Microdissection"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            264,
            398
          ],
          [
            437,
            398
          ],
          [
            437,
            421
          ],
          [
            264,
            421
          ]
        ],
        "transcription": "Targeted sequencing"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            264,
            435
          ],
          [
            360,
            435
          ],
          [
            360,
            458
          ],
          [
            264,
            458
          ]
        ],
        "transcription": "Epigenome"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            449,
            455
          ],
          [
            569,
            455
          ],
          [
            569,
            478
          ],
          [
            449,
            478
          ]
        ],
        "transcription": "Transcriptome"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            639,
            486
          ],
          [
            759,
            486
          ],
          [
            759,
            508
          ],
          [
            639,
            508
          ]
        ],
        "transcription": "Transcriptome"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            451,
            492
          ],
          [
            591,
            492
          ],
          [
            591,
            515
          ],
          [
            451,
            515
          ]
        ],
        "transcription": "Serum Cytokines"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            824,
            492
          ],
          [
            965,
            492
          ],
          [
            965,
            515
          ],
          [
            824,
            515
          ]
        ],
        "transcription": "Patient Reported"
      },
      {
        "index_in_para": 1,
        "index_para": 16,
        "points": [
          [
            823,
            520
          ],
          [
            906,
            523
          ],
          [
            905,
            546
          ],
          [
            822,
            542
          ]
        ],
        "transcription": "Outcome"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            637,
            523
          ],
          [
            717,
            523
          ],
          [
            717,
            547
          ],
          [
            637,
            547
          ]
        ],
        "transcription": "Histology"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            448,
            529
          ],
          [
            627,
            529
          ],
          [
            627,
            552
          ],
          [
            448,
            552
          ]
        ],
        "transcription": "Autoantibody Profiles"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            445,
            614
          ],
          [
            829,
            614
          ],
          [
            829,
            637
          ],
          [
            445,
            637
          ]
        ],
        "transcription": "AA Biomarker Study(R21AR061881"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            392,
            659
          ],
          [
            885,
            662
          ],
          [
            885,
            688
          ],
          [
            392,
            686
          ]
        ],
        "transcription": "Molecular Monitoring of Disease Activity"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1871000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            431,
            34
          ],
          [
            843,
            34
          ],
          [
            843,
            65
          ],
          [
            431,
            65
          ]
        ],
        "transcription": "Biomarkers in Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            271,
            124
          ],
          [
            563,
            124
          ],
          [
            563,
            152
          ],
          [
            271,
            152
          ]
        ],
        "transcription": "Three classes of data"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            288,
            212
          ],
          [
            603,
            212
          ],
          [
            603,
            247
          ],
          [
            288,
            247
          ]
        ],
        "transcription": "Genotype Risk Score"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            283,
            302
          ],
          [
            521,
            302
          ],
          [
            521,
            334
          ],
          [
            283,
            334
          ]
        ],
        "transcription": "Serum Markers"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            305,
            392
          ],
          [
            889,
            392
          ],
          [
            889,
            424
          ],
          [
            305,
            424
          ]
        ],
        "transcription": "Gene Expression profiling(ALADIN score"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            269,
            480
          ],
          [
            953,
            482
          ],
          [
            953,
            514
          ],
          [
            269,
            512
          ]
        ],
        "transcription": "GOAL: To develop an integrated biomarker panel"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            268,
            528
          ],
          [
            743,
            528
          ],
          [
            743,
            560
          ],
          [
            268,
            560
          ]
        ],
        "transcription": "for prognostic and predictive value"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            269,
            618
          ],
          [
            941,
            618
          ],
          [
            941,
            649
          ],
          [
            269,
            649
          ]
        ],
        "transcription": "Prognostic: will it get better/worse/stay the same"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            267,
            658
          ],
          [
            855,
            660
          ],
          [
            855,
            696
          ],
          [
            267,
            693
          ]
        ],
        "transcription": "Predictive: which therapy will benefit most"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1894000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            307,
            65
          ],
          [
            959,
            65
          ],
          [
            959,
            114
          ],
          [
            307,
            114
          ]
        ],
        "transcription": "AA-specific Disease Signature"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1920450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            349,
            63
          ],
          [
            919,
            66
          ],
          [
            919,
            115
          ],
          [
            349,
            112
          ]
        ],
        "transcription": "Gene Expression Modules"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            565,
            182
          ],
          [
            752,
            187
          ],
          [
            751,
            219
          ],
          [
            564,
            214
          ]
        ],
        "transcription": "IFN, CTL genes"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            421,
            218
          ],
          [
            444,
            218
          ],
          [
            444,
            573
          ],
          [
            421,
            573
          ]
        ],
        "transcription": "Normalized Enrichment Score vs."
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            447,
            279
          ],
          [
            469,
            279
          ],
          [
            469,
            518
          ],
          [
            447,
            518
          ]
        ],
        "transcription": "AA disease signature"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            605,
            540
          ],
          [
            738,
            546
          ],
          [
            736,
            573
          ],
          [
            604,
            567
          ]
        ],
        "transcription": "KRT genes"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            873,
            624
          ],
          [
            1006,
            629
          ],
          [
            1005,
            653
          ],
          [
            872,
            648
          ]
        ],
        "transcription": "IFN signature"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            872,
            655
          ],
          [
            1013,
            658
          ],
          [
            1013,
            682
          ],
          [
            872,
            679
          ]
        ],
        "transcription": "KER signature"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1958000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            357,
            71
          ],
          [
            909,
            74
          ],
          [
            909,
            105
          ],
          [
            357,
            102
          ]
        ],
        "transcription": "ALADIN analysis of AA patient biopsies"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            426,
            173
          ],
          [
            334,
            173
          ],
          [
            334,
            145
          ],
          [
            426,
            145
          ]
        ],
        "transcription": "AU/AT"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            545,
            149
          ],
          [
            636,
            152
          ],
          [
            635,
            176
          ],
          [
            544,
            173
          ]
        ],
        "transcription": "AA patchy"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            753,
            152
          ],
          [
            893,
            152
          ],
          [
            893,
            175
          ],
          [
            753,
            175
          ]
        ],
        "transcription": "Normal controls"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            935,
            180
          ],
          [
            968,
            180
          ],
          [
            968,
            196
          ],
          [
            935,
            196
          ]
        ],
        "transcription": "CD8A"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            935,
            197
          ],
          [
            972,
            197
          ],
          [
            972,
            214
          ],
          [
            935,
            214
          ]
        ],
        "transcription": "GZMB"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            933,
            214
          ],
          [
            968,
            214
          ],
          [
            968,
            234
          ],
          [
            933,
            234
          ]
        ],
        "transcription": "ICOS"
      },
      {
        "index_in_para": 3,
        "index_para": 4,
        "points": [
          [
            933,
            234
          ],
          [
            967,
            234
          ],
          [
            967,
            250
          ],
          [
            933,
            250
          ]
        ],
        "transcription": "PRF1"
      },
      {
        "index_in_para": 4,
        "index_para": 4,
        "points": [
          [
            935,
            254
          ],
          [
            967,
            254
          ],
          [
            967,
            270
          ],
          [
            935,
            270
          ]
        ],
        "transcription": "PRF1"
      },
      {
        "index_in_para": 5,
        "index_para": 4,
        "points": [
          [
            933,
            271
          ],
          [
            984,
            271
          ],
          [
            984,
            290
          ],
          [
            933,
            290
          ]
        ],
        "transcription": "CXCL10"
      },
      {
        "index_in_para": 6,
        "index_para": 4,
        "points": [
          [
            933,
            290
          ],
          [
            983,
            290
          ],
          [
            983,
            308
          ],
          [
            933,
            308
          ]
        ],
        "transcription": "CXCL11"
      },
      {
        "index_in_para": 7,
        "index_para": 4,
        "points": [
          [
            933,
            308
          ],
          [
            983,
            308
          ],
          [
            983,
            327
          ],
          [
            933,
            327
          ]
        ],
        "transcription": "CXCL11"
      },
      {
        "index_in_para": 8,
        "index_para": 4,
        "points": [
          [
            935,
            328
          ],
          [
            976,
            328
          ],
          [
            976,
            343
          ],
          [
            935,
            343
          ]
        ],
        "transcription": "CXCL9"
      },
      {
        "index_in_para": 9,
        "index_para": 4,
        "points": [
          [
            933,
            344
          ],
          [
            964,
            344
          ],
          [
            964,
            364
          ],
          [
            933,
            364
          ]
        ],
        "transcription": "MX1"
      },
      {
        "index_in_para": 10,
        "index_para": 4,
        "points": [
          [
            933,
            361
          ],
          [
            977,
            364
          ],
          [
            975,
            384
          ],
          [
            931,
            381
          ]
        ],
        "transcription": "STAT1"
      },
      {
        "index_in_para": 11,
        "index_para": 4,
        "points": [
          [
            933,
            381
          ],
          [
            975,
            381
          ],
          [
            975,
            400
          ],
          [
            933,
            400
          ]
        ],
        "transcription": "STAT1"
      },
      {
        "index_in_para": 12,
        "index_para": 4,
        "points": [
          [
            935,
            401
          ],
          [
            969,
            401
          ],
          [
            969,
            417
          ],
          [
            935,
            417
          ]
        ],
        "transcription": "DSG4"
      },
      {
        "index_in_para": 13,
        "index_para": 4,
        "points": [
          [
            933,
            418
          ],
          [
            987,
            418
          ],
          [
            987,
            437
          ],
          [
            933,
            437
          ]
        ],
        "transcription": "HOXC13"
      },
      {
        "index_in_para": 14,
        "index_para": 4,
        "points": [
          [
            933,
            437
          ],
          [
            976,
            437
          ],
          [
            976,
            455
          ],
          [
            933,
            455
          ]
        ],
        "transcription": "KRT31"
      },
      {
        "index_in_para": 15,
        "index_para": 4,
        "points": [
          [
            935,
            455
          ],
          [
            976,
            455
          ],
          [
            976,
            474
          ],
          [
            935,
            474
          ]
        ],
        "transcription": "KRT32"
      },
      {
        "index_in_para": 16,
        "index_para": 4,
        "points": [
          [
            933,
            474
          ],
          [
            983,
            474
          ],
          [
            983,
            492
          ],
          [
            933,
            492
          ]
        ],
        "transcription": "KRT33B"
      },
      {
        "index_in_para": 17,
        "index_para": 4,
        "points": [
          [
            933,
            494
          ],
          [
            976,
            494
          ],
          [
            976,
            512
          ],
          [
            933,
            512
          ]
        ],
        "transcription": "KRT82"
      },
      {
        "index_in_para": 18,
        "index_para": 4,
        "points": [
          [
            934,
            508
          ],
          [
            969,
            512
          ],
          [
            966,
            531
          ],
          [
            931,
            527
          ]
        ],
        "transcription": "PKP1"
      },
      {
        "index_in_para": 19,
        "index_para": 4,
        "points": [
          [
            935,
            531
          ],
          [
            965,
            531
          ],
          [
            965,
            547
          ],
          [
            935,
            547
          ]
        ],
        "transcription": "PKP1"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            874,
            597
          ],
          [
            1010,
            600
          ],
          [
            1009,
            624
          ],
          [
            873,
            621
          ]
        ],
        "transcription": "CTL signature"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            872,
            626
          ],
          [
            1004,
            629
          ],
          [
            1004,
            653
          ],
          [
            872,
            650
          ]
        ],
        "transcription": "IFN signature"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            872,
            655
          ],
          [
            1013,
            658
          ],
          [
            1013,
            680
          ],
          [
            872,
            678
          ]
        ],
        "transcription": "KERsignature"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1971000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            293,
            37
          ],
          [
            973,
            37
          ],
          [
            973,
            73
          ],
          [
            293,
            73
          ]
        ],
        "transcription": "Alopecia Areata Disease Activity Index"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            551,
            97
          ],
          [
            716,
            97
          ],
          [
            716,
            144
          ],
          [
            551,
            144
          ]
        ],
        "transcription": "(ALADIN)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            284,
            179
          ],
          [
            853,
            179
          ],
          [
            853,
            205
          ],
          [
            284,
            205
          ]
        ],
        "transcription": "Alopecia Areata Disease Activity Index(ALADIN)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            283,
            225
          ],
          [
            977,
            225
          ],
          [
            977,
            251
          ],
          [
            283,
            251
          ]
        ],
        "transcription": "a multi-dimensional guantitative composite score that may be"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            281,
            266
          ],
          [
            935,
            266
          ],
          [
            935,
            292
          ],
          [
            281,
            292
          ]
        ],
        "transcription": "used as an AA\"molecular distance to health\"(Pankla et al"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            279,
            302
          ],
          [
            357,
            302
          ],
          [
            357,
            336
          ],
          [
            279,
            336
          ]
        ],
        "transcription": "2009)."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            283,
            356
          ],
          [
            981,
            356
          ],
          [
            981,
            388
          ],
          [
            283,
            388
          ]
        ],
        "transcription": "ALADIN is comprised of three signature scores: a CTL"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            311,
            402
          ],
          [
            760,
            401
          ],
          [
            760,
            431
          ],
          [
            311,
            433
          ]
        ],
        "transcription": "score, an IFN score and a KER score."
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            284,
            455
          ],
          [
            984,
            455
          ],
          [
            984,
            486
          ],
          [
            284,
            486
          ]
        ],
        "transcription": "ALADIN is currently being assessed and refined in our"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            312,
            500
          ],
          [
            864,
            500
          ],
          [
            864,
            531
          ],
          [
            312,
            531
          ]
        ],
        "transcription": "biomarkers study for its utility in human AA."
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-1996450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            322,
            45
          ],
          [
            967,
            49
          ],
          [
            966,
            99
          ],
          [
            321,
            95
          ]
        ],
        "transcription": "Alopecia Areata Disease Activity"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            488,
            103
          ],
          [
            804,
            103
          ],
          [
            804,
            148
          ],
          [
            488,
            148
          ]
        ],
        "transcription": "Index (ALADIN)"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            805,
            246
          ],
          [
            888,
            246
          ],
          [
            888,
            279
          ],
          [
            805,
            279
          ]
        ],
        "transcription": "AU/AT"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            805,
            320
          ],
          [
            863,
            320
          ],
          [
            863,
            352
          ],
          [
            805,
            352
          ]
        ],
        "transcription": "AAP"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            804,
            394
          ],
          [
            904,
            394
          ],
          [
            904,
            427
          ],
          [
            804,
            427
          ]
        ],
        "transcription": "Normal"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            912,
            678
          ],
          [
            305,
            678
          ],
          [
            305,
            643
          ],
          [
            912,
            643
          ]
        ],
        "transcription": "Is AU/AT is more recalcitrant to therapy than AAP?"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            1009,
            698
          ],
          [
            607,
            698
          ],
          [
            607,
            671
          ],
          [
            1009,
            671
          ]
        ],
        "transcription": "Jabbari et al, ebiomedicine 7.240-247,2016"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2042000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            313,
            33
          ],
          [
            977,
            34
          ],
          [
            977,
            66
          ],
          [
            313,
            65
          ]
        ],
        "transcription": "Molecular signatures define alopecia areata"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            344,
            75
          ],
          [
            951,
            75
          ],
          [
            951,
            107
          ],
          [
            344,
            107
          ]
        ],
        "transcription": "subtypes and transcriptional biomarkers"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            285,
            181
          ],
          [
            921,
            181
          ],
          [
            921,
            212
          ],
          [
            285,
            212
          ]
        ],
        "transcription": "Unexpectedly, we see a more exaggerated profile in"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            311,
            220
          ],
          [
            895,
            221
          ],
          [
            895,
            253
          ],
          [
            311,
            251
          ]
        ],
        "transcription": "AU/AT compared with AAP, suggesting even long"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            312,
            262
          ],
          [
            881,
            262
          ],
          [
            881,
            289
          ],
          [
            312,
            289
          ]
        ],
        "transcription": "standing disease may be treatable using rational"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            307,
            295
          ],
          [
            420,
            298
          ],
          [
            419,
            331
          ],
          [
            306,
            328
          ]
        ],
        "transcription": "therapies"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            284,
            388
          ],
          [
            935,
            389
          ],
          [
            935,
            421
          ],
          [
            284,
            420
          ]
        ],
        "transcription": "Efficacy of topical immunotherapies in AU/AT may be"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            309,
            429
          ],
          [
            660,
            429
          ],
          [
            660,
            459
          ],
          [
            309,
            459
          ]
        ],
        "transcription": "lower in longstanding disease"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            284,
            520
          ],
          [
            865,
            520
          ],
          [
            865,
            551
          ],
          [
            284,
            551
          ]
        ],
        "transcription": "AUIAT biopsies often appear devoid of hair/hair"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            311,
            561
          ],
          [
            456,
            561
          ],
          [
            456,
            589
          ],
          [
            311,
            589
          ]
        ],
        "transcription": "components"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            911,
            677
          ],
          [
            310,
            677
          ],
          [
            310,
            645
          ],
          [
            911,
            645
          ]
        ],
        "transcription": "Is AU/AT is more recalcitrant to therapy than AAP?"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            1010,
            696
          ],
          [
            615,
            696
          ],
          [
            615,
            672
          ],
          [
            1010,
            672
          ]
        ],
        "transcription": "Jabbari et al, ebiomedicine 7.240-247,2016"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2043000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            557,
            58
          ],
          [
            711,
            61
          ],
          [
            710,
            114
          ],
          [
            556,
            111
          ]
        ],
        "transcription": "Outline"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            284,
            181
          ],
          [
            707,
            181
          ],
          [
            707,
            213
          ],
          [
            284,
            213
          ]
        ],
        "transcription": "Genetics of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            285,
            306
          ],
          [
            763,
            306
          ],
          [
            763,
            338
          ],
          [
            285,
            338
          ]
        ],
        "transcription": "Immunology of Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            288,
            428
          ],
          [
            844,
            428
          ],
          [
            844,
            458
          ],
          [
            288,
            458
          ]
        ],
        "transcription": "Translational and Biomarker Platform"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            284,
            549
          ],
          [
            496,
            549
          ],
          [
            496,
            581
          ],
          [
            284,
            581
          ]
        ],
        "transcription": "Clinical Trials"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2066000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            315,
            65
          ],
          [
            952,
            65
          ],
          [
            952,
            114
          ],
          [
            315,
            114
          ]
        ],
        "transcription": "FDA-Approved JAK Inhibitors"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            690,
            187
          ],
          [
            853,
            187
          ],
          [
            853,
            214
          ],
          [
            690,
            214
          ]
        ],
        "transcription": "JAK3 inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            292,
            212
          ],
          [
            569,
            212
          ],
          [
            569,
            271
          ],
          [
            292,
            271
          ]
        ],
        "transcription": "XELJANZ"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            332,
            292
          ],
          [
            621,
            292
          ],
          [
            621,
            328
          ],
          [
            332,
            328
          ]
        ],
        "transcription": "tofacitinib citrate"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            511,
            339
          ],
          [
            617,
            339
          ],
          [
            617,
            363
          ],
          [
            511,
            363
          ]
        ],
        "transcription": "5mg tablets"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            689,
            265
          ],
          [
            924,
            265
          ],
          [
            924,
            291
          ],
          [
            689,
            291
          ]
        ],
        "transcription": "Rheumatoid arthritis"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            336,
            457
          ],
          [
            523,
            457
          ],
          [
            523,
            484
          ],
          [
            336,
            484
          ]
        ],
        "transcription": "JAK1/2 Inhibitor"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            367,
            532
          ],
          [
            523,
            532
          ],
          [
            523,
            564
          ],
          [
            367,
            564
          ]
        ],
        "transcription": "Myelofibrosis"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            288,
            647
          ],
          [
            1011,
            647
          ],
          [
            1011,
            670
          ],
          [
            288,
            670
          ]
        ],
        "transcription": "JAK inhibitors are potent immunosuppressive agents with associated risks:"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            405,
            676
          ],
          [
            843,
            676
          ],
          [
            843,
            699
          ],
          [
            405,
            699
          ]
        ],
        "transcription": "Are they safe and effective in alopecia areata?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2092000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            482,
            33
          ],
          [
            784,
            37
          ],
          [
            784,
            78
          ],
          [
            481,
            74
          ]
        ],
        "transcription": "Ruxolitinib Study"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            335,
            101
          ],
          [
            931,
            101
          ],
          [
            931,
            142
          ],
          [
            335,
            142
          ]
        ],
        "transcription": "Julian Mackay-Wiggan, MD, MPH"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            284,
            169
          ],
          [
            645,
            169
          ],
          [
            645,
            196
          ],
          [
            284,
            196
          ]
        ],
        "transcription": "Open-label, single arm pilot study"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            285,
            206
          ],
          [
            907,
            206
          ],
          [
            907,
            229
          ],
          [
            285,
            229
          ]
        ],
        "transcription": "12 patientsinitially 10), duration of disease from 2-34years"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            283,
            238
          ],
          [
            955,
            238
          ],
          [
            955,
            265
          ],
          [
            283,
            265
          ]
        ],
        "transcription": "10 Moderate to severe patch type AA,2 AT/AUs/p modification)"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            287,
            277
          ],
          [
            852,
            277
          ],
          [
            852,
            299
          ],
          [
            287,
            299
          ]
        ],
        "transcription": "Treatment with ruxolitinib 20mg BID for 3 to 6 months"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            303,
            310
          ],
          [
            933,
            310
          ],
          [
            933,
            336
          ],
          [
            303,
            336
          ]
        ],
        "transcription": "Efficacy measured by hair re-growth as determined by physical"
      },
      {
        "index_in_para": 5,
        "index_para": 2,
        "points": [
          [
            309,
            339
          ],
          [
            948,
            339
          ],
          [
            948,
            365
          ],
          [
            309,
            365
          ]
        ],
        "transcription": "exam, SALT score and photography, and by patient and physician"
      },
      {
        "index_in_para": 6,
        "index_para": 2,
        "points": [
          [
            312,
            372
          ],
          [
            488,
            372
          ],
          [
            488,
            390
          ],
          [
            312,
            390
          ]
        ],
        "transcription": "evaluation scores."
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            307,
            404
          ],
          [
            891,
            404
          ],
          [
            891,
            426
          ],
          [
            307,
            426
          ]
        ],
        "transcription": "Patients followed for 3 months after treatment to evaluate"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            311,
            431
          ],
          [
            531,
            431
          ],
          [
            531,
            454
          ],
          [
            311,
            454
          ]
        ],
        "transcription": "durability of response."
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            309,
            467
          ],
          [
            979,
            467
          ],
          [
            979,
            490
          ],
          [
            309,
            490
          ]
        ],
        "transcription": "Biopsies and peripheral blood obtained at baseline and at 12 weeks"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            309,
            494
          ],
          [
            968,
            494
          ],
          [
            968,
            520
          ],
          [
            309,
            520
          ]
        ],
        "transcription": "for immune monitoring and molecular studies.Additional biopsies"
      },
      {
        "index_in_para": 4,
        "index_para": 3,
        "points": [
          [
            313,
            525
          ],
          [
            952,
            525
          ],
          [
            952,
            544
          ],
          [
            313,
            544
          ]
        ],
        "transcription": "and blood draws(1-3 anticipated)obtained as clinically indicated"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            292,
            559
          ],
          [
            935,
            559
          ],
          [
            935,
            581
          ],
          [
            292,
            581
          ]
        ],
        "transcription": "QOL measures at baseline and at various additional time points"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2114000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            422,
            66
          ],
          [
            846,
            72
          ],
          [
            845,
            113
          ],
          [
            421,
            107
          ]
        ],
        "transcription": "Ruxolitinib - response"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            304,
            173
          ],
          [
            927,
            176
          ],
          [
            927,
            213
          ],
          [
            307,
            209
          ]
        ],
        "transcription": "9 of 12 patients have achieved the primary"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            312,
            224
          ],
          [
            949,
            221
          ],
          [
            949,
            253
          ],
          [
            312,
            255
          ]
        ],
        "transcription": "outcome of at least 50%regrowth measured"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            313,
            270
          ],
          [
            505,
            270
          ],
          [
            505,
            302
          ],
          [
            313,
            302
          ]
        ],
        "transcription": "by SALT score"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            306,
            326
          ],
          [
            951,
            322
          ],
          [
            951,
            357
          ],
          [
            306,
            356
          ]
        ],
        "transcription": "Response is seen as early as 1 month (subtle"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            311,
            371
          ],
          [
            556,
            371
          ],
          [
            556,
            408
          ],
          [
            311,
            408
          ]
        ],
        "transcription": "patchy regrowth)"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            281,
            426
          ],
          [
            957,
            425
          ],
          [
            957,
            461
          ],
          [
            281,
            462
          ]
        ],
        "transcription": "Regrowth progresses steadily with continued"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            310,
            475
          ],
          [
            556,
            471
          ],
          [
            556,
            508
          ],
          [
            311,
            512
          ]
        ],
        "transcription": "patchy regrowth."
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            284,
            529
          ],
          [
            845,
            529
          ],
          [
            845,
            561
          ],
          [
            284,
            561
          ]
        ],
        "transcription": "1 AT patient has had slower regrowth"
      },
      {
        "index_in_para": 5,
        "index_para": 2,
        "points": [
          [
            312,
            578
          ],
          [
            808,
            578
          ],
          [
            808,
            609
          ],
          [
            312,
            609
          ]
        ],
        "transcription": "compared to the other responders"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2142000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            492,
            66
          ],
          [
            775,
            66
          ],
          [
            775,
            112
          ],
          [
            492,
            112
          ]
        ],
        "transcription": "Ruxo subject 2"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            648,
            163
          ],
          [
            968,
            163
          ],
          [
            968,
            189
          ],
          [
            648,
            189
          ]
        ],
        "transcription": "Week16(full regrowth but also"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            648,
            193
          ],
          [
            807,
            193
          ],
          [
            807,
            220
          ],
          [
            648,
            220
          ]
        ],
        "transcription": "has extensions)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            280,
            188
          ],
          [
            376,
            188
          ],
          [
            376,
            216
          ],
          [
            280,
            216
          ]
        ],
        "transcription": "Baseline"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2272000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            424,
            68
          ],
          [
            841,
            68
          ],
          [
            841,
            112
          ],
          [
            424,
            112
          ]
        ],
        "transcription": "Ruxo non-responders"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            298,
            182
          ],
          [
            568,
            179
          ],
          [
            568,
            214
          ],
          [
            304,
            217
          ]
        ],
        "transcription": "3 non-responders"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            304,
            244
          ],
          [
            925,
            244
          ],
          [
            925,
            276
          ],
          [
            304,
            276
          ]
        ],
        "transcription": "No clear reason to explain lack of response"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            304,
            303
          ],
          [
            957,
            304
          ],
          [
            957,
            336
          ],
          [
            304,
            336
          ]
        ],
        "transcription": "All 3 patients of African American or hispanic"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            313,
            357
          ],
          [
            789,
            357
          ],
          [
            789,
            389
          ],
          [
            313,
            389
          ]
        ],
        "transcription": "background-likely a coincidence"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            343,
            413
          ],
          [
            841,
            413
          ],
          [
            841,
            447
          ],
          [
            343,
            447
          ]
        ],
        "transcription": "1 subject also did not respond to IL TAC"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            346,
            467
          ],
          [
            907,
            467
          ],
          [
            907,
            503
          ],
          [
            346,
            503
          ]
        ],
        "transcription": "1 subject biopsy proven AA but had a diffuse"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            342,
            512
          ],
          [
            543,
            508
          ],
          [
            544,
            541
          ],
          [
            343,
            546
          ]
        ],
        "transcription": "pattern-?FPHL"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            339,
            566
          ],
          [
            925,
            562
          ],
          [
            925,
            594
          ],
          [
            341,
            601
          ]
        ],
        "transcription": "1 subject with MPHL but clear patches c/w AA"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2316000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            404,
            65
          ],
          [
            864,
            68
          ],
          [
            864,
            109
          ],
          [
            404,
            106
          ]
        ],
        "transcription": "Ruxolitinib - SALT score"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            547,
            331
          ],
          [
            700,
            331
          ],
          [
            700,
            349
          ],
          [
            547,
            349
          ]
        ],
        "transcription": "SALT Score(%)vs.Time"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            357,
            427
          ],
          [
            380,
            427
          ],
          [
            380,
            582
          ],
          [
            357,
            582
          ]
        ],
        "transcription": "SALT Score (%)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            586,
            677
          ],
          [
            648,
            681
          ],
          [
            647,
            706
          ],
          [
            585,
            702
          ]
        ],
        "transcription": "Weeks"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2329000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            411,
            37
          ],
          [
            855,
            37
          ],
          [
            855,
            82
          ],
          [
            411,
            82
          ]
        ],
        "transcription": "Ruxolitinib % regrowth"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            536,
            323
          ],
          [
            736,
            323
          ],
          [
            736,
            341
          ],
          [
            536,
            341
          ]
        ],
        "transcription": "Percent Regrowth (%) vs.Time"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            363,
            405
          ],
          [
            381,
            405
          ],
          [
            381,
            576
          ],
          [
            363,
            576
          ]
        ],
        "transcription": "Percent Regrowth (%)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            604,
            663
          ],
          [
            652,
            663
          ],
          [
            652,
            683
          ],
          [
            604,
            683
          ]
        ],
        "transcription": "Weeks"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2344000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            439,
            62
          ],
          [
            828,
            68
          ],
          [
            828,
            114
          ],
          [
            438,
            108
          ]
        ],
        "transcription": "Ruxolitinib - relapse"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            304,
            180
          ],
          [
            873,
            181
          ],
          [
            873,
            217
          ],
          [
            303,
            215
          ]
        ],
        "transcription": "1 responder noted significant shedding"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            311,
            232
          ],
          [
            941,
            230
          ],
          [
            941,
            266
          ],
          [
            311,
            267
          ]
        ],
        "transcription": "beginning at approximately week 3 post d/c"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            312,
            286
          ],
          [
            965,
            286
          ],
          [
            965,
            316
          ],
          [
            312,
            316
          ]
        ],
        "transcription": "ruxo with significant hair loss at week 12 post"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            309,
            332
          ],
          [
            432,
            332
          ],
          [
            432,
            371
          ],
          [
            309,
            371
          ]
        ],
        "transcription": "d/c ruxo"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            283,
            394
          ],
          [
            869,
            394
          ],
          [
            869,
            430
          ],
          [
            283,
            430
          ]
        ],
        "transcription": "Most responders report mild increased"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            313,
            449
          ],
          [
            919,
            449
          ],
          [
            919,
            480
          ],
          [
            313,
            480
          ]
        ],
        "transcription": "shedding but not significant hair loss at 12"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            309,
            499
          ],
          [
            528,
            496
          ],
          [
            528,
            533
          ],
          [
            310,
            536
          ]
        ],
        "transcription": "weeks post d/c"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2361000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            413,
            67
          ],
          [
            853,
            67
          ],
          [
            853,
            106
          ],
          [
            413,
            106
          ]
        ],
        "transcription": "Ruxo-Adverse effects"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            283,
            180
          ],
          [
            748,
            180
          ],
          [
            748,
            216
          ],
          [
            283,
            216
          ]
        ],
        "transcription": "Less frequent than anticipated"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            344,
            238
          ],
          [
            975,
            238
          ],
          [
            975,
            274
          ],
          [
            344,
            274
          ]
        ],
        "transcription": "Lowered white counts initially but remaining WNL"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            344,
            282
          ],
          [
            837,
            283
          ],
          [
            837,
            315
          ],
          [
            344,
            314
          ]
        ],
        "transcription": "therefore no dose adjustment required"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            345,
            336
          ],
          [
            836,
            336
          ],
          [
            836,
            371
          ],
          [
            345,
            371
          ]
        ],
        "transcription": "Lowered hgb - 1 patientreguired dose"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            344,
            382
          ],
          [
            508,
            382
          ],
          [
            508,
            410
          ],
          [
            344,
            410
          ]
        ],
        "transcription": "modification"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            339,
            437
          ],
          [
            980,
            434
          ],
          [
            980,
            465
          ],
          [
            339,
            467
          ]
        ],
        "transcription": "1 patient with2 episodes furuncles/abscesses and"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            345,
            482
          ],
          [
            827,
            482
          ],
          [
            827,
            512
          ],
          [
            345,
            512
          ]
        ],
        "transcription": "reported possible biopsy site infection"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            345,
            535
          ],
          [
            756,
            535
          ],
          [
            756,
            565
          ],
          [
            345,
            565
          ]
        ],
        "transcription": "Mild URIs,1 episode pneumonia"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            344,
            589
          ],
          [
            733,
            589
          ],
          [
            733,
            621
          ],
          [
            344,
            621
          ]
        ],
        "transcription": "No observed lowered platelets"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2408000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            343,
            40
          ],
          [
            976,
            40
          ],
          [
            976,
            62
          ],
          [
            343,
            62
          ]
        ],
        "transcription": "Oral Ruxolitinib Clinically Reverses Moderate/Severe Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            432,
            101
          ],
          [
            879,
            102
          ],
          [
            879,
            128
          ],
          [
            432,
            127
          ]
        ],
        "transcription": "\"On-Target\"Reversal of Inflammatory Biomarkers"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            392,
            136
          ],
          [
            925,
            136
          ],
          [
            925,
            159
          ],
          [
            392,
            159
          ]
        ],
        "transcription": "Early Data from Single Arm Open Label Study of 12 patients"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            311,
            225
          ],
          [
            356,
            225
          ],
          [
            356,
            240
          ],
          [
            311,
            240
          ]
        ],
        "transcription": "Baseline"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            485,
            225
          ],
          [
            532,
            225
          ],
          [
            532,
            240
          ],
          [
            485,
            240
          ]
        ],
        "transcription": "Week 12"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            661,
            282
          ],
          [
            701,
            282
          ],
          [
            701,
            296
          ],
          [
            661,
            296
          ]
        ],
        "transcription": "Row Z-Scom"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            1000,
            315
          ],
          [
            1016,
            316
          ],
          [
            1012,
            371
          ],
          [
            996,
            370
          ]
        ],
        "transcription": "IFN score"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            289,
            408
          ],
          [
            313,
            408
          ],
          [
            313,
            422
          ],
          [
            289,
            422
          ]
        ],
        "transcription": "CD8"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            439,
            409
          ],
          [
            500,
            409
          ],
          [
            500,
            422
          ],
          [
            439,
            422
          ]
        ],
        "transcription": "HLA-A/B/C"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            512,
            409
          ],
          [
            593,
            409
          ],
          [
            593,
            422
          ],
          [
            512,
            422
          ]
        ],
        "transcription": "HLA-DP/DQ/DR"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            375,
            410
          ],
          [
            399,
            410
          ],
          [
            399,
            421
          ],
          [
            375,
            421
          ]
        ],
        "transcription": "CD4"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            905,
            478
          ],
          [
            954,
            472
          ],
          [
            957,
            492
          ],
          [
            907,
            498
          ]
        ],
        "transcription": "CTLscore"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            659,
            542
          ],
          [
            608,
            542
          ],
          [
            608,
            526
          ],
          [
            659,
            526
          ]
        ],
        "transcription": "Baseline"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            702,
            528
          ],
          [
            738,
            528
          ],
          [
            738,
            541
          ],
          [
            702,
            541
          ]
        ],
        "transcription": "Normal"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            648,
            543
          ],
          [
            697,
            543
          ],
          [
            697,
            561
          ],
          [
            648,
            561
          ]
        ],
        "transcription": "Week 12"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            281,
            630
          ],
          [
            843,
            630
          ],
          [
            843,
            652
          ],
          [
            281,
            652
          ]
        ],
        "transcription": "Xing, et al.Alopecia areata is driven by cytotoxic T lymphocytes"
      },
      {
        "index_in_para": 1,
        "index_para": 14,
        "points": [
          [
            287,
            660
          ],
          [
            579,
            660
          ],
          [
            579,
            679
          ],
          [
            287,
            679
          ]
        ],
        "transcription": "and is reversed by JAK inhibition"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            281,
            690
          ],
          [
            861,
            690
          ],
          [
            861,
            708
          ],
          [
            281,
            708
          ]
        ],
        "transcription": "nature medicineVOLUME20INUMBER9|SEPTEMBER2014"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2461000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            289,
            21
          ],
          [
            957,
            21
          ],
          [
            957,
            48
          ],
          [
            289,
            48
          ]
        ],
        "transcription": "Gene expression profiling before and after ruxolitinib treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            776,
            98
          ],
          [
            819,
            98
          ],
          [
            819,
            118
          ],
          [
            776,
            118
          ]
        ],
        "transcription": "PRF1"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            776,
            123
          ],
          [
            821,
            123
          ],
          [
            821,
            143
          ],
          [
            776,
            143
          ]
        ],
        "transcription": "CD8A"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            777,
            147
          ],
          [
            824,
            147
          ],
          [
            824,
            167
          ],
          [
            777,
            167
          ]
        ],
        "transcription": "GZMB"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            777,
            171
          ],
          [
            817,
            171
          ],
          [
            817,
            191
          ],
          [
            777,
            191
          ]
        ],
        "transcription": "ICOS"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            776,
            195
          ],
          [
            819,
            195
          ],
          [
            819,
            214
          ],
          [
            776,
            214
          ]
        ],
        "transcription": "PRF1"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            776,
            218
          ],
          [
            827,
            218
          ],
          [
            827,
            238
          ],
          [
            776,
            238
          ]
        ],
        "transcription": "STAT1"
      },
      {
        "index_in_para": 6,
        "index_para": 1,
        "points": [
          [
            776,
            242
          ],
          [
            812,
            242
          ],
          [
            812,
            262
          ],
          [
            776,
            262
          ]
        ],
        "transcription": "MX1"
      },
      {
        "index_in_para": 7,
        "index_para": 1,
        "points": [
          [
            777,
            267
          ],
          [
            831,
            267
          ],
          [
            831,
            286
          ],
          [
            777,
            286
          ]
        ],
        "transcription": "CXCL9"
      },
      {
        "index_in_para": 8,
        "index_para": 1,
        "points": [
          [
            777,
            291
          ],
          [
            839,
            291
          ],
          [
            839,
            310
          ],
          [
            777,
            310
          ]
        ],
        "transcription": "CXCL10"
      },
      {
        "index_in_para": 9,
        "index_para": 1,
        "points": [
          [
            776,
            315
          ],
          [
            827,
            315
          ],
          [
            827,
            335
          ],
          [
            776,
            335
          ]
        ],
        "transcription": "STAT1"
      },
      {
        "index_in_para": 10,
        "index_para": 1,
        "points": [
          [
            777,
            339
          ],
          [
            837,
            339
          ],
          [
            837,
            359
          ],
          [
            777,
            359
          ]
        ],
        "transcription": "CXCL11"
      },
      {
        "index_in_para": 11,
        "index_para": 1,
        "points": [
          [
            777,
            364
          ],
          [
            837,
            364
          ],
          [
            837,
            382
          ],
          [
            777,
            382
          ]
        ],
        "transcription": "CXCL11"
      },
      {
        "index_in_para": 12,
        "index_para": 1,
        "points": [
          [
            776,
            386
          ],
          [
            821,
            386
          ],
          [
            821,
            406
          ],
          [
            776,
            406
          ]
        ],
        "transcription": "DSG4"
      },
      {
        "index_in_para": 13,
        "index_para": 1,
        "points": [
          [
            776,
            410
          ],
          [
            819,
            410
          ],
          [
            819,
            430
          ],
          [
            776,
            430
          ]
        ],
        "transcription": "PKP1"
      },
      {
        "index_in_para": 14,
        "index_para": 1,
        "points": [
          [
            776,
            435
          ],
          [
            827,
            435
          ],
          [
            827,
            454
          ],
          [
            776,
            454
          ]
        ],
        "transcription": "KRT31"
      },
      {
        "index_in_para": 15,
        "index_para": 1,
        "points": [
          [
            776,
            459
          ],
          [
            828,
            459
          ],
          [
            828,
            478
          ],
          [
            776,
            478
          ]
        ],
        "transcription": "KRT32"
      },
      {
        "index_in_para": 16,
        "index_para": 1,
        "points": [
          [
            777,
            483
          ],
          [
            837,
            483
          ],
          [
            837,
            502
          ],
          [
            777,
            502
          ]
        ],
        "transcription": "KRT33B"
      },
      {
        "index_in_para": 17,
        "index_para": 1,
        "points": [
          [
            776,
            507
          ],
          [
            841,
            507
          ],
          [
            841,
            525
          ],
          [
            776,
            525
          ]
        ],
        "transcription": "HOXC13"
      },
      {
        "index_in_para": 18,
        "index_para": 1,
        "points": [
          [
            776,
            531
          ],
          [
            819,
            531
          ],
          [
            819,
            551
          ],
          [
            776,
            551
          ]
        ],
        "transcription": "PKP1"
      },
      {
        "index_in_para": 19,
        "index_para": 1,
        "points": [
          [
            777,
            556
          ],
          [
            828,
            556
          ],
          [
            828,
            574
          ],
          [
            777,
            574
          ]
        ],
        "transcription": "KRT82"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            873,
            98
          ],
          [
            940,
            101
          ],
          [
            939,
            121
          ],
          [
            872,
            118
          ]
        ],
        "transcription": "Color Key"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            864,
            175
          ],
          [
            876,
            175
          ],
          [
            876,
            185
          ],
          [
            864,
            185
          ]
        ],
        "transcription": "3"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            860,
            182
          ],
          [
            954,
            185
          ],
          [
            953,
            204
          ],
          [
            860,
            201
          ]
        ],
        "transcription": "RowZ-Score"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            916,
            176
          ],
          [
            923,
            176
          ],
          [
            923,
            183
          ],
          [
            916,
            183
          ]
        ],
        "transcription": "1"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2476000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            448,
            16
          ],
          [
            833,
            16
          ],
          [
            833,
            42
          ],
          [
            448,
            42
          ]
        ],
        "transcription": "ALADIN score before and after"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            512,
            56
          ],
          [
            771,
            56
          ],
          [
            771,
            82
          ],
          [
            512,
            82
          ]
        ],
        "transcription": "ruxolitinib treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            561,
            142
          ],
          [
            747,
            142
          ],
          [
            747,
            164
          ],
          [
            561,
            164
          ]
        ],
        "transcription": "Responder, Baseline"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            516,
            233
          ],
          [
            545,
            233
          ],
          [
            545,
            254
          ],
          [
            516,
            254
          ]
        ],
        "transcription": "IFN"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            451,
            332
          ],
          [
            520,
            335
          ],
          [
            519,
            359
          ],
          [
            450,
            356
          ]
        ],
        "transcription": "Normal"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            659,
            345
          ],
          [
            811,
            345
          ],
          [
            811,
            372
          ],
          [
            659,
            372
          ]
        ],
        "transcription": "Responder, w12"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            656,
            377
          ],
          [
            872,
            376
          ],
          [
            872,
            401
          ],
          [
            656,
            402
          ]
        ],
        "transcription": "Nonresponder, baseline"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            668,
            435
          ],
          [
            700,
            435
          ],
          [
            700,
            458
          ],
          [
            668,
            458
          ]
        ],
        "transcription": "CTL"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            629,
            481
          ],
          [
            812,
            476
          ],
          [
            812,
            503
          ],
          [
            630,
            507
          ]
        ],
        "transcription": "Nonresponder, w12"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            465,
            510
          ],
          [
            493,
            510
          ],
          [
            493,
            528
          ],
          [
            465,
            528
          ]
        ],
        "transcription": "KRT"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2499000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            400,
            41
          ],
          [
            864,
            45
          ],
          [
            864,
            85
          ],
          [
            400,
            81
          ]
        ],
        "transcription": "Tofacitinib-study design"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            372,
            101
          ],
          [
            895,
            102
          ],
          [
            895,
            138
          ],
          [
            372,
            136
          ]
        ],
        "transcription": "PI: Julian Mackay-Wiggan, MD, MPH"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            287,
            171
          ],
          [
            644,
            171
          ],
          [
            644,
            193
          ],
          [
            287,
            193
          ]
        ],
        "transcription": "Open-label, single arm pilot study"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            289,
            206
          ],
          [
            980,
            206
          ],
          [
            980,
            229
          ],
          [
            289,
            229
          ]
        ],
        "transcription": "12 patients -6 moderate to severe patchy AA and 6 AT/AU, duration"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            311,
            236
          ],
          [
            573,
            236
          ],
          [
            573,
            258
          ],
          [
            311,
            258
          ]
        ],
        "transcription": "of disease from3-34years"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            292,
            269
          ],
          [
            985,
            269
          ],
          [
            985,
            295
          ],
          [
            292,
            295
          ]
        ],
        "transcription": "Treated for 6 to 12 months with tofacitinib 5mg BID, up to 10mg BID"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            308,
            303
          ],
          [
            909,
            304
          ],
          [
            909,
            328
          ],
          [
            308,
            327
          ]
        ],
        "transcription": "Efficacy will be measured by hair regrowth as determined by"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            309,
            331
          ],
          [
            937,
            332
          ],
          [
            937,
            359
          ],
          [
            309,
            357
          ]
        ],
        "transcription": "physical exam, SALT score and photography, and by patient and"
      },
      {
        "index_in_para": 6,
        "index_para": 1,
        "points": [
          [
            312,
            363
          ],
          [
            588,
            363
          ],
          [
            588,
            385
          ],
          [
            312,
            385
          ]
        ],
        "transcription": "physician evaluation scores."
      },
      {
        "index_in_para": 7,
        "index_para": 1,
        "points": [
          [
            309,
            396
          ],
          [
            895,
            396
          ],
          [
            895,
            418
          ],
          [
            309,
            418
          ]
        ],
        "transcription": "Patients will be followed for another 6 months after end of"
      },
      {
        "index_in_para": 8,
        "index_para": 1,
        "points": [
          [
            312,
            428
          ],
          [
            791,
            428
          ],
          [
            791,
            446
          ],
          [
            312,
            446
          ]
        ],
        "transcription": "treatment to evaluate the durability of response."
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            311,
            458
          ],
          [
            975,
            458
          ],
          [
            975,
            480
          ],
          [
            311,
            480
          ]
        ],
        "transcription": "Biopsies and peripheral blood will be obtained at baseline.weeks 4"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            313,
            488
          ],
          [
            959,
            488
          ],
          [
            959,
            511
          ],
          [
            313,
            511
          ]
        ],
        "transcription": "and 24, for immune monitoring and molecular studies.Additional"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            309,
            514
          ],
          [
            932,
            515
          ],
          [
            932,
            541
          ],
          [
            309,
            540
          ]
        ],
        "transcription": "biopsies and blood draws(1-3 anticipated) may be obtained as"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            312,
            545
          ],
          [
            493,
            545
          ],
          [
            493,
            568
          ],
          [
            312,
            568
          ]
        ],
        "transcription": "clinically indicated"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            292,
            580
          ],
          [
            936,
            580
          ],
          [
            936,
            602
          ],
          [
            292,
            602
          ]
        ],
        "transcription": "QOL measures at baseline and at various additional time points"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2547000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            512,
            66
          ],
          [
            755,
            66
          ],
          [
            755,
            107
          ],
          [
            512,
            107
          ]
        ],
        "transcription": "TOFACITINIB"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            539,
            168
          ],
          [
            728,
            168
          ],
          [
            728,
            220
          ],
          [
            539,
            220
          ]
        ],
        "transcription": "Subject 4"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            642,
            229
          ],
          [
            746,
            226
          ],
          [
            747,
            259
          ],
          [
            643,
            262
          ]
        ],
        "transcription": "Week 24"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            280,
            230
          ],
          [
            376,
            230
          ],
          [
            376,
            259
          ],
          [
            280,
            259
          ]
        ],
        "transcription": "Baseline"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            255,
            680
          ],
          [
            1003,
            680
          ],
          [
            1003,
            699
          ],
          [
            255,
            699
          ]
        ],
        "transcription": "BL SALT 84,6 months 5mg BID,0 months 10/5mg,0 months 10mg, End of treatment SALT0."
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2655000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            313,
            28
          ],
          [
            953,
            28
          ],
          [
            953,
            58
          ],
          [
            313,
            58
          ]
        ],
        "transcription": "TOFA Regrowth vs.time Essentially flat response in"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            304,
            74
          ],
          [
            959,
            73
          ],
          [
            959,
            101
          ],
          [
            304,
            102
          ]
        ],
        "transcription": "most patients on lower dose in the first 3-4 months."
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            297,
            116
          ],
          [
            969,
            119
          ],
          [
            969,
            151
          ],
          [
            297,
            148
          ]
        ],
        "transcription": "Improved after dose adjustment up to 15mg or 20mg"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            529,
            181
          ],
          [
            739,
            181
          ],
          [
            739,
            208
          ],
          [
            529,
            208
          ]
        ],
        "transcription": "Regrowth (%) vs. Time"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            292,
            320
          ],
          [
            315,
            320
          ],
          [
            315,
            471
          ],
          [
            292,
            471
          ]
        ],
        "transcription": "Regrowth(%)"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            604,
            597
          ],
          [
            669,
            597
          ],
          [
            669,
            622
          ],
          [
            604,
            622
          ]
        ],
        "transcription": "Weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            280,
            639
          ],
          [
            963,
            641
          ],
          [
            963,
            668
          ],
          [
            280,
            667
          ]
        ],
        "transcription": "Tofacitinib reguires higher dose and Tonger duration of"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            372,
            683
          ],
          [
            861,
            683
          ],
          [
            861,
            713
          ],
          [
            372,
            713
          ]
        ],
        "transcription": "treatment(15mg or 20mg;>6 months)"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2689450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            355,
            68
          ],
          [
            912,
            68
          ],
          [
            912,
            107
          ],
          [
            355,
            107
          ]
        ],
        "transcription": "TOFACITINIB Adverse effects"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            310,
            159
          ],
          [
            572,
            159
          ],
          [
            572,
            189
          ],
          [
            310,
            189
          ]
        ],
        "transcription": "No serious adverse effects"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            305,
            200
          ],
          [
            911,
            201
          ],
          [
            911,
            225
          ],
          [
            306,
            226
          ]
        ],
        "transcription": "1 patient discontinued treatment after 3 months on 5mg BID"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            311,
            240
          ],
          [
            913,
            240
          ],
          [
            913,
            262
          ],
          [
            311,
            262
          ]
        ],
        "transcription": "tofacitinib due to hypertension. Prior to discontinuation, she"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            311,
            273
          ],
          [
            548,
            273
          ],
          [
            548,
            299
          ],
          [
            311,
            299
          ]
        ],
        "transcription": "achieved 15%regrowth."
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            311,
            316
          ],
          [
            869,
            316
          ],
          [
            869,
            341
          ],
          [
            311,
            341
          ]
        ],
        "transcription": "1 subject had study medication held due to low platelets"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            309,
            348
          ],
          [
            956,
            349
          ],
          [
            956,
            376
          ],
          [
            309,
            375
          ]
        ],
        "transcription": "129x10(9)/L(normal165-415).Platelet levels returned to normal"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            311,
            384
          ],
          [
            919,
            385
          ],
          [
            919,
            412
          ],
          [
            311,
            410
          ]
        ],
        "transcription": "after 2 weeks off tofacitinib and have subsequently remained"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            308,
            422
          ],
          [
            856,
            420
          ],
          [
            856,
            446
          ],
          [
            308,
            449
          ]
        ],
        "transcription": "normal even with gradual dose escalation to 10mg BID."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            307,
            465
          ],
          [
            956,
            465
          ],
          [
            956,
            489
          ],
          [
            307,
            489
          ]
        ],
        "transcription": "1 subiect had elevated liver function tests at week 4.The patient"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            312,
            500
          ],
          [
            900,
            500
          ],
          [
            900,
            523
          ],
          [
            312,
            523
          ]
        ],
        "transcription": "attributed this to moderate alcohol intake. The patient was"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            312,
            535
          ],
          [
            931,
            535
          ],
          [
            931,
            557
          ],
          [
            312,
            557
          ]
        ],
        "transcription": "counseled to avoid alcohol intake.Her liver function tests have"
      },
      {
        "index_in_para": 3,
        "index_para": 4,
        "points": [
          [
            309,
            570
          ],
          [
            751,
            569
          ],
          [
            751,
            593
          ],
          [
            309,
            594
          ]
        ],
        "transcription": "subsequently remained within normal limits."
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            305,
            616
          ],
          [
            960,
            611
          ],
          [
            960,
            638
          ],
          [
            307,
            633
          ]
        ],
        "transcription": "2 subjects with loose stools.1 with transient increased frequency."
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            311,
            647
          ],
          [
            823,
            646
          ],
          [
            823,
            670
          ],
          [
            311,
            671
          ]
        ],
        "transcription": "Study drug held for 1 mth for GI eval.Full eval.WNL"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2721000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            331,
            66
          ],
          [
            935,
            68
          ],
          [
            935,
            107
          ],
          [
            331,
            106
          ]
        ],
        "transcription": "TOFACITINIB: Outcome to date"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            309,
            181
          ],
          [
            945,
            179
          ],
          [
            945,
            210
          ],
          [
            309,
            211
          ]
        ],
        "transcription": "8 subjects have achieved at least 50% regrowth"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            306,
            238
          ],
          [
            951,
            238
          ],
          [
            951,
            272
          ],
          [
            306,
            272
          ]
        ],
        "transcription": "2 subjects with good regrowth, but not yet 50%"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            305,
            295
          ],
          [
            887,
            295
          ],
          [
            887,
            327
          ],
          [
            305,
            327
          ]
        ],
        "transcription": "1 subject early terminated at 3mths due to"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            313,
            344
          ],
          [
            977,
            344
          ],
          [
            977,
            375
          ],
          [
            313,
            375
          ]
        ],
        "transcription": "elevated blood pressure.Patient self reported ful"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            312,
            393
          ],
          [
            841,
            390
          ],
          [
            841,
            422
          ],
          [
            312,
            425
          ]
        ],
        "transcription": "regrowth after study drug discontinued"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            284,
            565
          ],
          [
            867,
            565
          ],
          [
            867,
            596
          ],
          [
            284,
            596
          ]
        ],
        "transcription": "Overall: interim~70-75% response rate"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2760000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            297,
            48
          ],
          [
            971,
            49
          ],
          [
            971,
            81
          ],
          [
            297,
            79
          ]
        ],
        "transcription": "Tofacitinib in Psoriasis: perhaps higher doses are"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            387,
            95
          ],
          [
            876,
            93
          ],
          [
            876,
            123
          ],
          [
            387,
            126
          ]
        ],
        "transcription": "needed for skin and hair disorders?"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            459,
            168
          ],
          [
            656,
            168
          ],
          [
            656,
            197
          ],
          [
            459,
            197
          ]
        ],
        "transcription": "Tofacitinib 5mg twice daily"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            459,
            194
          ],
          [
            667,
            189
          ],
          [
            668,
            221
          ],
          [
            456,
            226
          ]
        ],
        "transcription": "Tofacitinib 10 mg twice daily"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            457,
            223
          ],
          [
            679,
            223
          ],
          [
            679,
            246
          ],
          [
            457,
            246
          ]
        ],
        "transcription": "Etanercept 50 mg twice weekly"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            456,
            248
          ],
          [
            520,
            248
          ],
          [
            520,
            272
          ],
          [
            456,
            272
          ]
        ],
        "transcription": "Placebo"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            317,
            226
          ],
          [
            340,
            226
          ],
          [
            339,
            511
          ],
          [
            316,
            511
          ]
        ],
        "transcription": "Proportion of patients achieving"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            339,
            273
          ],
          [
            363,
            273
          ],
          [
            361,
            465
          ],
          [
            337,
            464
          ]
        ],
        "transcription": "PASI75 response(%)"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            765,
            690
          ],
          [
            1024,
            690
          ],
          [
            1024,
            708
          ],
          [
            765,
            708
          ]
        ],
        "transcription": "Bachelez et al..Lancet.2015"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2814000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            371,
            20
          ],
          [
            920,
            21
          ],
          [
            920,
            57
          ],
          [
            371,
            56
          ]
        ],
        "transcription": "Next Generation JAK inhibitors"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            485,
            73
          ],
          [
            809,
            71
          ],
          [
            809,
            99
          ],
          [
            485,
            101
          ]
        ],
        "transcription": "Selectivity for specific JAKs"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            723,
            259
          ],
          [
            737,
            259
          ],
          [
            737,
            269
          ],
          [
            723,
            269
          ]
        ],
        "transcription": "10"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            848,
            265
          ],
          [
            916,
            265
          ],
          [
            916,
            286
          ],
          [
            848,
            286
          ]
        ],
        "transcription": "filgotinib"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            846,
            285
          ],
          [
            910,
            282
          ],
          [
            911,
            304
          ],
          [
            847,
            307
          ]
        ],
        "transcription": "abt-494"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            865,
            306
          ],
          [
            893,
            306
          ],
          [
            893,
            320
          ],
          [
            865,
            320
          ]
        ],
        "transcription": "JAK1"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            309,
            300
          ],
          [
            419,
            300
          ],
          [
            419,
            318
          ],
          [
            309,
            318
          ]
        ],
        "transcription": "Decernotinib and"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            311,
            319
          ],
          [
            405,
            319
          ],
          [
            405,
            332
          ],
          [
            311,
            332
          ]
        ],
        "transcription": "CovalentJAK3is"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            851,
            343
          ],
          [
            924,
            343
          ],
          [
            924,
            361
          ],
          [
            851,
            361
          ]
        ],
        "transcription": "tofacitinib"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            865,
            364
          ],
          [
            909,
            364
          ],
          [
            909,
            379
          ],
          [
            865,
            379
          ]
        ],
        "transcription": "JAK1/2/3"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            816,
            388
          ],
          [
            965,
            388
          ],
          [
            965,
            406
          ],
          [
            816,
            406
          ]
        ],
        "transcription": "baricitinib, ruxolitinib"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            871,
            409
          ],
          [
            904,
            409
          ],
          [
            904,
            424
          ],
          [
            871,
            424
          ]
        ],
        "transcription": "JAK1/2"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            309,
            365
          ],
          [
            387,
            365
          ],
          [
            387,
            380
          ],
          [
            309,
            380
          ]
        ],
        "transcription": "Aclaris/rigel"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            335,
            381
          ],
          [
            388,
            381
          ],
          [
            388,
            396
          ],
          [
            335,
            396
          ]
        ],
        "transcription": "JAK1/3"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            269,
            652
          ],
          [
            496,
            652
          ],
          [
            496,
            666
          ],
          [
            269,
            666
          ]
        ],
        "transcription": "Adapted from Gadina, Arth & RheumV68, no.12016 pp31-4"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2834000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            400,
            209
          ],
          [
            893,
            212
          ],
          [
            893,
            252
          ],
          [
            400,
            249
          ]
        ],
        "transcription": "Environmental Factors:"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            476,
            336
          ],
          [
            803,
            340
          ],
          [
            802,
            387
          ],
          [
            476,
            382
          ]
        ],
        "transcription": "Alopecia Areata"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            559,
            401
          ],
          [
            719,
            401
          ],
          [
            719,
            443
          ],
          [
            559,
            443
          ]
        ],
        "transcription": "and the"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            515,
            466
          ],
          [
            764,
            469
          ],
          [
            764,
            510
          ],
          [
            515,
            507
          ]
        ],
        "transcription": "Microbiome"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2854000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            409,
            41
          ],
          [
            859,
            41
          ],
          [
            859,
            68
          ],
          [
            409,
            68
          ]
        ],
        "transcription": "MICROBIOME AND AUTOIMMUNITY"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            472,
            185
          ],
          [
            947,
            185
          ],
          [
            947,
            202
          ],
          [
            472,
            202
          ]
        ],
        "transcription": "Bacteroides inoculation in mice induces T-reg cells and protects"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            472,
            209
          ],
          [
            739,
            209
          ],
          [
            739,
            228
          ],
          [
            472,
            228
          ]
        ],
        "transcription": "against experimental encephalitis"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            472,
            233
          ],
          [
            764,
            233
          ],
          [
            764,
            251
          ],
          [
            472,
            251
          ]
        ],
        "transcription": "(Ochoa-Reparaz et al, JImmunol2010"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            459,
            380
          ],
          [
            808,
            380
          ],
          [
            808,
            398
          ],
          [
            459,
            398
          ]
        ],
        "transcription": "Clostridiuminoculation in mice prevents colitis"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            593,
            406
          ],
          [
            809,
            406
          ],
          [
            809,
            425
          ],
          [
            593,
            425
          ]
        ],
        "transcription": "Atarashi et al, Science 2011"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            471,
            551
          ],
          [
            989,
            551
          ],
          [
            989,
            569
          ],
          [
            471,
            569
          ]
        ],
        "transcription": "Increase in gut Bacteroides dorei coincides with the onset of Type 1"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            472,
            574
          ],
          [
            765,
            574
          ],
          [
            765,
            592
          ],
          [
            472,
            592
          ]
        ],
        "transcription": "Diabetes in a cohort of Finnish children"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            471,
            598
          ],
          [
            808,
            598
          ],
          [
            808,
            617
          ],
          [
            471,
            617
          ]
        ],
        "transcription": "(Davis Richardson et al, Front Microbiol2014"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2879000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            289,
            45
          ],
          [
            736,
            45
          ],
          [
            736,
            68
          ],
          [
            289,
            68
          ]
        ],
        "transcription": "MICROBIOMEANDAUTOIMMUNITY"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            295,
            199
          ],
          [
            600,
            199
          ],
          [
            600,
            221
          ],
          [
            295,
            221
          ]
        ],
        "transcription": "RHEUMATOID ARTHRITIS(RA)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            291,
            277
          ],
          [
            740,
            277
          ],
          [
            740,
            295
          ],
          [
            291,
            295
          ]
        ],
        "transcription": "16S rRNA sequencing of gut microbiome in RA patients vs controls"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            291,
            335
          ],
          [
            985,
            335
          ],
          [
            985,
            353
          ],
          [
            291,
            353
          ]
        ],
        "transcription": "Over-abundance of Prevotella copri in untreated, new-onset RA(75%)compared to chronic RA(37.5%)"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            291,
            360
          ],
          [
            433,
            360
          ],
          [
            433,
            379
          ],
          [
            291,
            379
          ]
        ],
        "transcription": "and controls(21.4%)"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            288,
            413
          ],
          [
            992,
            414
          ],
          [
            992,
            437
          ],
          [
            288,
            435
          ]
        ],
        "transcription": "Colonization of C57BL/6 mice with P.copri leads to a pro-inflammatory state and were more susceptible"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            291,
            441
          ],
          [
            409,
            441
          ],
          [
            409,
            459
          ],
          [
            291,
            459
          ]
        ],
        "transcription": "to induced colitis"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            289,
            498
          ],
          [
            440,
            499
          ],
          [
            440,
            518
          ],
          [
            289,
            516
          ]
        ],
        "transcription": "Prevotella abundance"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            307,
            528
          ],
          [
            607,
            528
          ],
          [
            607,
            545
          ],
          [
            307,
            545
          ]
        ],
        "transcription": "-Promotes pro-inflammatory environment"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            309,
            556
          ],
          [
            883,
            556
          ],
          [
            883,
            574
          ],
          [
            309,
            574
          ]
        ],
        "transcription": "Out-competes anti-inflammatoryspecies like Bacteriodes and Group XIV Clostridia"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            883,
            670
          ],
          [
            1036,
            670
          ],
          [
            1036,
            688
          ],
          [
            883,
            688
          ]
        ],
        "transcription": "Scher et al, Elife 2015"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2880000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            414,
            247
          ],
          [
            859,
            250
          ],
          [
            858,
            291
          ],
          [
            413,
            288
          ]
        ],
        "transcription": "Can alterations in the"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            512,
            315
          ],
          [
            761,
            315
          ],
          [
            761,
            356
          ],
          [
            512,
            356
          ]
        ],
        "transcription": "microbiome"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            363,
            376
          ],
          [
            909,
            376
          ],
          [
            909,
            425
          ],
          [
            363,
            425
          ]
        ],
        "transcription": "affect the development of"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            457,
            441
          ],
          [
            815,
            441
          ],
          [
            815,
            490
          ],
          [
            457,
            490
          ]
        ],
        "transcription": "Alopecia Areata?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2899000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            555,
            369
          ],
          [
            635,
            372
          ],
          [
            634,
            396
          ],
          [
            554,
            393
          ]
        ],
        "transcription": "5 weeks"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            688,
            380
          ],
          [
            941,
            381
          ],
          [
            941,
            408
          ],
          [
            688,
            406
          ]
        ],
        "transcription": "HAIR LOSS (starting around"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            685,
            413
          ],
          [
            773,
            413
          ],
          [
            773,
            437
          ],
          [
            685,
            437
          ]
        ],
        "transcription": "the belly)"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            326,
            458
          ],
          [
            479,
            461
          ],
          [
            478,
            487
          ],
          [
            325,
            484
          ]
        ],
        "transcription": "C3H/H3J mouse"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            325,
            491
          ],
          [
            432,
            491
          ],
          [
            432,
            515
          ],
          [
            325,
            515
          ]
        ],
        "transcription": "- Skin from"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            324,
            519
          ],
          [
            460,
            519
          ],
          [
            460,
            545
          ],
          [
            324,
            545
          ]
        ],
        "transcription": "alopecic mice"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            324,
            549
          ],
          [
            501,
            548
          ],
          [
            501,
            572
          ],
          [
            324,
            573
          ]
        ],
        "transcription": "grafted at 9 weeks"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            323,
            574
          ],
          [
            391,
            579
          ],
          [
            389,
            607
          ],
          [
            321,
            602
          ]
        ],
        "transcription": "of age"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            667,
            533
          ],
          [
            900,
            533
          ],
          [
            900,
            569
          ],
          [
            667,
            569
          ]
        ],
        "transcription": "Can antibiotic"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            649,
            586
          ],
          [
            919,
            586
          ],
          [
            919,
            623
          ],
          [
            649,
            623
          ]
        ],
        "transcription": "cocktail prevent"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            645,
            638
          ],
          [
            920,
            638
          ],
          [
            920,
            675
          ],
          [
            645,
            675
          ]
        ],
        "transcription": "alopecia areata?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2951000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            867,
            106
          ],
          [
            1011,
            106
          ],
          [
            1011,
            139
          ],
          [
            867,
            139
          ]
        ],
        "transcription": "Still no AA"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            864,
            152
          ],
          [
            999,
            152
          ],
          [
            999,
            184
          ],
          [
            864,
            184
          ]
        ],
        "transcription": "in treated"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            580,
            177
          ],
          [
            733,
            177
          ],
          [
            733,
            200
          ],
          [
            580,
            200
          ]
        ],
        "transcription": "9weeks: Grafted"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            262,
            180
          ],
          [
            344,
            183
          ],
          [
            343,
            207
          ],
          [
            261,
            204
          ]
        ],
        "transcription": "4 weeks:"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            264,
            212
          ],
          [
            380,
            212
          ],
          [
            380,
            234
          ],
          [
            264,
            234
          ]
        ],
        "transcription": "Treatment or"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            263,
            240
          ],
          [
            327,
            240
          ],
          [
            327,
            263
          ],
          [
            263,
            263
          ]
        ],
        "transcription": "control"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            865,
            201
          ],
          [
            965,
            201
          ],
          [
            965,
            229
          ],
          [
            865,
            229
          ]
        ],
        "transcription": "mice..."
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            531,
            250
          ],
          [
            749,
            253
          ],
          [
            749,
            279
          ],
          [
            531,
            277
          ]
        ],
        "transcription": "15 weeks after grafting"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            697,
            551
          ],
          [
            977,
            551
          ],
          [
            977,
            573
          ],
          [
            697,
            573
          ]
        ],
        "transcription": "Antibiotic cocktail(Ampicillin"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            704,
            577
          ],
          [
            973,
            578
          ],
          [
            973,
            605
          ],
          [
            704,
            603
          ]
        ],
        "transcription": "Vancomycin, Neomycin and"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            723,
            609
          ],
          [
            955,
            609
          ],
          [
            955,
            631
          ],
          [
            723,
            631
          ]
        ],
        "transcription": "Metronidazole, with 10%"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            696,
            638
          ],
          [
            984,
            638
          ],
          [
            984,
            660
          ],
          [
            696,
            660
          ]
        ],
        "transcription": "sucrose)started at4weeks of"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            819,
            668
          ],
          [
            860,
            668
          ],
          [
            860,
            694
          ],
          [
            819,
            694
          ]
        ],
        "transcription": "age"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            379,
            562
          ],
          [
            477,
            562
          ],
          [
            477,
            586
          ],
          [
            379,
            586
          ]
        ],
        "transcription": "CONTROL"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2966000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            251,
            66
          ],
          [
            1004,
            66
          ],
          [
            1004,
            102
          ],
          [
            251,
            102
          ]
        ],
        "transcription": "Microbiota is required for development of AA"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            320,
            164
          ],
          [
            916,
            163
          ],
          [
            916,
            193
          ],
          [
            320,
            195
          ]
        ],
        "transcription": "Antibiotic cocktail prevents development of AA"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            788,
            344
          ],
          [
            835,
            344
          ],
          [
            835,
            363
          ],
          [
            788,
            363
          ]
        ],
        "transcription": "Control"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            889,
            344
          ],
          [
            956,
            344
          ],
          [
            956,
            363
          ],
          [
            889,
            363
          ]
        ],
        "transcription": "Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            264,
            363
          ],
          [
            283,
            363
          ],
          [
            283,
            420
          ],
          [
            264,
            420
          ]
        ],
        "transcription": "Control"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            517,
            547
          ],
          [
            496,
            547
          ],
          [
            496,
            392
          ],
          [
            517,
            392
          ]
        ],
        "transcription": "% without hair loss"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            636,
            424
          ],
          [
            717,
            424
          ],
          [
            717,
            438
          ],
          [
            636,
            438
          ]
        ],
        "transcription": "Control(n=5"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            633,
            445
          ],
          [
            732,
            445
          ],
          [
            732,
            459
          ],
          [
            633,
            459
          ]
        ],
        "transcription": "Treatment(n=7"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            268,
            510
          ],
          [
            283,
            510
          ],
          [
            283,
            582
          ],
          [
            268,
            582
          ]
        ],
        "transcription": "Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            617,
            593
          ],
          [
            664,
            593
          ],
          [
            664,
            613
          ],
          [
            617,
            613
          ]
        ],
        "transcription": "Weeks"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-2984000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            411,
            163
          ],
          [
            861,
            163
          ],
          [
            861,
            204
          ],
          [
            411,
            204
          ]
        ],
        "transcription": "How does antibiotic"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            413,
            228
          ],
          [
            860,
            228
          ],
          [
            860,
            267
          ],
          [
            413,
            267
          ]
        ],
        "transcription": "treatment affect the"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            419,
            291
          ],
          [
            852,
            288
          ],
          [
            852,
            333
          ],
          [
            419,
            336
          ]
        ],
        "transcription": "composition of the"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            483,
            352
          ],
          [
            788,
            349
          ],
          [
            788,
            396
          ],
          [
            483,
            399
          ]
        ],
        "transcription": "microbiome?"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            320,
            478
          ],
          [
            952,
            481
          ],
          [
            952,
            531
          ],
          [
            320,
            528
          ]
        ],
        "transcription": "Is it working via skin or gut"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            375,
            541
          ],
          [
            891,
            544
          ],
          [
            890,
            594
          ],
          [
            375,
            592
          ]
        ],
        "transcription": "microbiome (or both)?"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3045450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            313,
            47
          ],
          [
            943,
            58
          ],
          [
            942,
            107
          ],
          [
            312,
            96
          ]
        ],
        "transcription": "JAK inhibitors in dermatology"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            549,
            182
          ],
          [
            707,
            176
          ],
          [
            709,
            217
          ],
          [
            550,
            223
          ]
        ],
        "transcription": "psoriasis"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            488,
            233
          ],
          [
            770,
            230
          ],
          [
            771,
            267
          ],
          [
            488,
            270
          ]
        ],
        "transcription": "atopic dermatitis"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            568,
            276
          ],
          [
            691,
            281
          ],
          [
            689,
            327
          ],
          [
            566,
            322
          ]
        ],
        "transcription": "vitiligo"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            483,
            332
          ],
          [
            776,
            335
          ],
          [
            776,
            376
          ],
          [
            483,
            373
          ]
        ],
        "transcription": "Sezary syndrome"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            404,
            388
          ],
          [
            854,
            384
          ],
          [
            855,
            421
          ],
          [
            404,
            425
          ]
        ],
        "transcription": "epidermolysis bullosa/Scc"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            468,
            434
          ],
          [
            791,
            437
          ],
          [
            790,
            477
          ],
          [
            468,
            474
          ]
        ],
        "transcription": "CANDLE syndrome"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            504,
            540
          ],
          [
            756,
            540
          ],
          [
            756,
            577
          ],
          [
            504,
            577
          ]
        ],
        "transcription": "alopecia areata"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            367,
            625
          ],
          [
            892,
            623
          ],
          [
            892,
            655
          ],
          [
            367,
            656
          ]
        ],
        "transcription": "...other inflammatory alopecias, CA, FFA."
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3088000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            764,
            13
          ],
          [
            881,
            13
          ],
          [
            881,
            30
          ],
          [
            764,
            30
          ]
        ],
        "transcription": "C3H/HeJ mouse model"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            797,
            36
          ],
          [
            884,
            36
          ],
          [
            884,
            49
          ],
          [
            797,
            49
          ]
        ],
        "transcription": "SystemicTopical"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            796,
            50
          ],
          [
            985,
            50
          ],
          [
            985,
            64
          ],
          [
            796,
            64
          ]
        ],
        "transcription": "Treatment Treatment Treatment Treatment"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            915,
            15
          ],
          [
            969,
            15
          ],
          [
            969,
            29
          ],
          [
            915,
            29
          ]
        ],
        "transcription": "Human AA"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            897,
            34
          ],
          [
            979,
            34
          ],
          [
            979,
            49
          ],
          [
            897,
            49
          ]
        ],
        "transcription": "SystemicTopical"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            632,
            30
          ],
          [
            692,
            30
          ],
          [
            692,
            45
          ],
          [
            632,
            45
          ]
        ],
        "transcription": "Drug Class"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            750,
            44
          ],
          [
            795,
            41
          ],
          [
            796,
            54
          ],
          [
            751,
            57
          ]
        ],
        "transcription": "Prevention"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            628,
            77
          ],
          [
            696,
            77
          ],
          [
            696,
            90
          ],
          [
            628,
            90
          ]
        ],
        "transcription": "JAK Inhibitors"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            575,
            90
          ],
          [
            624,
            90
          ],
          [
            624,
            105
          ],
          [
            575,
            105
          ]
        ],
        "transcription": "Ruxolitinib"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            575,
            105
          ],
          [
            620,
            105
          ],
          [
            620,
            119
          ],
          [
            575,
            119
          ]
        ],
        "transcription": "Baricitinib"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            573,
            120
          ],
          [
            624,
            120
          ],
          [
            624,
            135
          ],
          [
            573,
            135
          ]
        ],
        "transcription": "Totacitinib"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            573,
            135
          ],
          [
            632,
            135
          ],
          [
            632,
            150
          ],
          [
            573,
            150
          ]
        ],
        "transcription": "Decernotinib"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            575,
            151
          ],
          [
            624,
            151
          ],
          [
            624,
            165
          ],
          [
            575,
            165
          ]
        ],
        "transcription": "R548/R507"
      },
      {
        "index_in_para": 5,
        "index_para": 5,
        "points": [
          [
            575,
            165
          ],
          [
            623,
            165
          ],
          [
            623,
            179
          ],
          [
            575,
            179
          ]
        ],
        "transcription": "Oclacitinib"
      },
      {
        "index_in_para": 6,
        "index_para": 5,
        "points": [
          [
            573,
            180
          ],
          [
            617,
            180
          ],
          [
            617,
            195
          ],
          [
            573,
            195
          ]
        ],
        "transcription": "Filgotinib"
      },
      {
        "index_in_para": 7,
        "index_para": 5,
        "points": [
          [
            572,
            195
          ],
          [
            618,
            191
          ],
          [
            619,
            210
          ],
          [
            573,
            214
          ]
        ],
        "transcription": "AZD1480"
      },
      {
        "index_in_para": 8,
        "index_para": 5,
        "points": [
          [
            575,
            210
          ],
          [
            632,
            210
          ],
          [
            632,
            224
          ],
          [
            575,
            224
          ]
        ],
        "transcription": "Momelotinib"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            287,
            95
          ],
          [
            512,
            95
          ],
          [
            512,
            118
          ],
          [
            287,
            118
          ]
        ],
        "transcription": "Pre-clinical and Clinical"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            285,
            122
          ],
          [
            511,
            120
          ],
          [
            511,
            143
          ],
          [
            285,
            144
          ]
        ],
        "transcription": "Research Studies in AA"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            695,
            97
          ],
          [
            724,
            97
          ],
          [
            724,
            111
          ],
          [
            695,
            111
          ]
        ],
        "transcription": "Jak1/2"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            865,
            123
          ],
          [
            872,
            123
          ],
          [
            872,
            131
          ],
          [
            865,
            131
          ]
        ],
        "transcription": "A"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            691,
            127
          ],
          [
            729,
            127
          ],
          [
            729,
            142
          ],
          [
            691,
            142
          ]
        ],
        "transcription": "Jak1/2/3"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            695,
            156
          ],
          [
            725,
            156
          ],
          [
            725,
            172
          ],
          [
            695,
            172
          ]
        ],
        "transcription": "Jak1/3"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            699,
            180
          ],
          [
            721,
            180
          ],
          [
            721,
            195
          ],
          [
            699,
            195
          ]
        ],
        "transcription": "Jak1"
      },
      {
        "index_in_para": 2,
        "index_para": 10,
        "points": [
          [
            697,
            201
          ],
          [
            723,
            201
          ],
          [
            723,
            217
          ],
          [
            697,
            217
          ]
        ],
        "transcription": "Jak2"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            291,
            228
          ],
          [
            507,
            229
          ],
          [
            507,
            253
          ],
          [
            291,
            251
          ]
        ],
        "transcription": "Therapeutic Approaches"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            344,
            257
          ],
          [
            455,
            257
          ],
          [
            455,
            279
          ],
          [
            344,
            279
          ]
        ],
        "transcription": "tested in the"
      },
      {
        "index_in_para": 2,
        "index_para": 11,
        "points": [
          [
            295,
            281
          ],
          [
            503,
            282
          ],
          [
            503,
            306
          ],
          [
            295,
            304
          ]
        ],
        "transcription": "C3H/H3J mouse model"
      },
      {
        "index_in_para": 3,
        "index_para": 11,
        "points": [
          [
            281,
            312
          ],
          [
            516,
            312
          ],
          [
            516,
            331
          ],
          [
            281,
            331
          ]
        ],
        "transcription": "and in human clinical trials"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            596,
            233
          ],
          [
            725,
            232
          ],
          [
            725,
            246
          ],
          [
            596,
            248
          ]
        ],
        "transcription": "y chain cytokine blockade"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            575,
            246
          ],
          [
            640,
            246
          ],
          [
            640,
            259
          ],
          [
            575,
            259
          ]
        ],
        "transcription": "Anti-II-2 mAb"
      },
      {
        "index_in_para": 1,
        "index_para": 13,
        "points": [
          [
            575,
            262
          ],
          [
            641,
            262
          ],
          [
            641,
            277
          ],
          [
            575,
            277
          ]
        ],
        "transcription": "Anti-Il-4 mAb"
      },
      {
        "index_in_para": 2,
        "index_para": 13,
        "points": [
          [
            575,
            277
          ],
          [
            641,
            277
          ],
          [
            641,
            291
          ],
          [
            575,
            291
          ]
        ],
        "transcription": "Anti-IL-7 mAb"
      },
      {
        "index_in_para": 3,
        "index_para": 13,
        "points": [
          [
            575,
            292
          ],
          [
            640,
            292
          ],
          [
            640,
            306
          ],
          [
            575,
            306
          ]
        ],
        "transcription": "Anti-IL-15 mAb"
      },
      {
        "index_in_para": 4,
        "index_para": 13,
        "points": [
          [
            575,
            308
          ],
          [
            640,
            308
          ],
          [
            640,
            322
          ],
          [
            575,
            322
          ]
        ],
        "transcription": "Anti-II-21 mAb"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            617,
            331
          ],
          [
            705,
            331
          ],
          [
            705,
            344
          ],
          [
            617,
            344
          ]
        ],
        "transcription": "Biological agents"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            575,
            344
          ],
          [
            640,
            344
          ],
          [
            640,
            357
          ],
          [
            575,
            357
          ]
        ],
        "transcription": "Anti-IL-12 mAb"
      },
      {
        "index_in_para": 1,
        "index_para": 15,
        "points": [
          [
            575,
            360
          ],
          [
            656,
            360
          ],
          [
            656,
            373
          ],
          [
            575,
            373
          ]
        ],
        "transcription": "Anti-IL-12/23 mAb"
      },
      {
        "index_in_para": 2,
        "index_para": 15,
        "points": [
          [
            575,
            376
          ],
          [
            656,
            376
          ],
          [
            656,
            390
          ],
          [
            575,
            390
          ]
        ],
        "transcription": "Anti-IL-23p19 mAb"
      },
      {
        "index_in_para": 3,
        "index_para": 15,
        "points": [
          [
            575,
            389
          ],
          [
            641,
            389
          ],
          [
            641,
            402
          ],
          [
            575,
            402
          ]
        ],
        "transcription": "Anti-IL-13 mAb"
      },
      {
        "index_in_para": 4,
        "index_para": 15,
        "points": [
          [
            575,
            404
          ],
          [
            641,
            404
          ],
          [
            641,
            418
          ],
          [
            575,
            418
          ]
        ],
        "transcription": "Anti-IL-17 mAb"
      },
      {
        "index_in_para": 5,
        "index_para": 15,
        "points": [
          [
            575,
            420
          ],
          [
            641,
            420
          ],
          [
            641,
            434
          ],
          [
            575,
            434
          ]
        ],
        "transcription": "Anti-IFN-y mAb"
      },
      {
        "index_in_para": 6,
        "index_para": 15,
        "points": [
          [
            575,
            435
          ],
          [
            645,
            435
          ],
          [
            645,
            449
          ],
          [
            575,
            449
          ]
        ],
        "transcription": "Anti-OXCR3 mAb"
      },
      {
        "index_in_para": 7,
        "index_para": 15,
        "points": [
          [
            575,
            450
          ],
          [
            649,
            450
          ],
          [
            649,
            465
          ],
          [
            575,
            465
          ]
        ],
        "transcription": "Anti-NKG2D mAb"
      },
      {
        "index_in_para": 8,
        "index_para": 15,
        "points": [
          [
            574,
            462
          ],
          [
            643,
            463
          ],
          [
            642,
            478
          ],
          [
            573,
            476
          ]
        ],
        "transcription": "Anti-TNF mAbs"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            589,
            479
          ],
          [
            743,
            479
          ],
          [
            743,
            488
          ],
          [
            589,
            488
          ]
        ],
        "transcription": "Etanercept/alefacept/efalizumab"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            608,
            496
          ],
          [
            715,
            496
          ],
          [
            715,
            514
          ],
          [
            608,
            514
          ]
        ],
        "transcription": "Protein Therapeutics"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            575,
            512
          ],
          [
            624,
            512
          ],
          [
            624,
            527
          ],
          [
            575,
            527
          ]
        ],
        "transcription": "CTLA-4-igG"
      },
      {
        "index_in_para": 1,
        "index_para": 18,
        "points": [
          [
            575,
            528
          ],
          [
            635,
            528
          ],
          [
            635,
            541
          ],
          [
            575,
            541
          ]
        ],
        "transcription": "Low dose Il-2"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            619,
            548
          ],
          [
            703,
            549
          ],
          [
            703,
            564
          ],
          [
            619,
            562
          ]
        ],
        "transcription": "Small molecules"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            575,
            565
          ],
          [
            624,
            565
          ],
          [
            624,
            578
          ],
          [
            575,
            578
          ]
        ],
        "transcription": "Apremilast"
      },
      {
        "index_in_para": 1,
        "index_para": 20,
        "points": [
          [
            576,
            581
          ],
          [
            673,
            581
          ],
          [
            673,
            594
          ],
          [
            576,
            594
          ]
        ],
        "transcription": "Simvastatin/Ezetimibe"
      },
      {
        "index_in_para": 2,
        "index_para": 20,
        "points": [
          [
            573,
            597
          ],
          [
            612,
            597
          ],
          [
            612,
            611
          ],
          [
            573,
            611
          ]
        ],
        "transcription": "Onglyza"
      },
      {
        "index_in_para": 3,
        "index_para": 20,
        "points": [
          [
            575,
            610
          ],
          [
            621,
            610
          ],
          [
            621,
            623
          ],
          [
            575,
            623
          ]
        ],
        "transcription": "Vorinostat"
      },
      {
        "index_in_para": 4,
        "index_para": 20,
        "points": [
          [
            576,
            626
          ],
          [
            689,
            626
          ],
          [
            689,
            639
          ],
          [
            576,
            639
          ]
        ],
        "transcription": "Bimatoprost/unoprostone"
      },
      {
        "index_in_para": 5,
        "index_para": 20,
        "points": [
          [
            575,
            642
          ],
          [
            608,
            642
          ],
          [
            608,
            654
          ],
          [
            575,
            654
          ]
        ],
        "transcription": "CXCR3i"
      },
      {
        "index_in_para": 0,
        "index_para": 21,
        "points": [
          [
            440,
            655
          ],
          [
            555,
            655
          ],
          [
            555,
            672
          ],
          [
            440,
            672
          ]
        ],
        "transcription": "From the literature"
      },
      {
        "index_in_para": 1,
        "index_para": 21,
        "points": [
          [
            374,
            670
          ],
          [
            555,
            672
          ],
          [
            554,
            691
          ],
          [
            373,
            688
          ]
        ],
        "transcription": "From our lab and the literature"
      },
      {
        "index_in_para": 0,
        "index_para": 22,
        "points": [
          [
            623,
            663
          ],
          [
            699,
            663
          ],
          [
            699,
            676
          ],
          [
            623,
            676
          ]
        ],
        "transcription": "Cell and Tissue"
      },
      {
        "index_in_para": 0,
        "index_para": 23,
        "points": [
          [
            575,
            678
          ],
          [
            664,
            678
          ],
          [
            664,
            692
          ],
          [
            575,
            692
          ]
        ],
        "transcription": "Platelet Rich Plasma"
      },
      {
        "index_in_para": 1,
        "index_para": 23,
        "points": [
          [
            572,
            691
          ],
          [
            695,
            692
          ],
          [
            695,
            707
          ],
          [
            572,
            705
          ]
        ],
        "transcription": "Stem Cell Educator Therapy"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3169000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            360,
            52
          ],
          [
            881,
            52
          ],
          [
            881,
            87
          ],
          [
            360,
            87
          ]
        ],
        "transcription": "JAK inhibitors in Clinical"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            276,
            114
          ],
          [
            964,
            115
          ],
          [
            964,
            156
          ],
          [
            276,
            155
          ]
        ],
        "transcription": "Development for Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            356,
            261
          ],
          [
            885,
            261
          ],
          [
            885,
            296
          ],
          [
            356,
            296
          ]
        ],
        "transcription": "Incyte (ruxolitinib, JAK1/2)- topical"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            311,
            351
          ],
          [
            929,
            351
          ],
          [
            929,
            386
          ],
          [
            311,
            386
          ]
        ],
        "transcription": "Leo Pharma (JTE-052, pan-JAK)-topical"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            255,
            437
          ],
          [
            983,
            439
          ],
          [
            983,
            475
          ],
          [
            255,
            472
          ]
        ],
        "transcription": "Concert Pharma - oral deuterated ruxo (CTP-543)"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            356,
            532
          ],
          [
            884,
            532
          ],
          [
            884,
            564
          ],
          [
            356,
            564
          ]
        ],
        "transcription": "Aclaris -topical(A-301), oral (A-201)"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            287,
            617
          ],
          [
            953,
            618
          ],
          [
            953,
            654
          ],
          [
            287,
            652
          ]
        ],
        "transcription": "Pfizer - oral PF06651600 (JAK3 covalent) and"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3235000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            424,
            53
          ],
          [
            855,
            54
          ],
          [
            855,
            78
          ],
          [
            424,
            77
          ]
        ],
        "transcription": "Timeline of Alopecia Areata Translational"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            464,
            83
          ],
          [
            813,
            86
          ],
          [
            813,
            114
          ],
          [
            464,
            111
          ]
        ],
        "transcription": "Research at Columbia University"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            293,
            65
          ],
          [
            389,
            65
          ],
          [
            389,
            79
          ],
          [
            293,
            79
          ]
        ],
        "transcription": "COLUMBIA UNIVERSITY"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            291,
            75
          ],
          [
            370,
            78
          ],
          [
            369,
            97
          ],
          [
            290,
            94
          ]
        ],
        "transcription": "MEDICAL CENTER"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            249,
            142
          ],
          [
            359,
            142
          ],
          [
            359,
            160
          ],
          [
            249,
            160
          ]
        ],
        "transcription": "Translational"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            247,
            165
          ],
          [
            340,
            168
          ],
          [
            340,
            187
          ],
          [
            246,
            184
          ]
        ],
        "transcription": "Milestones"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            372,
            269
          ],
          [
            443,
            269
          ],
          [
            443,
            283
          ],
          [
            372,
            283
          ]
        ],
        "transcription": "Identification of"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            369,
            279
          ],
          [
            444,
            279
          ],
          [
            444,
            298
          ],
          [
            369,
            298
          ]
        ],
        "transcription": "AA Biomarkers"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            378,
            293
          ],
          [
            438,
            297
          ],
          [
            437,
            315
          ],
          [
            377,
            312
          ]
        ],
        "transcription": "in Skin and"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            391,
            311
          ],
          [
            425,
            311
          ],
          [
            425,
            326
          ],
          [
            391,
            326
          ]
        ],
        "transcription": "Blood"
      },
      {
        "index_in_para": 4,
        "index_para": 3,
        "points": [
          [
            375,
            326
          ],
          [
            440,
            326
          ],
          [
            440,
            340
          ],
          [
            375,
            340
          ]
        ],
        "transcription": "(R21AR081881)"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            697,
            269
          ],
          [
            767,
            269
          ],
          [
            767,
            283
          ],
          [
            697,
            283
          ]
        ],
        "transcription": "Developing an"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            703,
            282
          ],
          [
            764,
            282
          ],
          [
            764,
            296
          ],
          [
            703,
            296
          ]
        ],
        "transcription": "AA Disease"
      },
      {
        "index_in_para": 2,
        "index_para": 4,
        "points": [
          [
            701,
            295
          ],
          [
            764,
            295
          ],
          [
            764,
            314
          ],
          [
            701,
            314
          ]
        ],
        "transcription": "Activity Index"
      },
      {
        "index_in_para": 3,
        "index_para": 4,
        "points": [
          [
            709,
            311
          ],
          [
            759,
            311
          ],
          [
            759,
            326
          ],
          [
            709,
            326
          ]
        ],
        "transcription": "ALADIN)"
      },
      {
        "index_in_para": 4,
        "index_para": 4,
        "points": [
          [
            700,
            326
          ],
          [
            764,
            326
          ],
          [
            764,
            339
          ],
          [
            700,
            339
          ]
        ],
        "transcription": "(U01AR087173"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            248,
            273
          ],
          [
            307,
            273
          ],
          [
            307,
            287
          ],
          [
            248,
            287
          ]
        ],
        "transcription": "Founding of"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            247,
            283
          ],
          [
            308,
            286
          ],
          [
            307,
            305
          ],
          [
            246,
            301
          ]
        ],
        "transcription": "AA Registry"
      },
      {
        "index_in_para": 2,
        "index_para": 5,
        "points": [
          [
            250,
            298
          ],
          [
            304,
            301
          ],
          [
            303,
            317
          ],
          [
            249,
            313
          ]
        ],
        "transcription": "CUMC site"
      },
      {
        "index_in_para": 3,
        "index_para": 5,
        "points": [
          [
            244,
            315
          ],
          [
            307,
            315
          ],
          [
            307,
            328
          ],
          [
            244,
            328
          ]
        ],
        "transcription": "(NCT00089589"
      },
      {
        "index_in_para": 4,
        "index_para": 5,
        "points": [
          [
            242,
            327
          ],
          [
            308,
            324
          ],
          [
            308,
            339
          ],
          [
            243,
            342
          ]
        ],
        "transcription": "NOAR082279"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            541,
            279
          ],
          [
            597,
            279
          ],
          [
            597,
            298
          ],
          [
            541,
            298
          ]
        ],
        "transcription": "Open label"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            541,
            294
          ],
          [
            597,
            294
          ],
          [
            597,
            312
          ],
          [
            541,
            312
          ]
        ],
        "transcription": "ctinicaltrial"
      },
      {
        "index_in_para": 2,
        "index_para": 6,
        "points": [
          [
            539,
            308
          ],
          [
            603,
            308
          ],
          [
            603,
            327
          ],
          [
            539,
            327
          ]
        ],
        "transcription": "for Abatacept"
      },
      {
        "index_in_para": 3,
        "index_para": 6,
        "points": [
          [
            543,
            323
          ],
          [
            601,
            323
          ],
          [
            601,
            338
          ],
          [
            543,
            338
          ]
        ],
        "transcription": "NCT02018042"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            472,
            282
          ],
          [
            511,
            282
          ],
          [
            511,
            296
          ],
          [
            472,
            296
          ]
        ],
        "transcription": "RCTof"
      },
      {
        "index_in_para": 1,
        "index_para": 7,
        "points": [
          [
            463,
            296
          ],
          [
            520,
            296
          ],
          [
            520,
            311
          ],
          [
            463,
            311
          ]
        ],
        "transcription": "intralesional"
      },
      {
        "index_in_para": 2,
        "index_para": 7,
        "points": [
          [
            461,
            311
          ],
          [
            521,
            311
          ],
          [
            521,
            326
          ],
          [
            461,
            326
          ]
        ],
        "transcription": "triamcinolone"
      },
      {
        "index_in_para": 3,
        "index_para": 7,
        "points": [
          [
            461,
            324
          ],
          [
            521,
            324
          ],
          [
            521,
            339
          ],
          [
            461,
            339
          ]
        ],
        "transcription": "(NCT0189880"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            623,
            282
          ],
          [
            676,
            282
          ],
          [
            676,
            296
          ],
          [
            623,
            296
          ]
        ],
        "transcription": "Open label"
      },
      {
        "index_in_para": 1,
        "index_para": 8,
        "points": [
          [
            621,
            294
          ],
          [
            677,
            294
          ],
          [
            677,
            312
          ],
          [
            621,
            312
          ]
        ],
        "transcription": "ctinicaltrial"
      },
      {
        "index_in_para": 2,
        "index_para": 8,
        "points": [
          [
            619,
            310
          ],
          [
            681,
            310
          ],
          [
            681,
            324
          ],
          [
            619,
            324
          ]
        ],
        "transcription": "for Ruxolitinib"
      },
      {
        "index_in_para": 3,
        "index_para": 8,
        "points": [
          [
            620,
            323
          ],
          [
            680,
            323
          ],
          [
            680,
            338
          ],
          [
            620,
            338
          ]
        ],
        "transcription": "NCTO1950780"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            827,
            282
          ],
          [
            880,
            282
          ],
          [
            880,
            296
          ],
          [
            827,
            296
          ]
        ],
        "transcription": "Openlabel"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            825,
            295
          ],
          [
            880,
            295
          ],
          [
            880,
            310
          ],
          [
            825,
            310
          ]
        ],
        "transcription": "clinical trial"
      },
      {
        "index_in_para": 2,
        "index_para": 9,
        "points": [
          [
            818,
            309
          ],
          [
            885,
            305
          ],
          [
            886,
            324
          ],
          [
            819,
            327
          ]
        ],
        "transcription": "for Tofacitinib"
      },
      {
        "index_in_para": 3,
        "index_para": 9,
        "points": [
          [
            824,
            323
          ],
          [
            881,
            323
          ],
          [
            881,
            338
          ],
          [
            824,
            338
          ]
        ],
        "transcription": "NCT02299297"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            936,
            289
          ],
          [
            1000,
            289
          ],
          [
            1000,
            303
          ],
          [
            936,
            303
          ]
        ],
        "transcription": "Publication of"
      },
      {
        "index_in_para": 1,
        "index_para": 10,
        "points": [
          [
            939,
            303
          ],
          [
            1000,
            303
          ],
          [
            1000,
            318
          ],
          [
            939,
            318
          ]
        ],
        "transcription": "Clinical Trials"
      },
      {
        "index_in_para": 2,
        "index_para": 10,
        "points": [
          [
            939,
            318
          ],
          [
            1005,
            318
          ],
          [
            1005,
            332
          ],
          [
            939,
            332
          ]
        ],
        "transcription": "NCTO1950780)"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            279,
            404
          ],
          [
            347,
            405
          ],
          [
            346,
            420
          ],
          [
            279,
            418
          ]
        ],
        "transcription": "First genome-"
      },
      {
        "index_in_para": 1,
        "index_para": 11,
        "points": [
          [
            284,
            420
          ],
          [
            344,
            420
          ],
          [
            344,
            434
          ],
          [
            284,
            434
          ]
        ],
        "transcription": "widelinkage"
      },
      {
        "index_in_para": 2,
        "index_para": 11,
        "points": [
          [
            287,
            433
          ],
          [
            343,
            433
          ],
          [
            343,
            451
          ],
          [
            287,
            451
          ]
        ],
        "transcription": "study of AA"
      },
      {
        "index_in_para": 3,
        "index_para": 11,
        "points": [
          [
            284,
            444
          ],
          [
            346,
            448
          ],
          [
            345,
            462
          ],
          [
            284,
            459
          ]
        ],
        "transcription": "(RO1AR52579)"
      },
      {
        "index_in_para": 4,
        "index_para": 11,
        "points": [
          [
            273,
            465
          ],
          [
            360,
            465
          ],
          [
            360,
            478
          ],
          [
            273,
            478
          ]
        ],
        "transcription": "(Martinex-Miret al."
      },
      {
        "index_in_para": 5,
        "index_para": 11,
        "points": [
          [
            276,
            478
          ],
          [
            352,
            478
          ],
          [
            352,
            491
          ],
          [
            276,
            491
          ]
        ],
        "transcription": "Am J Hum Genet"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            669,
            406
          ],
          [
            697,
            406
          ],
          [
            697,
            421
          ],
          [
            669,
            421
          ]
        ],
        "transcription": "First"
      },
      {
        "index_in_para": 1,
        "index_para": 12,
        "points": [
          [
            643,
            421
          ],
          [
            724,
            419
          ],
          [
            724,
            434
          ],
          [
            643,
            436
          ]
        ],
        "transcription": "demonstration of"
      },
      {
        "index_in_para": 2,
        "index_para": 12,
        "points": [
          [
            649,
            435
          ],
          [
            716,
            435
          ],
          [
            716,
            450
          ],
          [
            649,
            450
          ]
        ],
        "transcription": "JAK inhibitors"
      },
      {
        "index_in_para": 3,
        "index_para": 12,
        "points": [
          [
            648,
            450
          ],
          [
            719,
            450
          ],
          [
            719,
            465
          ],
          [
            648,
            465
          ]
        ],
        "transcription": "reversingAA in"
      },
      {
        "index_in_para": 4,
        "index_para": 12,
        "points": [
          [
            641,
            465
          ],
          [
            724,
            465
          ],
          [
            724,
            479
          ],
          [
            641,
            479
          ]
        ],
        "transcription": "mice and humans"
      },
      {
        "index_in_para": 5,
        "index_para": 12,
        "points": [
          [
            652,
            478
          ],
          [
            716,
            478
          ],
          [
            716,
            491
          ],
          [
            652,
            491
          ]
        ],
        "transcription": "(R01AR058018)"
      },
      {
        "index_in_para": 0,
        "index_para": 13,
        "points": [
          [
            371,
            409
          ],
          [
            427,
            409
          ],
          [
            427,
            422
          ],
          [
            371,
            422
          ]
        ],
        "transcription": "First GWAS"
      },
      {
        "index_in_para": 1,
        "index_para": 13,
        "points": [
          [
            371,
            422
          ],
          [
            427,
            422
          ],
          [
            427,
            437
          ],
          [
            371,
            437
          ]
        ],
        "transcription": "Study in AA"
      },
      {
        "index_in_para": 2,
        "index_para": 13,
        "points": [
          [
            365,
            435
          ],
          [
            431,
            435
          ],
          [
            431,
            449
          ],
          [
            365,
            449
          ]
        ],
        "transcription": "(RO1AR05801e)"
      },
      {
        "index_in_para": 3,
        "index_para": 13,
        "points": [
          [
            368,
            451
          ],
          [
            432,
            451
          ],
          [
            432,
            465
          ],
          [
            368,
            465
          ]
        ],
        "transcription": "(Petukhovaet"
      },
      {
        "index_in_para": 4,
        "index_para": 13,
        "points": [
          [
            360,
            465
          ],
          [
            435,
            465
          ],
          [
            435,
            478
          ],
          [
            360,
            478
          ]
        ],
        "transcription": "al.Nature 2010"
      },
      {
        "index_in_para": 0,
        "index_para": 14,
        "points": [
          [
            743,
            409
          ],
          [
            809,
            409
          ],
          [
            809,
            424
          ],
          [
            743,
            424
          ]
        ],
        "transcription": "FirstAA meta-"
      },
      {
        "index_in_para": 1,
        "index_para": 14,
        "points": [
          [
            741,
            418
          ],
          [
            812,
            421
          ],
          [
            811,
            440
          ],
          [
            740,
            437
          ]
        ],
        "transcription": "GWAS, higher"
      },
      {
        "index_in_para": 2,
        "index_para": 14,
        "points": [
          [
            745,
            438
          ],
          [
            807,
            438
          ],
          [
            807,
            451
          ],
          [
            745,
            451
          ]
        ],
        "transcription": "resolution of"
      },
      {
        "index_in_para": 3,
        "index_para": 14,
        "points": [
          [
            751,
            451
          ],
          [
            804,
            451
          ],
          [
            804,
            466
          ],
          [
            751,
            466
          ]
        ],
        "transcription": "HLA locus"
      },
      {
        "index_in_para": 4,
        "index_para": 14,
        "points": [
          [
            743,
            465
          ],
          [
            809,
            465
          ],
          [
            809,
            478
          ],
          [
            743,
            478
          ]
        ],
        "transcription": "(R01AR05801"
      },
      {
        "index_in_para": 0,
        "index_para": 15,
        "points": [
          [
            905,
            409
          ],
          [
            976,
            409
          ],
          [
            976,
            424
          ],
          [
            905,
            424
          ]
        ],
        "transcription": "First functional"
      },
      {
        "index_in_para": 1,
        "index_para": 15,
        "points": [
          [
            916,
            425
          ],
          [
            967,
            425
          ],
          [
            967,
            438
          ],
          [
            916,
            438
          ]
        ],
        "transcription": "genomics"
      },
      {
        "index_in_para": 2,
        "index_para": 15,
        "points": [
          [
            915,
            438
          ],
          [
            968,
            438
          ],
          [
            968,
            453
          ],
          [
            915,
            453
          ]
        ],
        "transcription": "study in AA"
      },
      {
        "index_in_para": 3,
        "index_para": 15,
        "points": [
          [
            911,
            453
          ],
          [
            973,
            453
          ],
          [
            973,
            467
          ],
          [
            911,
            467
          ]
        ],
        "transcription": "(startedJuly)"
      },
      {
        "index_in_para": 4,
        "index_para": 15,
        "points": [
          [
            909,
            467
          ],
          [
            973,
            467
          ],
          [
            973,
            480
          ],
          [
            909,
            480
          ]
        ],
        "transcription": "(R01AR085983)"
      },
      {
        "index_in_para": 0,
        "index_para": 16,
        "points": [
          [
            833,
            412
          ],
          [
            904,
            412
          ],
          [
            904,
            426
          ],
          [
            833,
            426
          ]
        ],
        "transcription": "First systems"
      },
      {
        "index_in_para": 1,
        "index_para": 16,
        "points": [
          [
            841,
            426
          ],
          [
            895,
            426
          ],
          [
            895,
            441
          ],
          [
            841,
            441
          ]
        ],
        "transcription": "level gene"
      },
      {
        "index_in_para": 2,
        "index_para": 16,
        "points": [
          [
            828,
            442
          ],
          [
            907,
            442
          ],
          [
            907,
            455
          ],
          [
            828,
            455
          ]
        ],
        "transcription": "expression study"
      },
      {
        "index_in_para": 3,
        "index_para": 16,
        "points": [
          [
            853,
            454
          ],
          [
            881,
            454
          ],
          [
            881,
            469
          ],
          [
            853,
            469
          ]
        ],
        "transcription": "ofAA"
      },
      {
        "index_in_para": 4,
        "index_para": 16,
        "points": [
          [
            835,
            469
          ],
          [
            903,
            469
          ],
          [
            903,
            482
          ],
          [
            835,
            482
          ]
        ],
        "transcription": "(R21AR081881)"
      },
      {
        "index_in_para": 5,
        "index_para": 16,
        "points": [
          [
            831,
            483
          ],
          [
            901,
            482
          ],
          [
            901,
            496
          ],
          [
            831,
            498
          ]
        ],
        "transcription": "(Chenet al, Cell"
      },
      {
        "index_in_para": 6,
        "index_para": 16,
        "points": [
          [
            832,
            496
          ],
          [
            898,
            495
          ],
          [
            899,
            509
          ],
          [
            832,
            511
          ]
        ],
        "transcription": "Systems 2015)"
      },
      {
        "index_in_para": 0,
        "index_para": 17,
        "points": [
          [
            748,
            495
          ],
          [
            800,
            495
          ],
          [
            800,
            510
          ],
          [
            748,
            510
          ]
        ],
        "transcription": "(Betzetal,"
      },
      {
        "index_in_para": 1,
        "index_para": 17,
        "points": [
          [
            743,
            508
          ],
          [
            808,
            508
          ],
          [
            808,
            521
          ],
          [
            743,
            521
          ]
        ],
        "transcription": "NatureComm"
      },
      {
        "index_in_para": 0,
        "index_para": 18,
        "points": [
          [
            657,
            502
          ],
          [
            708,
            502
          ],
          [
            708,
            516
          ],
          [
            657,
            516
          ]
        ],
        "transcription": "Kingetal,"
      },
      {
        "index_in_para": 1,
        "index_para": 18,
        "points": [
          [
            655,
            514
          ],
          [
            711,
            514
          ],
          [
            711,
            527
          ],
          [
            655,
            527
          ]
        ],
        "transcription": "NatureMed"
      },
      {
        "index_in_para": 0,
        "index_para": 19,
        "points": [
          [
            247,
            581
          ],
          [
            424,
            581
          ],
          [
            424,
            598
          ],
          [
            247,
            598
          ]
        ],
        "transcription": "Basic and Preclinical"
      },
      {
        "index_in_para": 1,
        "index_para": 19,
        "points": [
          [
            247,
            605
          ],
          [
            342,
            608
          ],
          [
            341,
            626
          ],
          [
            246,
            623
          ]
        ],
        "transcription": "Milestones"
      },
      {
        "index_in_para": 0,
        "index_para": 20,
        "points": [
          [
            892,
            626
          ],
          [
            988,
            626
          ],
          [
            988,
            639
          ],
          [
            892,
            639
          ]
        ],
        "transcription": "Translational Stucies"
      },
      {
        "index_in_para": 0,
        "index_para": 21,
        "points": [
          [
            892,
            649
          ],
          [
            955,
            649
          ],
          [
            955,
            663
          ],
          [
            892,
            663
          ]
        ],
        "transcription": "Clinical Trials"
      },
      {
        "index_in_para": 1,
        "index_para": 21,
        "points": [
          [
            881,
            671
          ],
          [
            986,
            677
          ],
          [
            985,
            696
          ],
          [
            880,
            690
          ]
        ],
        "transcription": "Key Partnerships"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3254450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            325,
            513
          ],
          [
            939,
            513
          ],
          [
            939,
            592
          ],
          [
            325,
            592
          ]
        ],
        "transcription": "AACORT"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            344,
            593
          ],
          [
            904,
            593
          ],
          [
            904,
            611
          ],
          [
            344,
            611
          ]
        ],
        "transcription": "AlopeciaAreata Center of Research Translation"
      },
      {
        "index_in_para": 2,
        "index_para": 0,
        "points": [
          [
            488,
            619
          ],
          [
            753,
            619
          ],
          [
            753,
            638
          ],
          [
            488,
            638
          ]
        ],
        "transcription": "at Columbia University"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            740,
            654
          ],
          [
            983,
            654
          ],
          [
            983,
            676
          ],
          [
            740,
            676
          ]
        ],
        "transcription": "NIAMS P5OAR070588-01"
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3317450.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            253,
            50
          ],
          [
            1019,
            50
          ],
          [
            1019,
            82
          ],
          [
            253,
            82
          ]
        ],
        "transcription": "Reengineering Translational Science: The Time is Right"
      },
      {
        "index_in_para": 1,
        "index_para": 0,
        "points": [
          [
            251,
            90
          ],
          [
            649,
            89
          ],
          [
            649,
            111
          ],
          [
            251,
            113
          ]
        ],
        "transcription": "Francis Collins, Sci.Trans.Med.3: 1-6.2011"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            275,
            179
          ],
          [
            1001,
            180
          ],
          [
            1001,
            203
          ],
          [
            275,
            201
          ]
        ],
        "transcription": "Table 1.The GWAS potential.GWAS*can reveal new therapeutic targets for complex diseases"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            273,
            243
          ],
          [
            343,
            247
          ],
          [
            342,
            270
          ],
          [
            272,
            267
          ]
        ],
        "transcription": "Disease"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            555,
            243
          ],
          [
            733,
            245
          ],
          [
            733,
            267
          ],
          [
            555,
            266
          ]
        ],
        "transcription": "GWAS hits associated"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            557,
            274
          ],
          [
            736,
            274
          ],
          [
            736,
            292
          ],
          [
            557,
            292
          ]
        ],
        "transcription": "with marketed drugst"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            415,
            245
          ],
          [
            512,
            245
          ],
          [
            512,
            267
          ],
          [
            415,
            267
          ]
        ],
        "transcription": "TotalGWAS"
      },
      {
        "index_in_para": 1,
        "index_para": 4,
        "points": [
          [
            415,
            271
          ],
          [
            459,
            271
          ],
          [
            459,
            294
          ],
          [
            415,
            294
          ]
        ],
        "transcription": "hitst"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            785,
            245
          ],
          [
            961,
            245
          ],
          [
            961,
            267
          ],
          [
            785,
            267
          ]
        ],
        "transcription": "GWAS hits associated"
      },
      {
        "index_in_para": 1,
        "index_para": 5,
        "points": [
          [
            785,
            274
          ],
          [
            932,
            274
          ],
          [
            932,
            292
          ],
          [
            785,
            292
          ]
        ],
        "transcription": "with drug effectss"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            275,
            310
          ],
          [
            327,
            310
          ],
          [
            327,
            330
          ],
          [
            275,
            330
          ]
        ],
        "transcription": "Type2"
      },
      {
        "index_in_para": 1,
        "index_para": 6,
        "points": [
          [
            275,
            334
          ],
          [
            343,
            334
          ],
          [
            343,
            355
          ],
          [
            275,
            355
          ]
        ],
        "transcription": "diabetes"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            275,
            368
          ],
          [
            391,
            368
          ],
          [
            391,
            390
          ],
          [
            275,
            390
          ]
        ],
        "transcription": "Hyperlipidemia"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            275,
            404
          ],
          [
            407,
            404
          ],
          [
            407,
            424
          ],
          [
            275,
            424
          ]
        ],
        "transcription": "Multiple sclerosis"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            275,
            442
          ],
          [
            340,
            442
          ],
          [
            340,
            462
          ],
          [
            275,
            462
          ]
        ],
        "transcription": "Psoriasis"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            263,
            487
          ],
          [
            429,
            487
          ],
          [
            429,
            514
          ],
          [
            263,
            514
          ]
        ],
        "transcription": "Alopecia Areata"
      },
      {
        "index_in_para": 0,
        "index_para": 11,
        "points": [
          [
            585,
            492
          ],
          [
            969,
            492
          ],
          [
            969,
            511
          ],
          [
            585,
            511
          ]
        ],
        "transcription": "abataceptCTLA4-Ig), jakafiJak1i, xeljanzJak3i"
      },
      {
        "index_in_para": 0,
        "index_para": 12,
        "points": [
          [
            277,
            548
          ],
          [
            1001,
            548
          ],
          [
            1001,
            565
          ],
          [
            277,
            565
          ]
        ],
        "transcription": "*Genome-wide association studies (GWAS) assume no knowledge of disease pathogenesis and provide a comprehensive"
      },
      {
        "index_in_para": 1,
        "index_para": 12,
        "points": [
          [
            275,
            572
          ],
          [
            1000,
            572
          ],
          [
            1000,
            589
          ],
          [
            275,
            589
          ]
        ],
        "transcription": "approach to the discovery of common genetic risk factors Many known drug targets and associated pathways appear on the"
      },
      {
        "index_in_para": 2,
        "index_para": 12,
        "points": [
          [
            275,
            594
          ],
          [
            999,
            594
          ],
          [
            999,
            611
          ],
          [
            275,
            611
          ]
        ],
        "transcription": "list of GWAS hits for common diseases, suggesting that other GWAS hits likely represent\"druggable targets worthy of further"
      },
      {
        "index_in_para": 3,
        "index_para": 12,
        "points": [
          [
            275,
            618
          ],
          [
            1000,
            618
          ],
          [
            1000,
            635
          ],
          [
            275,
            635
          ]
        ],
        "transcription": "investigation. Genetic variants strongly linked to disease susceptibility.Genetic variants that are primary targets of drugs"
      },
      {
        "index_in_para": 4,
        "index_para": 12,
        "points": [
          [
            275,
            641
          ],
          [
            1000,
            641
          ],
          [
            1000,
            658
          ],
          [
            275,
            658
          ]
        ],
        "transcription": "currently marketed for the listed indication. SGenetic variants associated with cellular, pharmacokinetic, pharmacodynamic,"
      },
      {
        "index_in_para": 5,
        "index_para": 12,
        "points": [
          [
            273,
            664
          ],
          [
            844,
            664
          ],
          [
            844,
            682
          ],
          [
            273,
            682
          ]
        ],
        "transcription": "or clinical variations in response to one or more drugs currently marketed for thelisted indication."
      }
    ]
  },
  {
    "check": "paddleocr+check",
    "name": "NIH-EC45B-3340000.jpg",
    "ocr_data": [
      {
        "index_in_para": 0,
        "index_para": 0,
        "points": [
          [
            427,
            26
          ],
          [
            839,
            31
          ],
          [
            838,
            72
          ],
          [
            427,
            67
          ]
        ],
        "transcription": "Acknowledgements"
      },
      {
        "index_in_para": 0,
        "index_para": 1,
        "points": [
          [
            660,
            95
          ],
          [
            816,
            95
          ],
          [
            816,
            118
          ],
          [
            660,
            118
          ]
        ],
        "transcription": "Lynn Petukhova"
      },
      {
        "index_in_para": 1,
        "index_para": 1,
        "points": [
          [
            659,
            119
          ],
          [
            795,
            125
          ],
          [
            794,
            149
          ],
          [
            658,
            143
          ]
        ],
        "transcription": "Claire Higgins"
      },
      {
        "index_in_para": 2,
        "index_para": 1,
        "points": [
          [
            661,
            152
          ],
          [
            787,
            152
          ],
          [
            787,
            175
          ],
          [
            661,
            175
          ]
        ],
        "transcription": "Colin Jahoda"
      },
      {
        "index_in_para": 3,
        "index_para": 1,
        "points": [
          [
            659,
            180
          ],
          [
            819,
            183
          ],
          [
            818,
            205
          ],
          [
            659,
            202
          ]
        ],
        "transcription": "Peter Gregersen"
      },
      {
        "index_in_para": 4,
        "index_para": 1,
        "points": [
          [
            660,
            209
          ],
          [
            805,
            209
          ],
          [
            805,
            232
          ],
          [
            660,
            232
          ]
        ],
        "transcription": "David Altshuler"
      },
      {
        "index_in_para": 5,
        "index_para": 1,
        "points": [
          [
            661,
            235
          ],
          [
            755,
            238
          ],
          [
            754,
            262
          ],
          [
            660,
            259
          ]
        ],
        "transcription": "Mark Daly"
      },
      {
        "index_in_para": 6,
        "index_para": 1,
        "points": [
          [
            660,
            266
          ],
          [
            861,
            269
          ],
          [
            861,
            291
          ],
          [
            660,
            288
          ]
        ],
        "transcription": "Abraham Zlotogorski"
      },
      {
        "index_in_para": 7,
        "index_para": 1,
        "points": [
          [
            661,
            296
          ],
          [
            776,
            296
          ],
          [
            776,
            319
          ],
          [
            661,
            319
          ]
        ],
        "transcription": "Regina Betz"
      },
      {
        "index_in_para": 8,
        "index_para": 1,
        "points": [
          [
            660,
            323
          ],
          [
            807,
            326
          ],
          [
            806,
            348
          ],
          [
            660,
            345
          ]
        ],
        "transcription": "Marcus Nothen"
      },
      {
        "index_in_para": 9,
        "index_para": 1,
        "points": [
          [
            661,
            353
          ],
          [
            801,
            353
          ],
          [
            801,
            376
          ],
          [
            661,
            376
          ]
        ],
        "transcription": "James Januzzi"
      },
      {
        "index_in_para": 10,
        "index_para": 1,
        "points": [
          [
            663,
            385
          ],
          [
            773,
            385
          ],
          [
            773,
            404
          ],
          [
            663,
            404
          ]
        ],
        "transcription": "Jane Cerise"
      },
      {
        "index_in_para": 11,
        "index_para": 1,
        "points": [
          [
            660,
            410
          ],
          [
            769,
            410
          ],
          [
            769,
            433
          ],
          [
            660,
            433
          ]
        ],
        "transcription": "Esther Drill"
      },
      {
        "index_in_para": 12,
        "index_para": 1,
        "points": [
          [
            659,
            439
          ],
          [
            815,
            441
          ],
          [
            815,
            463
          ],
          [
            659,
            462
          ]
        ],
        "transcription": "Andrea Califano"
      },
      {
        "index_in_para": 0,
        "index_para": 2,
        "points": [
          [
            299,
            100
          ],
          [
            468,
            103
          ],
          [
            468,
            130
          ],
          [
            299,
            127
          ]
        ],
        "transcription": "Raphael Clynes"
      },
      {
        "index_in_para": 1,
        "index_para": 2,
        "points": [
          [
            303,
            134
          ],
          [
            537,
            136
          ],
          [
            537,
            163
          ],
          [
            303,
            160
          ]
        ],
        "transcription": "Julian Mackay-Wiggan"
      },
      {
        "index_in_para": 2,
        "index_para": 2,
        "points": [
          [
            300,
            165
          ],
          [
            452,
            167
          ],
          [
            452,
            189
          ],
          [
            300,
            188
          ]
        ],
        "transcription": "Madeleine Duvic"
      },
      {
        "index_in_para": 3,
        "index_para": 2,
        "points": [
          [
            299,
            193
          ],
          [
            445,
            196
          ],
          [
            445,
            219
          ],
          [
            299,
            216
          ]
        ],
        "transcription": "Maria Hordinsky"
      },
      {
        "index_in_para": 4,
        "index_para": 2,
        "points": [
          [
            301,
            221
          ],
          [
            396,
            224
          ],
          [
            395,
            248
          ],
          [
            300,
            245
          ]
        ],
        "transcription": "Vera Price"
      },
      {
        "index_in_para": 5,
        "index_para": 2,
        "points": [
          [
            300,
            253
          ],
          [
            413,
            253
          ],
          [
            413,
            275
          ],
          [
            300,
            275
          ]
        ],
        "transcription": "David Norris"
      },
      {
        "index_in_para": 0,
        "index_para": 3,
        "points": [
          [
            300,
            310
          ],
          [
            472,
            312
          ],
          [
            472,
            335
          ],
          [
            300,
            332
          ]
        ],
        "transcription": "Annemieke deJong"
      },
      {
        "index_in_para": 1,
        "index_para": 3,
        "points": [
          [
            298,
            336
          ],
          [
            430,
            339
          ],
          [
            429,
            367
          ],
          [
            297,
            364
          ]
        ],
        "transcription": "Zhenpeng Dai"
      },
      {
        "index_in_para": 2,
        "index_para": 3,
        "points": [
          [
            300,
            368
          ],
          [
            396,
            368
          ],
          [
            396,
            390
          ],
          [
            300,
            390
          ]
        ],
        "transcription": "Ali Jabbari"
      },
      {
        "index_in_para": 3,
        "index_para": 3,
        "points": [
          [
            299,
            394
          ],
          [
            414,
            397
          ],
          [
            413,
            421
          ],
          [
            298,
            418
          ]
        ],
        "transcription": "Luzhou Xing"
      },
      {
        "index_in_para": 0,
        "index_para": 4,
        "points": [
          [
            316,
            430
          ],
          [
            381,
            430
          ],
          [
            381,
            449
          ],
          [
            316,
            449
          ]
        ],
        "transcription": "LocksoiLWv"
      },
      {
        "index_in_para": 0,
        "index_para": 5,
        "points": [
          [
            768,
            511
          ],
          [
            945,
            511
          ],
          [
            945,
            529
          ],
          [
            768,
            529
          ]
        ],
        "transcription": "American Skin Association"
      },
      {
        "index_in_para": 0,
        "index_para": 6,
        "points": [
          [
            428,
            525
          ],
          [
            538,
            528
          ],
          [
            537,
            548
          ],
          [
            428,
            545
          ]
        ],
        "transcription": "AAlnitiative"
      },
      {
        "index_in_para": 0,
        "index_para": 7,
        "points": [
          [
            589,
            531
          ],
          [
            684,
            531
          ],
          [
            684,
            623
          ],
          [
            589,
            623
          ]
        ],
        "transcription": "DE"
      },
      {
        "index_in_para": 0,
        "index_para": 8,
        "points": [
          [
            308,
            585
          ],
          [
            449,
            585
          ],
          [
            449,
            617
          ],
          [
            308,
            617
          ]
        ],
        "transcription": "NYSTEM"
      },
      {
        "index_in_para": 0,
        "index_para": 9,
        "points": [
          [
            769,
            595
          ],
          [
            980,
            587
          ],
          [
            982,
            643
          ],
          [
            771,
            650
          ]
        ],
        "transcription": "NYSTAR"
      },
      {
        "index_in_para": 1,
        "index_para": 9,
        "points": [
          [
            736,
            647
          ],
          [
            1005,
            649
          ],
          [
            1005,
            667
          ],
          [
            736,
            666
          ]
        ],
        "transcription": "New York State Foundation for Science,"
      },
      {
        "index_in_para": 2,
        "index_para": 9,
        "points": [
          [
            779,
            666
          ],
          [
            968,
            666
          ],
          [
            968,
            683
          ],
          [
            779,
            683
          ]
        ],
        "transcription": "Technology and Innovation"
      },
      {
        "index_in_para": 0,
        "index_para": 10,
        "points": [
          [
            315,
            656
          ],
          [
            695,
            658
          ],
          [
            695,
            680
          ],
          [
            315,
            679
          ]
        ],
        "transcription": "NATIONALALOPECIAAREATA FOUNDATIOI"
      }
    ]
  }
]